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A dense cloud of all positions (330,000) of the center-of-mass of CO sampled
via TAMD simulations is shown (panel a) along with 635 unique positions/centers used for mean-force calculations (panel b). The protein backbone is
shown as a white cartoon, and points representing the center-of-mass positions
of CO are colored from red to blue corresponding to an increasing distance
from the H-cluster (shown in a black space-filling representation). . . . . . .
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33

(a) The front and side views of the free-energy isosurfaces for CO diffusion are
shown at three different energy levels: 4 kcal/mol (red), 8 kcal/mol (green),
and 12 kcal/mol (blue). (b) The locations of 44 local minima, the global
minimum (labeled G), the Xenon cavity (labeled Xe), and the 2Fe subcluster
(black sticks) are shown. The minima with the free-energy values higher
than 12 kcal/mol (cyan spheres) are also labeled. (c) Isosurfaces at three
different energy levels and associated local minima are shown: red spheres
(0-4 kcal/mol), green spheres (4-8 kcal/mol), and blue spheres (8-12 kcal/mol). 34

3.4

(a) Front and back views of MFEPs for CO diffusion are depicted on the structure of the FeFe-hydrogenase along with the positions of all minima (indicated
by spheres). (b) The MFEPs for CO diffusion from the other local minima to
the local minimum 7 are shown. (c) The MFEPs for CO diffusion within 0-18
Å (leftmost panel), 18-25 Å (middle panel), and over 25 Å (rightmost panel)
of the local minimum 7 are shown. All local minima, the global minimum,
and the Xe cavity are labeled as in Figure 3.3. The locations of the energy
barriers are shown by transparent magenta spheres in panels b and c. . . . .
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3.5

Locations of the minima for CO (filled spheres) and O2 (wireframe spheres)
diffusion in the CpI FeFe-hydrogenase are shown. The global minimum for
both gases are shown in black filled or wireframe spheres and are labeled (G
for CO and G-O2 for O2 ). The Xenon cavity is shown as a pink sphere and
labeled as Xe. For CO, colors of other minima are consistent with Figure 3.4:
red (0-4 kcal/mol), green (4-8 kcal/mol), blue (8-12 kcal/mol), and cyan (over
12 kcal/mol). For O2 , colors of minima indicate the following energy ranges:
red (0-12 kcal/mol), green (12-16 kcal/mol), and blue (over 16 kcal/mol). . .
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(A) The molecular structure of the PAP channel is shown with the central
pillar-arene ring (brown sticks) and the peptide arms (transparent gray sticks).
(B, C, D, and E) Shown are the top-views of four simulation systems in two
types of membranes (panels B and C, POPC; and panels D and E, PB-PEO).
All molecules are shown in space-filling representations: PAP (black), POPC
and PEO chains (white), and PB chains (gray). Water molecules are not
shown for clarity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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48

Snapshots from one of the three MD runs highlighting the evolution of each
system at different time points are shown. All panels are labeled, where
panels A and B correspond to systems with 2 PAP channels and panels C
and D correspond to systems with 4 PAP channels. All PAP channels and
membrane molecules are shown in black and gray wireframe representations,
respectively. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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4.3

The evolution of interfacial buried surface area (BSA) vs. simulation time (ns)
between pairs of PAP channels from three independent runs is shown. Data
shown in panels on the left correspond to systems in the POPC membrane,
while that on the right correspond to systems in the PB-PEO membrane. The
pair of PAP channels for which the BSA is reported are highlighted by filled
black circles on the top left corner of each panel. For systems with 4 PAP
channels, BSA data are reported for adjacent as well as diagonally opposite
channels. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Probability distributions of the data on the orientational angles (θ) of PAP
channels are shown for all four systems (panels A and B, systems in the POPC
membrane; and panels C and D, systems in the PB-PEO membrane). The
distributions included data on θ values computed from three independent runs.
The traces in black indicate the Gaussian functions fitted to describe the data
in distributions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Data similar to Figure 4 are shown for the distributions of RMSD of PAP
channels in all four systems. The distributions included data on RMSD values
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The 2D number density maps for the hydrophobic tails of lipids or hydrophobic
(PB) blocks of BCP membranes are shown. Panels A and B are for systems
in the POPC membrane, respectively, and panels C and D are for systems in
the PB-PEO membrane. Blue to red color indicates lower to higher values of
the number density (ranging between 0 and 150 Å−3 for the POPC membrane
and between 0 and 80 Å−3 for the PB-PEO membrane).
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Probability distributions of the data on the number of hydrogen bonds (NH )
between the PAP channel and the surrounding POPC or PB-PEO matrix are
shown for all four systems (panels A and B, systems in the POPC membrane;
and panels C and D, systems in the PB-PEO membrane). The distributions
included data on NH averaged over all PAP channels and three independent
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Free-energy profiles of channel dimerization in each membrane (panel A,
POPC; and panel B, PB-PEO) are plotted against the chosen collective variable (dCV ). The free-energy scale is plotted to have the free-energy minimum
in each profile corresponding to a free energy value of zero. Shown also are
side-view snapshots of both PAP channels at the free-energy minima (labeled
1 and 10 ) and at the free-energy barrier (labeled 2 and 20 ) to dissociation. The
central pillar[5]arene rings are colored as yellow or green spheres, the backbone of the peptide arms of each channel is colored as cyan or magenta sticks,
and the aromatic rings in each peptide arm are colored in blue sticks. The
corresponding top-views of channel snapshots are shown in Figure D.7. . . .
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(A) The channel volume selected for measuring the number of water molecules
(Nw ) is highlighted as a transparent cylinder centered around the pillar-arene
ring of the PAP channel. (B and C) Probability distributions of Nw are shown
for 2PAP configurations (panel B) and 4PAP configurations (panel C) in each
membrane. The distributions were computed from data averaged over all PAP
channels and from three independent MD simulations. . . . . . . . . . . . . .
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4.10 Permeability of each PAP channel in both POPC (panel A, 2PAP/POPC; and
panel B, 4PAP/POPC) and PB-PEO (panel C, 2PAP/PB-PEO; and panel D,
4PAP/PB-PEO) membranes. The permeability values for each channel are
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4.11 Snapshots of wetting/dewetting states of a single PAP channel are shown
in the POPC membrane (panel A; wetting states: 105.92 ns and 121.12 ns,
and the dewetting state: 110.92 ns) and in the PB-PEO membrane (panel
B; wetting states: 472.08 and 475.48 ns, and the dewetting state: 473.48
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lipids/BCP molecules via gray lines, neighboring water molecules via cyan
spheres, and water molecules inside channels in van der Waals representations
(oxygen atoms in red and hydrogen atoms in white). . . . . . . . . . . . . .
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Structural similarities and key residues in RGS proteins (A) Shown are the
front and back views of the overlay of structures of five RGS proteins: RGS4
(PDB code 1AGR), RGS8 (PDB code 2ODE), RGS9 (PDB code 1FQI),
RGS17 (PDB code 6AM3), and RGS19 (PDB code 1CMZ). The alignment is
based on the Cα -atoms of the α4-helix. (B) Sequence similarity between RGS
proteins is highlighted. The similarity between a pair of RGS proteins was
computed based upon the sequence alignment (Figure E.2) and residues 52 to
178 (RGS4), 46 to 172 (RGS8), 289 to 414 (RGS9), 74 to 200 (RGS17), and 80
to 206 (RGS19). Shown also are cartoon representations of all RGS proteins,
classified by their subfamily, and highlighting the conserved cysteine residues
(cyan spheres) that are targeted by covalent inhibitors. Six key residues of
each RGS protein that participate in the RGS/Gα protein-protein interface
are shown by colored spheres and labeled. The structures of three known
RGS/Gα complexes are shown in Figure E.3.
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The root mean squared fluctuations (RMSF) per residue are shown based upon
experimental structures (panel A) and MD simulations (panel B). The residue
numbers on the x-axis are for RGS4 (52-178) that correspond to the following
residues in other RGS proteins: 46 to 172 (RGS8), 289 to 414 (RGS9), 74 to
200 (RGS17), and 80-206 (RGS19). . . . . . . . . . . . . . . . . . . . . . . .
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5.3

Conserved salt-bridges in RGS proteins. (A) Four salt-bridges conserved
across 5 RGS proteins are highlighted on the structure of RGS4, a canonical member of the RGS family. The conserved cysteine residue is highlighted
as a cyan sphere and labeled C95. Three key helices connected via inter-helical
salt-bridges are also colored uniquely in cartoon representations: α4 (yellow),
α5 (green), and α7 (magenta). (B) Shown is the percentage occupancy of
conserved salt-bridges computed based on fractional time of the simulation
trajectory during which a given salt-bridge was intact based on a distance
criterion. The subscript “L” in salt-bridge labels for helices indicates a loop
connecting two helices. For example, (α3 /α4 )L signifies the loop connecting
the α3 and α4 helices. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Community network in RGS proteins. The network of communities and their
schematic community maps in RGS proteins, as organized by their subfamily
memberships.The Cα -atoms of residues forming each community are uniquely
colored and mapped on respective protein structures. The communities are
labeled 1 through 7 or 8 in corresponding community schematic maps. The
cumulative edge betweenness is represented as the width of intercommunity
links. Additional details about critical nodes and listing of residue memberships for each community are shown in Tables E.1-E.5. . . . . . . . . . . . .
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Allosteric pathways between source and sink residues. Shown are optimal
pathways from the conserved cysteine residue (cyan sphere) to six sink residues.
Panels A-F depict each of the six pathways on the structure of RGS4 along
with the details of residues for each pathway in all RGS proteins, where the
first residue serves as a source residue and the last residue serves as a sink
residue. See also Figure E.7. Additional pathways originating at a second cysteine residue conserved only among RGS4 and RGS8 are shown in Figure E.8
and discussed in Appendix E. . . . . . . . . . . . . . . . . . . . . . . . . . .
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6.1

(A) Front and back views of the RGS8 structure (PDB code 2ODE) are shown.
(B) Chemical structures of TDZD inhibitors are shown. (C) I1 docked RGS8
systems (left panel: RGS8C89/I1 , RGS8C142/I1 , and RGS8WT/I1 ) and I2 docked
RGS8 systems (right panel: RGS8C89/I2 , RGS8C142/I2 , and RGS8WT/I2 ). . . .
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(A) The calculated difference of RMSF(∆RMSF) and cross-correlation (∆DCC)
maps for RGS8 mutants with the reference of RGS8WT . The color bar values
from -1 to 1 indicate more decreased correlations (darker blue color) to more
increased correlations (darker red color) (B) Community network for RGS8
mutants. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Shown are difference RMSF (∆RMSF) and cross-correlation (∆DCC) maps:
aliphatic inhibitor I1 (left panel) or aromatic I2 (right panel) binding to RGS8
mutants and dual inhibitor occupancy RGS8WT with their corresponding reference structures. The color bar values from -1 to 1 indicate more decreased
correlations (darker blue color) to more increased correlations (darker red color).100

6.5

Shown are the networks of communities and their schematic community maps
for inhibitor I1 (left panel) and I2 (right panel) binding RGS8 mutants and
dual inhibitor occupancy RGS8WT . The communities are labeled 1 through 7,
8, or 9 in the schematic maps. The width of the intercommunity links denotes
the cumulative edge betweenness. The communities where inhibitors located
are labeled with an asterisk. Community network of other systems are shown
in Figures 6.2 and 6.3. Critical nodes connecting communities are shown in
Figure F.3, and residue memberships are shown in Tables F.1- F.9. . . . . . 101
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α7-helix. Vertical lines are BSAs from the crystal structure. The plots are
shown both for the probability values (P) in distributions and for cumulative
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Probability distributions of solvent accessible surface area of inhibitors I1
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7.1

Dynamics and stability of the crystal structure of the PDE6 GAFab homodimer as characterized by various conformational metrics. (A) Cartoon representation of the X-ray structure with color scheme for the subdomains [Nterminal region of GAFa (N-GAFa or α1, residues 55-74), GAFa (residues
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various domains of the homodimer. Vertical lines marked on distributions
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MD simulations of the apo and cGMP-bound states of GAFab. Differences
in the root mean squared fluctuations (∆RMSF) per residue were analyzed
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and D. Changes in protein dynamics upon cGMP binding to each subunit of
GAFab were evaluated by plotting the ∆RMSF per residue for the apo and
cGMP-bound states for subunit A (panel C) and subunit B (panel D).
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Conformational metrics highlighting dynamics of the cGMP-bound state of
the PDE6 GAFab homodimer. For the cGMP-bound state of PDE6 (A), data
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The flexible LID (residues 156-178) and LOOP (residues 286-310) indicated
by snapshots of structures of (A) apo-state GAFab and (B) cGMP-bound
GAFab. Initial coordinates and end coordinates are colored as green and
red, respectively. The middle states are colored as cyan and purple. cGMP
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Difference dynamic cross-correlation (∆DCC) analysis of the differences in
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D.1 Snapshots from a second set of independent MD simulations highlighting the
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A; t = 10 ns) and the 4PAP/POPC system (panel B; t = 5 ns). Coloring
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representations, the peptide arms are shown in cyan sticks, and the aromatic
side chains in the peptide arms are shown in blue sticks. . . . . . . . . . . . 158
D.6 Shown are the top-views highlighting the locations of the center of mass of
those POPC (panel A) and PB-PEO (panel B) molecules that were initially in
the vicinity of the PAP channel (shown in a black space-filling representation).
The locations are higlighted in color: t = 0 µs (red spheres), 0.25 µs (green
spheres), and 0.5 µs (blue spheres). To highlight the diffusion of lipid/BCP
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D.7 The top-views of dimerized PAP channels corresponding to Figure 4.7 are
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E.2 Sequence alignment of RGS proteins is shown (RGS4: residues 51-178; RGS8:
residues 46-174; RGS9: residues 288-416; RGS17: residues 73-202; RGS19:
residues 79-206). Highly conserved residues are highlighted in red except
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the highly conserved cysteine residue (labeled C95), and (B) tabulated are
eight salt bridges conserved among all RGS proteins. See also Figure 5.3. . . 169
E.5 Unique and non-conserved salt-bridges in RGS proteins. (A-E) Salt-bridges
that are not conserved across five RGS proteins but are identified uniquely for
each RGS protein are highlighted. Residues highlighted in blue are positively
charged and in red are negatively charged. . . . . . . . . . . . . . . . . . . . 170
E.6 The Cα -Cα residue-residue correlation maps: (A) RGS4, (B) RGS8, (C) RGS9,
(D) RGS17, and (E) RGS19. The horizontal and vertical black lines in each
map indicate the location of a common and conserved cysteine residue in each
RGS protein. The color bar values from 0 to 1 indicate uncorrelated motions
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E.7 Allosteric pathways between source and sink residues. Shown are optimal
pathways from the conserved cysteine residue shared by five RGS proteins to
sink residues: (A) RGS4, (B) RGS8, (C) RGS9, (D) RGS17, and (E) RGS19.
Shown also are details of residues for each pathway in all RGS proteins with
the first residue as a source residue and the last residue as a sink residue. The
numbers in parenthesis indicate the length of each pathway. See also Figure 5.5.172
E.8 Pathways for an additional shared cysteine residue between RGS4 and RGS8.
Allosteric pathways between a second shared cysteine residue (C148 in RGS4
and C142 in RGS8), and six sink residues. Other details are similar to Figure E.7.173
E.9 Shown are difference cross-correlation (∆DCC) maps: (top row) maps for
RGS8, RGS9, RGS17, and RGS19 with RGS4 as a reference; (middle row)
maps for RGS9, RGS17, and RGS19 with RGS8 as a reference; (bottom row)
maps for RGS17 and RGS19 with RGS9 as a reference, and for RGS19 with
RGS17 as a reference. Red indicates an increased correlation, blue a decreased
correlation, and white no change in correlation. . . . . . . . . . . . . . . . . 174
E.10 Shown are communities and pathways computed from an additional simulation
(2 µs each) for RGS4 (PDB 1EZT), RGS8 (PDB 2IHD), RGS9 (PDB 1FQI),
and RGS17 (PDB 6AM3). See also Figures 5.4 and E.7.
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E.11 The effect of changing the cut-off distance (4.5 Å, 5 Å, 6 Å, 7 Å) for computing
communities and pathways is highlighted for RGS9. See also Figures 5.4 and E.7.176
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ABSTRACT

COMPUTATIONAL STUDIES OF SMALL MOLECULE TRANSPORT AND BINDING
by
Yong Liu
University of New Hampshire, December, 2020

In this thesis, I have studied two classes of systems using molecular dynamics (MD)
simulations as a primary approach. The first class of systems is responsible for transport
of small molecules. Specifically, I have investigated diffusion pathways of inhibitory gas CO
within the enzyme FeFe-hydrogenase as well as water transport in artificial water channels.
The second class of systems are biological proteins and their interactions with ligands. I
have focused on Regulators of G-protein Signaling (RGS) proteins and their binding to
thiadiazolidinone (TDZD) based small-molecule inhibitors as well as phosphosdiesterase 6
(PDE6) binding with cyclic guanosine monophosphate (cGMP).
Specifically, I have studied the thermodynamics of CO diffusion in the Clostridium pasteurianum CpI FeFe-hydrogenase, which is sensitive to the inhibitory gas CO that deactivates
this enzyme. Given that the active site is deeply buried in the FeFe-hydrogenase structure,
it is highly likely that mutagenesis of specific amino acids lining gas diffusion pathways can
improve the tolerance of this enzyme to inhibitory gases. To achieve that goal, the first step
is to have detailed knowledge on diffusion network of CO inside the protein matrix. Therefore, I used advanced sampling methods to reveal the three-dimensional diffusion network
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of CO. I discovered that one of the minima in the vicinity of the active site suggests a high
affinity for CO. I proposed several potential candidate residues located in the vicinity of
the free-energy barriers for disrupting the CO diffusion network and for providing guidance
to future experimental studies. In addition, comparisons between the diffusion networks of
two inhibitory gases CO and O2 suggested several residues of the mutations of which can
simultaneously improve the tolerance of the enzyme to both inhibitory gases CO and O2 .
I have also studied the conformational dynamics in an artificial peptide-appended pillar[5]arene (PAP) water channel with perturbations from the surrounding membrane and
other channels. Specifically, I have incorporated multiple PAP channels in a lipid membrane matrix or a block copolymer membrane matrix to probe the channel-channel and
channel-membrane interactions. MD simulations showed clustering of PAP channels only
in a lipid membrane matrix, while enhanced sampling simulations showed a thermodynamically favored dimeric state of PAP channels in both membrane matrices. I discovered that
the free-energy barrier for the dissociation of dimerized channels was ∼4 kcal/mol higher in
the BCP membrane than in the lipid membrane. While the water permeability values of
all PAP channels are at the same order of magnitude, the results suggested that the water
permeability of PAP channels correlated with the flexibility of PAP channels: a higher flexibility leads to a lower permeability. Collectively, the channel-channel and channel-membrane
interactions governed the structural and functional water transport characteristics of PAP
channels.
Among second class of systems, I studied RGS proteins that bind to Gα subunits of
G-proteins to terminate signaling by G-protein coupled receptors (GPCRs) by accelerating
hydrolysis of GTP. The pathways in which RGS proteins participate are implicated in various
diseases including cancer, cardiovascular diseases, and central nervous system disorders. The
binding of RGS proteins to G-proteins can be terminated by inhibitors that allosterically
bind to cysteine residues in RGS proteins and inhibit the RGS/Gα interaction. TDZD
inhibitors are potential drugs that covalently bind to cysteine residues in RGS proteins.
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However, TDZD inhibitors have shown different potencies and selectivities toward different
RGS proteins. Protein dynamics is an important approach to explain the similarities and
differences in behavior toward allosteric inhibition originating at a conserved cysteine in
RGS proteins (Cys95 at RGS4). To probe this, I studied the dynamics in five homologous
proteins of the RGS family (RGS4, RGS8, RGS9, RGS17, and RGS19) using MD simulations
which revealed differences in structural dynamics, allosteric communication and pathways,
and salt-bridging interactions. This study probed the allosteric pathways originating at the
conserved cysteine residue.
Besides the conserved cysteine residue, RGS proteins contain other cysteine residues
that can be targeted with covalent inhibitors. It is expected that targeting one of cysteine
residues may lead to different allosteric perturbations in the RGS/Gα interface. Therefore,
dissecting the role of each cysteine is of importance to evaluate differences in perturbations.
In addition, inhibitor binding to one cysteine can perturb other unbound cysteines such as
increasing their exposure window. Therefore, I have further investigated RGS8 protein with
two cysteine residues that were chosen as a model system to dissect the role of individual
cysteines when different TDZD inhibitors are bound. These studies revealed different roles for
each cysteine, their synergistic inhibitory effect, and the effect of different TDZD inhibitors
on perturbations in the protein-protein interface.
In final set of studies reported here, I have employed MD simulations to probe the conformational dynamics of cone PDE6 GAFab domain, which plays a critical role in phototransduction process, with and without the ligand cyclic guanosine monophosphate (cGMP). A
stable crystal structure of cone PDE6, which I used in my work, was recently obtained. I
observed different conformational dynamics in two identical subunits in both apo (unbound)
and cGMP-bound PDE6. I also observed allosteric communication between the GAFa domain and the GAFb domain through the GAFb β1/β2 loop.
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CHAPTER 1
INTRODUCTION

1.1

Protein Structure
Proteins are biopolymers of amino acids that usually fold into three-dimensional struc-

tures with four distinct types of structural organization: primary structure, secondary structure, tertiary structure, and quaternary structure [6]. While the primary structure refers to
the amino acid sequence linked through peptide bonds, it can turn into secondary structures
such as α-helices, β-sheets, and turns which are stabilized by hydrogen bonds. These elements can further fold into a tertiary structure with the formation of a hydrophobic core,
disulfide bonds, salt-bridges, and additional hydrogen bonds. The tertiary structure of a
protein is a single protein chain, but the quaternary structure usually consists of several
chains termed as subunits.
Proteins are one of the most abundant and important elements in a cell. For example,
consider Escherichia coli cell, where proteins occupy approximately 50% of the dry weight
of the cell, indicating their critical roles in biological processes [7]. Proteins bind to various
ligands (small molecules, other proteins, or cell membrane) to carry out various biological
functions. The binding affinity originates from the tertiary structure of a protein which can
form binding sites (also termed as pockets). One of the common types of binding processes
are the protein-protein interactions (PPIs) that are established in protein complexes and
thereby regulate protein activity [8]. For example, the 2019 Coronavirus Disease (COVID-19)
caused by the virus SARS-CoV-2 is infectious due to a high affinity PPI between the receptorbinding domain (RBD) of the spike protein of the virus and the angiotensin-converting
1
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Figure 1.1: Protein-Protein Interactions. The protein complexes of (A) the RBD of the
spike protein of SARS-CoV-2 (red) with the ACE2 of the human cell (blue) and (B) RGS4
(purple) with Gα (cyan).
enzyme 2 (ACE2) of the human cell (Figure 1.1A) [9]. Another example is the PPI between
the RGS proteins [10] and the Gα subunits of G-proteins (Figure 1.1B), which is one of the
key topics in this thesis.
Proteins are also key targets in drug discovery due to their multifaceted physiological
roles [11–13]. Therefore, it is conceivable that inhibitors can be designed to bind to proteins
and thereby prevent or inhibit undesired biological processes [14]. Such inhibitors can be
classified into covalent and noncovalent inhibitors. Covalent inhibitors form covalent bonds
with proteins, while noncovalent inhibitors bind to proteins based on a high affinity between a given inhibitor/protein pair. Covalent inhibitors are beneficial due to their high site
specificity, long residence time, and lower doses. While noncovalent inhibitors may lack site
specificity and require higher doses [15–18]. The sites where inhibitors bind on proteins can
be classified as orthosteric and allosteric sites [10, 19]. The orthosteric site is the one where
inhibitors can directly target the active site. Alternatively, inhibitors can also indirectly
perturb the active site by targeting a distal site, termed an allosteric site [10, 19].
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1.2

Ligands
Ligands play many important roles in modulating protein functions such as by inhibit-

ing or enhancing protein activity. They can be classified by their size or by site selection:
small molecules, orthosteric ligands, and allosteric ligands. In this thesis, I have studied
ligands of three types (Figure 1.2): (i) small gaseous molecules such as CO which inhibit
the FeFe-hydrogenase and water which is transported by artificial water channels; (ii) thiadiazolidinone (TDZD) based allosteric inhibitors, CCG-50014 and CCG-203769, which bind
to RGS proteins and inhibit their binding to G-proteins; and (iii) orthosteric ligands such
as cyclic guanosine monophosphate (cGMP) which binds to GAFa domains in phosphodiesterase 6 (PDE6).

Figure 1.2: The molecular structures of ligands studied in work reported in this thesis.

1.3

Background on Systems Studied
In this thesis, I have studied two different classes of systems that are either responsible

for transport of molecules or where ligand binding is involved. The first class of systems are
enzymes (FeFe hydrogenases) or artificial channels where gas or water transport is critical to
their function. The second class of systems are proteins (RGS and PDE6) where binding of
small molecules (TDZD inhibitors) is coupled with conformational dynamics. Here, I provide
a brief description of these two classes of systems.
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1.3.1

FeFe-Hydrogenase

Enzymes use their active sites to exquisitely perform essential processes in living organisms by catalyzing chemical transformations. Given that the active sites are buried within
the protein matrices, ligand migration between the solvent and the active site is an indispensable process for chemical reactions to occur. This observation hints at the existence
of ligand entry/exit channels through which the activity of enzymes can be modulated by
altering ligand diffusion (e.g. limiting the diffusion of inhibitory gases) [20, 21]. Although
permanent diffusion channels may not exist in flexible structures of enzymes, transient thermal fluctuations throughout the protein matrix can potentially lead to the formation of a
network of metastable pockets that can serve as conduits for site-to-site hopping of ligands.
In this thesis work, I have studied the thermodynamics of gas diffusion pathways in
the FeFe-hydrogenase, an enzyme of the hydrogenase superfamily, that is reported to be a
key source of biological hydrogen production due to its ability to catalyze proton reduction
and/or H2 -oxidation under optimal conditions [22–28]. The crystal structure of the CpI
FeFe-hydrogenase from Clostridium pasteurianum revealed a deeply-buried active site (the
H-cluster) with three 4Fe4S and one 2Fe2S accessory metal-clusters (Figure 1.3a) [29, 30].
The H-cluster is comprised of one Fe4 S4 subcluster and one 2Fe subcluster with a vacant site
on Fed (distal) which can bind different ligands [26] including inhibitory gases CO and O2
that can severely hamper the enzymatic activity of the FeFe-hydrogenase.
Specifically, it has been suggested that O2 attacks and irreversibly deactivates the Hcluster, while CO can compete with O2 for binding to the H-cluster and prevent inhibition
by O2 when the enzyme is oxidizing H2 or is at the resting state (no reaction) [31–33]. Regardless, CO can still irreversibly deactivate the enzyme during H2 -production [33]. Importantly,
both CO and O2 attack the same site, the Fed of the 2Fe subcluster of the H-cluster [5,34,35].
Moreover, with CO binding to the active site, O2 cannot access the active site, and previous studies have suggested a faster binding rate for CO than O2 [34, 36]. Since accessing
the active site requires channels connecting to the solvent, several possible scenarios can be
4
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Figure 1.3: (a) Five metal-clusters are highlighted and labeled in the crystal structure of the
FeFe-hydrogenase (PDB 1FEH). (b) Residues along two hydrophobic pathways are shown
in sticks (red, pathway A; blue, pathway B) and a water pathway is shown as a green
transparent surface. (c) Shown are residues previously tested in experiments (underlined) or
proposed in simulation studies. The Cα -atoms of these residues are highlighted by spheres
along with a proposed Xe cavity (pink sphere) [5].
hypothesized to explain the phenomenon of the protective effect and inhibition by CO: (a)
CO diffuses faster than O2 if both gases compete for the same diffusion pathway; (b) CO migrates along shorter diffusion pathways if each gas has an independent pathway; and/or (c)
CO has a higher binding-affinity for Fed than O2 . Therefore, a detailed mapping of diffusion
pathways of CO and O2 in the FeFe-hydrogenase is not only needed for resolving these questions, but also for developing approaches to enhance the tolerance of the FeFe-hydrogenase
to inhibitory gases.
Previous studies have identified three major pathways (highlighted in Figure 1.3b as
pathway A, pathway B, and the water pathway) connecting the H-cluster to the solvent
space [5,31,37–39]. Among these, the water pathway is mainly comprised of polar or charged
residues S298, S319, S320, S323, E361, K571, and Y572 (green surface in Figure 1.3b), while
pathways A and B are primarily assumed as hydrophobic channels containing the following
residues: A280, L283, V284, I287, F293, M295, M424, L428, A431, V459, I461, V468, and
F493 along pathway A (highlighted as red sticks in Figure 1.3b), and residues M274, A321,
I327, A331, M551, F556, A564, I567, and L568 along pathway B (highlighted as blue sticks
in Figure 1.3b). A presumed Xenon (Xe) cavity has also been suggested in the proximity of
5
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residues A427, F493, and L283 (labeled as Xe in Figure 1.3c), which has been hypothesized
as a location with potentially high probability of gas residence [5].
Furthermore, to improve the tolerance of hydrogenase enzymes to inhibitory gases, mutations in specific amino-acid residues have been carried out. For example, the rates of
CO and H2 diffusion in another enzyme of the hydrogenase family, D. fructosovorans NiFehydrogenase, can be decreased after mutations of two residues (V74 and L122) [34,36]. However, it is highly challenging to rationally choose residues for mutations among a large number
of residues (e.g. 574 residues in the CpI FeFe-hydrogenase), especially without the knowledge
of diffusion channels and the location of the free-energy barriers along them. This is evident
in an experimental study on mutations of seven residues in the CpI FeFe-hydrogenase (labeled in Figure 1.3c as C299, F417, V423, A427, A431, I461, and F493), where none of the
residues showed any strong effect on the kinetic performance of this hydrogenase although
some of these residues (A427, A431, I461, F493) are located in the pathway A [5]. This
suggests the existence of additional pathways for gas diffusion in the FeFe-hydrogenase. Indeed, a previous study [1] disclosed an exhaustive mapping of the diffusion network of O2
in the CpI FeFe-hydrogenase showing several new pathways to access the active site besides
those previously suggested (pathways A, B, and the water pathway). The previous work
suggested several new candidate residues lining diffusion pathways of O2 (labeled in spheres
in Figure 1.3c) whose mutations have the potential to significantly disrupt the O2 diffusion
network, as these residues are located in the vicinity of the free-energy barriers. However,
no studies on the exhaustive mapping of the diffusion pathways of the competing inhibitor
CO in the FeFe-hydrogenase have been carried out so far although pathways of CO diffusion
in structurally-unrelated NiFe-hydrogenase have been studied [40]. I report studies on CO
transport pathways in FeFe-hydrogenase in Chapter 3.
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1.3.2

Peptide Appended Pillarene (PAP) Artificial Water Channel

Protein channels are known to efficiently transport water or ion molecules across cellular
membranes with high in vivo selectivity. Aquaporins (AQPs) are one family of these protein
channels that have also been employed in vitro as water channels embedded in synthetic
polymeric membranes for designing biomimetic separation materials [41–45]. For example,
AqpZ water channel was inserted into a self-assembled synthetic block copolymer (BCP)
membrane to achieve high efficiency in water transport [46]. However, laborious and expensive methods of fabrication and low stability of biological water channels make it challenging
to integrate them in large-scale applications [43–45].
Inspired by the separation mechanism of protein channels [41, 45, 47–51], self-assembling
channels and unimolecular channels are two main types of biomimetic artificial water channels (AWCs) that have been proposed as alternatives to protein channels, primarily due
to simplicity of synthesis and low energy input. Among these, self-assembling channels
are designed using several building blocks including imidazole quartets [52, 53], dendritic
dipeptides [54, 55], hexa(m-phenylene ethynylene) molecules [56], aquafoldamers [57], and
triarylamines [58], while unimolecular channels are typically single supramolecules including
carbon nanotubes [59, 60] and (peptide or hydrazide) appended pillar[5]arenes [61–64].
In this thesis work, I have studied molecular details of the functional behavior of a
∼5 Å pore-size peptide-appended pillar[5]arene (PAP) channel (Figure 1.4) that can selfassemble into two-dimensional arrays [65,66] and has shown a high water permeability (∼108
molecules/s/channel) [61–63, 65, 66]. Specifically, the water permeability values measured
for liposomes containing PAP channels were 3.7 × 106 water molecules/s/channel and 3.5 ×
108 water molecules/s/channel under vesicle shrinking and swelling conditions, respectively.
From a practical membrane design perspective, it is worth noting here that the lipid matrix
suffers from low chemical and mechanical stability [44], but the synthetic counterparts of
lipids are amphiphilic BCPs that have been employed as alternative membrane matrices
with the ability to assemble water channels into two-dimensional crystals [45].
7
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Figure 1.4: The molecular structure of the PAP channel is shown with the central pillar-arene
ring (brown sticks) and the peptide arms (transparent gray sticks).
In a recent study [66], the conformational dynamics of a single PAP channel in lipid as
well as in BCP membranes was reported. A previous study highlighted that an increase
in the length of the hydrophobic block in BCP membranes led to less favorable insertion
of the PAP channel likely due to the physical hydrophobic mismatch [67–69]. Moreover,
long time-scale molecular dynamics (MD) simulations of a single PAP channel indicated a
decrease in the flexibility of the channel in the BCP membrane in comparison to the lipid
membrane likely due to the chemical hydrophobic mismatch [66]. However, from an application standpoint, it is desirable to have a higher packing density of channels per unit surface
area of the membrane for efficient separations, which significantly increases the likelihood
of channel-channel interactions that can alter the conformational and functional behavior of
channels. As an example, the proximity of channels due to a denser packing could result
in the clustering of channels, where the clusters could be stabilized by a hydrogen bonding
network between the phenylalanine chains of neighboring PAPs [65].
Although the effect of channel-channel interactions and clustering on the permeability
and selectivity of the PAP channel remains unknown, keeping channels in their active functional states is a desired characteristic for designing efficient separation systems. Besides the
clustering of channels, it is critical to examine perturbations resulting from lipids or polymers which could affect the function of channels [70]. This is evidenced by the observation
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that the pore of the PAP channel can be blocked by lipid molecules transiently entering the
channel pore [65]. Although it is non-trivial to predict the molecular details of the effect of
the membrane matrix on channel’s functional characteristics, MD simulations are emerging
as a useful tool to probe atomistic details of channel-channel and channel-membrane interactions, thereby assisting in the knowledge required to overcome challenges in designing stable
membranes [71]. I report studies on water transport in PAP channels in Chapter 4.

1.3.3

Regulators of G-protein Signaling (RGS) Proteins

Protein-protein interactions (PPIs) are commonly involved in biological functions [72].
Given that aberrant PPIs are implicated in several diseases, a traditional approach to inhibit
PPIs is to target orthosteric sites using small-molecules [10,73,74]. However, it is challenging
to inhibit protein-protein interfaces that are often flat, lack well-defined binding pockets or
have pockets that are buried within the interface and require transient exposure for binding of small-molecules [75–79]. Alternatively, small-molecules can be targeted at allosteric
sites with the goal of inhibiting the protein-protein interface by perturbing the conformational dynamics of proteins involved. Moreover, targeting allosteric sites over orthosteric
sites has several advantages because: (i) binding at allosteric sites is noncompetitive with
the direct binding of endogenous ligands; (ii) allosteric binding sites may be more accessible
than a buried orthosteric site; and (iii) allosteric effects are saturable while effects of orthosteric binding are concentration-dependent [10, 77–81]. Furthermore, small-molecules that
covalently modify allosteric sites may increase specificity and also reduce drug dosage [82].
While covalent inhibitors are of concern due to off-target effects, they can significantly decrease the off-rate and thereby improve the potency, as is known for marketed drugs like
aspirin [83].
However, targeting allosteric sites is challenging due to a poor understanding of protein
conformational dynamics and allosteric communication between various structural motifs.
Moreover, it is difficult to discern structural changes based only upon the crystal structures
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of proteins. In addition, the selectivity of small-molecules covalently targeting allosteric sites
on proteins from a common family cannot be predicted solely from their structures due to
significant similarities in structural folds. Therefore, molecular dynamics (MD) simulations
are increasingly playing a pivotal role in resolving the details of protein conformational
dynamics and allosteric communication pathways [84–86]. For example, MD simulations
have been successfully applied to map allosteric communication pathways in the kinase
family [87–92].
In this thesis work, I aim to probe using MD simulations pathways originating at covalent
allosteric sites, specifically at conserved cysteine residues, in homologus proteins of the Regulators of G-protein Signaling (RGS) family. Structurally, RGS proteins have a conserved
RGS-box domain consisting of nine α-helices (α1 through α9) (Figure 1.5A). The functional
role of RGS proteins is to bind to activated (GTP-bound) Gα subunits of G-proteins and
accelerate the rate of GTP-hydrolysis, thereby deactivating Gα and terminating signaling by
G-protein coupled receptors (GPCRs) [10,93–95]. Therefore, small-molecule inhibitors of the
RGS/Gα PPI, that enhance signaling via GPCRs, are potentially useful to develop therapeutics for cancer, cardiovascular diseases, and central nervous system disorders [10, 75, 96, 97].
Specifically, TDZD inhibitors (Figure 1.5C) that covalentally modify cysteine residues in
RGS proteins have shown promise in inhibiting the RGS/Gα PPI via an allosteric mechanism [94, 95, 98–101]. The selectivity and potency of TDZD inhibitors is thought to be related to the number of cysteine residues in RGS proteins [102] because the TDZD inhibitor
CCG-50014 is selective for RGS4 (with 4 cysteine residues) over RGS8 (with 2 cysteine
residues) [98, 100]. However, previous work has shown correlations between the inhibitor
potency and protein dynamics, especially conformational changes leading to the exposure
of buried and conserved cysteine residues in RGS proteins [94, 95, 101]. For example, it
has been shown that RGS proteins retaining only a single shared cysteine residue showed
differences in potencies of CCG-50014 [95]. While covalent inhibitors are known to be irreversible, some covalent inhibitors (CCG-63802 and CCG-63808; Figure E.1) of RGS proteins
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Figure 1.5: (A) The conserved RGS-box (PDB ID: 1FQI). (B) Sequence alignment of RGS4,
RGS8, RGS9, RGS17, and RGS19. (C) Chemical of a TDZD inhibitor with R1 and R2 as
functional groups.
are reversible [99].
Besides the comparisons among RGS proteins, it is of importance to understand the role
of each binding site. For example, RGS8 has two cysteine residues which are the targets of
TDZD inhibitors and it is highly likely that each shows different inhibitory effect. Moreover,
binding to one cysteine residue might lead to increased exposure window for a buried cysteine
residue, which can further facilitate inhibitor binding and thereby may lead to a synergistic
inhibitory effect. I report studies on RGS proteins in Chapters 5 and 6.

1.3.4

Phosphodiesterase 6 (PDE6)

PDE6 (Figure 1.6) is one of the eleven type I PDE family members (PDEs 1-11) in
mammals which share sequence homology of 25∼52% in the catalytic domain [103, 104].
Cyclic nucleotide PDEs break phosphodiester bond of cAMP and/or cGMP [105]. While
PDEs 4, 7, and 8 are selective cAMP hydrolases, PDEs 5, 6, and 9 selectively hydrolyse
cGMP to GMP. Other PDEs show hydrolytic activity toward both cGMP and cAMP. PDE6
11
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Figure 1.6: Shown are α subunit and β subunit of GAFab domains of cone PDE6 (without
the C-terminal catalytic domain in each subunit).
resides on the photoreceptor’s outer segment and is essential for visual phototransduction.
In response to light, PDE6 is activated and shows high efficiency of hydrolysis of cGMP to
GMP that is close to the diffusion limit of cGMP.
PDE6 is classified into rod PDE6 and cone PDE6 with four subunits: two catalytic
subunits and two inhibitory subunits. While rod PDE6 has two heterodimeric catalytic
subunits PDE6αβ, the two subunits of cone PDE6 are homodimeric. The catalytic subunit
has three domains: two N-terminal GAF domains (GAFa and GAFb, or termed GAFab)
and one C-terminal catalytic domain. The GAFa domain has a binding pocket with a
high cyclic guanosine monophosphate (cGMP) specificity. GAF domains were first found in
cGMP-binding PDEs, cyanobacterial Adenylyl cyclases, and transcription factor FhlA [106].
The PDE6γ subunits inhibit the catalytic activity of PDE6 with higher affinity if cGMP
binds to the GAFa domain. PDE6γ subunit binding to the C-terminal catalytic domain
of PDE6 leads to increased affinity of cGMP for the GAFa domain (or noncatalytic sites)
12
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and vice verse [107–109]. During phototransduction, the affinities between cGMP and the
GAFa domain, between the C-terminal catalytic domain and PDE6γ are reduced, thereby
leading to cGMP binding and subsequent hydrolysis at the enzyme active site in the catalytic
domain [108]. I report studies on conformational dynamics in PDE6 in Chapter 7.

1.4

Specific Aims
The main goal in this thesis is to study the transport of small molecules (e.g. CO, water,

cGMP), their binding, and/or inhibitory effect in biomimetic and biological systems. In the
following, I introduce specific aims of my work.

1.4.1

Specific Aim 1: Discover candidate residues for mutagenesis to alter trans-

port of inhibitory gases in FeFe-hydrogenase
Given that the active site of hydrogen producing enzymes FeFe-hydrogenase is buried in
the protein matrix, it is potentially feasible to block CO diffusion toward the active site.
Therefore, I have investigated through MD simulations the CO diffusion network within the
FeFe-hydrogenase protein matrix. The activation barriers of CO hopping between pairs of
energy minima were calculated which led to the identification of key residues for mutagenesis
studies and comparison with previously proposed residues for O2 , another inhibitor of this
enzyme. These studies are reported in chapter 3.

1.4.2

Specific Aim 2: Resolve channel-channel and channel-membrane interac-

tions and their effect on water transport in artificial water channels
The conformational dynamics of the PAP channel when inserted into membrane matrices
are likely affected by the surrounding membrane. In addition, PAP channels may also
dimerize or aggregate due to diffusion within the membrane matrices, which may further
affect the channel structure and thereby its water transport characteristics. I report on MD
simulations to understand the interactions between channels as well as between the channel
13
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and membrane, and their effect on water transport. These studies are reported in chapter 4.

1.4.3

Specific Aim 3: Characterize allosteric pathways in RGS proteins

Besides the number of cysteine residues targeted by TDZD inhibitors, protein dynamics
have been suggested as another important factor contributing to the selectivity of inhibitors.
However, the underlying similarities and differences in protein dynamics within the RGS
protein family are not fully understood. I have reported on the residue community and
allosteric pathway analyses of five RGS proteins using MD simulations. The study revealed
similarities and differences in the community network, allosteric pathways, and salt-bridges,
which contributes to the pharmacology and selectivity in inhibition of the RGS/Gα PPI.
These studies are reported in chapter 5.

1.4.4

Specific Aim 4: Dissect the role of individual cysteine residues in TDZD

based inhibition of RGS8
Many RGS proteins contain multiple cysteine residues that are targets of covalent inhibitors. However, the role of individual cysteine residues is not well understood. I employed
MD simulations to study two TDZD inhibitors bound at two different cysteine residues in
a model protein, RGS8. The results support a synergistic effect arising from binding of
inhibitors at both cysteine residues. These studies are reported in chapter 6.

1.4.5

Specific Aim 5: Probe the conformational dynamics of PDE6 GAFab

domains with and without cGMP
Using a recent crystal structure of GAFab domains of cone PDE6, I carried out MD
simulations to probe the dynamics of PDE6 GAFab domains with and without cGMP. I first
tested the stability of the crystal structure of GAFab domains. Then, I studied the dynamics
of GAFab with/without the ligand cGMP. These studies are reported in chapter 7.
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1.5

Thesis Outline
This thesis is structured in 8 chapters and 6 appendices: Aside from the introductory

chapter 1, chapter 2 provides details on computational methods, software tools, and methods
of analyses used in my thesis work. Chapter 3 illustrates a study of the diffusion network
of an inhibitory gas CO in FeFe-hydrogenase. Chapter 4 describes conformational dynamics of PAP water channels in a lipid membrane and a block-copolymer (BCP) membrane
matrix and their relation to functional water transport characteristics. Chapter 5 describes
allosteric pathways of inhibition in five RGS proteins: RGS4, RGS8, RGS9, RGS17, and
RGS19, through community network analysis. Chapter 6 describes the role of individual
cysteine residues in inhibition of RGS8 by TDZD inhibitors. Chapter 7 describes structural
analysis of allosteric regulation in PDE6 by cGMP. Chapter 8 shares my ideas on future
work. Appendices A and B detail examples of simulation scripts and analyses codes used in
this thesis. Appendices C through F provide supporting information for studies outlined in
chapters 3 through 6, respectively. Appendix G is my brief curriculum vitae.
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CHAPTER 2
COMPUTATIONAL METHODS

2.1

Introduction
This chapter describes MD simulation techniques including classical MD and enhanced

sampling MD. The software used include Visual Molecular Dynamics (VMD) [110] and
NAnoscale Molecular Dynamics (NAMD) [111]. VMD is used for system preparation and
analysis, while NAMD is used for MD simulations. I also used MATLAB (MATrix LABoratory), TCL (Tool Command Language), and Linux bash scripting for analyses. All
simulations were performed on local supercomputing resources at UNH (Trillian, Premise,
and Biomade) and external supercomputing resources at San Diego Supercomputing Center
(Comet Supercomputer) [112].

2.2

Molecular Dynamics Simulations
MD simulations have been widely used in chemistry, materials science, pharmaceutical

science, and molecular biology to reveal mechanisms and structural dynamics [113, 114].
While experiments provide macroscopic properties of systems such as temperature, pressure, and permeability, MD simulations show microscopic properties such as atomic motions
which are not easily detected using experimental tools. To convert MD simulation data to
measurable macroscopic properties, statistical mechanics is a key mathematical physics tool
that plays a critical role. The field of statistical mechanics involves probability theories, laws
of thermodynamics, and Newton’s laws of motion [115].
MD simulations are based on Newton’s Second Law (equation 2.1) to solve the equations
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of motions of a system of a large number of particles:
∂U
F~i = mi~ai = −
∂ri

(2.1)

where F~i is the force on the particle i with a mass of mi and an acceleration of ~ai , U is
the interatomic potential energy, and ri denotes the Cartesian coordinates of the particle
i. To improve dynamical stability, the implementation of MD simulations in NAMD uses
a partially stochastic Langevin equation (equation 2.2) rather than Newton’s equation of
motion (equation 2.1) [111, 116]. The partially stochastic Langevin equation is given as:
r
mv̇ = F~ (r) − mγv − mγ

2kB T
R(t)
m

(2.2)

where m is the mass of a particle, v̇ is the acceleration, F~ is the force, v = ṙ is the velocity,
r is the position vector, γ is the friction coefficient (typical value is 5 ps−1 or 10 ps−1 ), kB is
the Boltzmann’s constant, T is the temperature, and R(t) is a univariate Gaussian random
process. The fluctuating force (the last term) and the dissipative (-mγv) force are added to
the Newton’s equations of motion to fulfill partial stochasticity of the model [111,116]. Below,
I describe various elements of an MD simulation starting with the interatomic potential
energy (U).

2.2.1

Interatomic Potential Energy (U )

In MD simulations, one of the key elements is observing atomic motions that are related
to the conformational evolution of a many-body system. To find the solutions of equations of
motions, it is essential to calculate the potential energy (U). Typically, the potential energy
is a complex function including bonded interactions (the first five terms in equation 2.3) and
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nonbonded interactions (the last two terms in equation 2.3) [117].

U=

X

kb (b − b0 )2 +

bonds

X

kθ (θ − θ0 )2 +

angles

+

X

X
dihedrals

X X
VDW Sij

X

kω (ω − ω0 )2 +

impropers

+

kφ [1 + cos(nφ − δ)]
ku (u − u0 )2

(2.3)

Urey-Bradley

"
4ij
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rij
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Rminij
rij

6 #
+

X
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qi qj
4π0 rij

The first term in equation 2.3 describes the bond oscillations where kb is the bond forceconstant and bond oscillates around the equilibrium length b0 . The second term describes the
bond angle oscillations where kθ is the angle force-constant and the angle oscillates around
the equilibrium angle θ0 . The third term accounts for dihedrals or torsional rotations where
kφ is the force constant, n indicates the periodicity, φ is the angle, and δ is the phase shift
angle. The fourth term describes impropers, which is out of plane bending, where kω is
the force-constant and ω − ω0 is the angle deviation relative to the equilibrium angle ω0 .
The fifth term is Urey-Bradley component (cross-terms accounting for angle bending using
1,3 nonbonded interactions), where ku is the respective force constant and u is the distance
between the 1,3 atoms in the harmonic potential.
Nonbonded interactions between pairs of atoms (i, j) are illustrated by the last two
terms. By definition, the nonbonded forces are only applied to atom pairs separated by at
least three bonds. The van Der Waals (VDW) energy is calculated with a 12-6 LennardJones potential (the 6th term in equation 2.3) and the electrostatic energy with a Coulombic
potential (the final term in equation 2.3). The energy well depth in the Lennard-Jones
potential and the distance at which the Lennard-Jones potential is zero, are defined as ij and
Rminij , respectively. The dielectric constant and the partial charge are denoted by 0 and q,
respectively. Hydrogen bonding is taken into account via nonbonded interactions. To run an
MD simulation, one needs all the parameters in the potential energy function (equation 2.3)
which are usually computed through quantum-mechanical calculations and optimized using
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the experimental data [111].The potential energy (U ) is also termed as the force-field, as it
provides all parameters for an MD simulation. The force-field for biomelcules are developed
by specific research groups1 and are accepted by the practitioners of MD simulations.
In this thesis, I used the well-tested CHARMM force-field (with the CMAP correction)
for proteins, lipids, block polymers, TIP3P water, and ions [117–120], and the AMBER
force field for RGS proteins [121]. The parameters for small molecules CO, CCG-50014, and
CCG-203769 were generated using the Multipurpose Atom-Type for CHARMM (MATCH)
tool [122]. The parameters for the PAP channel and metal clusters in the FeFe-hydrogenase
were taken from previous publications [65, 123, 124].

2.2.2

Ensembles

The macroscopic state of a system can be specified by its macro properties such as pressure (P), volume (V), and temperature (T) . However, the microscopic state, also known as
a microstate, is defined by the coordinates and momentum of each atom in the system. Although the atoms move rapidly, the macrostate will not necessarily change. In other words,
a given macrostate corresponds to many different microstates. By definition, ensembles are a
collection of weighted microstates that are compatible with a given macrostate [125]. In statistical mechanics, different ensembles are characterized by fixed values of thermodynamics
variables including P, V, T, total number of particles (N), total energy (E), or chemical potential (µ). In this thesis, all MD simulations were performed using either the NPT ensemble
with fixed variables N, P, and T, or the NVT ensemble with fixed variables N, V, and T.
These two ensembles are consistent with typical experimental conditions, thereby becoming
common ensembles used in MD simulations. For the MD simulation of a biological system,
the typical values include 1 atm pressure and 310 K.
1

https://www.charmm.org/charmm/community/developers/; https://ambermd.org/contributors.html
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2.2.3

Numerical Integration

To obtain macroscopic properties, numerical integration of the equations of motion is an
indispensable process. However, a large number of particles (> 10000) and the stochastic
nature of the evolution of multi-particle systems coupled with a small time-step (∆t ∼ 1 − 2
fs) make convergence of a numerical integration algorithm very challenging. In addition, it is
required to maintain the accuracy of the system properties, for instance, systems in the NPT
ensemble must keep the temperature and pressure around specified values with acceptable
accuracy.

2.2.4

Integration Time-step (∆t)

The time-step (∆t) in an MD simulation is an important variable determining the convergence and accuracy of numerical integration. A small ∆t increases the accuracy, while
it also increases the computational cost. A large ∆t leads to instability in integration, although it would allow exploration of a larger conformational space. Therefore, one should
be careful in choosing a suitable ∆t to meet the requirements of the accuracy of integration
and the stability of simulation [126]. Typically, the time-step ∆t is set as 1 fs when bonds
to hydrogen atoms are flexible, while 2 fs is recommended when bonds to hydrogen atoms
are fixed [111].

2.2.5

Initial Conditions

In an MD simulation, initial positions and velocities of atoms must be specified. To get
the initial positions of atoms, for example those of protein atoms, one can first obtain the
initial coordinates of protein atoms from Research Collaboratory for Structural Bioinformatics (RCSB) website2 which provides the Protein Data Bank (PDB) files for experimentally
resolved protein structures. The three-dimensional coordinates for biomolecules in PDB
are deposited after experimental characterization via X-ray crystallography and NMR spec2

https://www.rcsb.org/
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troscopy. The initial velocities for atoms are randomly assigned from a Maxwell-Boltzmann
distribution:

s
P (v) =

m
2πkB T

3

2

mv
− 2k
T

4πv 2 e

B

(2.4)

where T is the temperature, v is the velocity, m is the mass of a particle, and kB is the
Boltzmann’s constant.

2.2.6

Boundary Conditions

Boundary conditions should be defined to run an MD simulation. Three types of boundary conditions can be used: (i) vacuum, (ii) a reflecting wall, and (iii) periodic boundary
conditions (PBC). With a vacuum BC, the computed properties cannot illustrate the properties of the condensed phase [127]. A reflecting wall BC keeps the particles inside the
simulation domain, which requires an additional potential applied to the boundaries [128].
In PBC, the simulation domain with particles is infinitely replicated by periodic translations
in all dimensions [127]. In 3D, each unit cell has 26 nearest neighbors. Any particle leaving
the simulation domain from one side is replaced by an image that enters the simulation box
from the opposite side. Therefore, the number of particles (N) is conserved, as required in
the NVT and NPT ensembles. PBC are applied for all MD simulations in this thesis.

2.2.7

Minimization

Initial structures obtained from PDB or modeled by VMD usually requires further steps
including mutagenesis, docking, guessing missing hydrogen atoms, solvation, and ionization to generate the initial system. Therefore, prior to MD simulations, all particles in the
simulation domain should be energy-minimized using methods such as steepest descents or
conjugate gradient schemes [129]. In this thesis, I employed conjugate gradient method
implemented in NAMD to energy minimize all initial structures before conducting MD simulations.
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2.2.8

Temperature and Pressure Control

For temperature control, the Langevin thermostat method, where additional damping
and random forces are introduced to the system, was applied in all MD simulations reported
in this thesis. The temperature control is realized through a frequent adjustment of momenta of all atoms in the system. The pressure is controlled using the Nosé-Hoover barostat
algorithm [130–132].

2.3

Software Packages

2.3.1

MD Simulation Software

I used the NAMD software package (ver. 2.12 and 2.13) for all MD simulations reported
in this thesis. As a parallel MD simulation package, NAMD is designed for high-performance
simulations of large biomolecular systems [111]. NAMD can efficiently use hundreds of cores
for typical simulations and beyond 500,000 cores for the largest simulations. One of the
largest systems simulated using NAMD is the HIV-1 virus capsid with approximately 64
million atoms [133]. It has been reported that NAMD will be used for COVID-19 coronavirus
system with 200 million atoms on up to 4,000 nodes or about 250,000 processing cores of the
Frontera supercomputer.3 Advanced techniques such as metadynamics (see section 2.4.2)
are also implemented in NAMD. This software is free for academic users and has an open
source code which can be modified by users, if needed.

2.3.2

Procedures for MD Simulations

As highlighted above, I carried out all simulations using NAMD, and all systems were
simulated in an aqueous environment. Here, I give a brief introduction on performing an
MD simulation. Typically, there are three steps to perform an MD simulation.
3

https://www.hpcwire.com/off-the-wire/coronavirus-massive-simulations-completed-on-fronterasupercomputer/
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(a) Preparation of input files: PDB, PSF (protein structure file), topology, parameter,
and configuration files are initially needed. The information on these files can be found on
the NAMD website4 . During this step, the system is usually required to be solvated with
water and then neutrialized with ions which can be done via VMD.
(b) Performing MD simulations: Prior to conducting long timescale MD simulations,
it is usually required to do an energy minimization. Then, longer MD simulations can be
performed in the NPT ensemble or the NVT ensemble. For membrane systems (chapter 4),
I first relaxed the membrane with other atoms fixed. Then, the channel atoms were fixed
and other atoms were allowed to move except that water was kept out of artificial water
channels. Finally, I performed longer MD simulations.
(c) Data analysis: All atomic coordinates are recorded in a simulation trajectory file.
One can then write scripts to extract the data of interest from the trajectory (section 2.3.2).

2.3.3

Modeling and Analysis

VMD (version 1.9) [110] is a graphics program and the companion software for NAMD. I
used VMD to prepare simulation files and trajectory analyses. For preparing the input files,
I used the plugin tools such as psfgen, solvation, ionization, and membrane builder. VMD
is an interface to run Tcl scripts for analysis of root mean squared deviation (RMSD), root
mean squared fluctuation (RMSF), solvent accessible surface area (SASA), buried surface
area (BSA), distance between atom pairs, hydrogen bonds (H-bonds), and so on. All VMD
and NAMD scripts are included in Appendix A.
MATLAB (versions 2018-2019) was employed for calculations, data analysis, and making
plots. All MATLAB codes used in this thesis are included in Appendix B.
Carma [134] is the software I used to calculate dynamic cross correlation (DCC) values.
The calculation was based on the Cα atoms of amino acid residues. The DCC maps are
pertaining to chapters 5, 6, and 7 (Figures E.6, E.9,and 7.7). The pairwise correlation is
4

http://www.ks.uiuc.edu/Training/Tutorials/
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defined in the following equation:

Cij =

h∆~ri (t) · ∆~rj (t)i
(h∆~ri (t)2 i h∆~rj (t)2 i)1/2

(2.5)

where ∆~ri (t) = ~ri (t) − h~ri (t)i, ~ri (t) is the position of Cα atom of the residue i, and h~ri (t)i is
the mean position.
For the RGS studies (chapters 5 and 6), I used the VMD plugin tool networkview developed by Sethi et al. [85] to perform community network analysis and allosteric pathway
analysis. The Girvan-Newman algorithm [135] was employed for community partitioning.
The length between two residues was defined using the following equation:

lij = − log (|Cij |)

(2.6)

where |Cij | is the normalized correlation value between two residues i and j. Here, the path
links edges which were formed when the two Cα atoms of the residues i and j are within a
cutoff distance of 4.5 Å for at least 75% of an MD trajectory [85]. The optimal path has
the shortest calculated distance from the source (pathway beginning) residue to the sink
(pathway ending) residue.
All simulation preparations and data analyses were performed using the Linux operating
systems including openSUSE and CentOS. Therefore, I also wrote simple bash shell scripts
for analyses. The MATCH web server5 was used to generate the topology and parameter files
for inhibitors. The catdcd tool was employed for concatenating trajectory files and selecting
partial trajectories of interest.

2.4

Advanced Sampling Methods
Although classical MD simulations are aimed at predicting conformational dynamics of

all atoms in complex molecular systems, a large part of unexplored conformational space
5

https://brooks.chem.lsa.umich.edu/index.php?matchserver=submit
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remains due to a large number of degrees of freedom in biomolecular systems. Therefore.
advanced sampling methods have been developed to exhaustively explore all conformations of
interest. These enhanced sampling methods includes temperature-accelerated MD (TAMD),
metadynamics, steered MD, umbrella sampling, and adaptive biasing force [136, 137]. These
methods are advantageous in overcoming energy barriers, accelerating sampling, and resolving free energy [111, 138–141]. In this thesis, I used two enhance sampling methods, TAMD
and metadynamics. TAMD was used to explore gas (CO) diffusion pathways in the FeFehydrogenase (chapter 3), while metadynamics was applied to study dimerization of artificial
PAP channels (chapter 4).

2.4.1

TAMD Algorithm

TAMD is an extended Lagrangian enhanced sampling algorithm for exploring the physical
free-energy landscape in a large but finite number of collective variables (CVs), which are
functions of the atomic Cartesian coordinates [136, 137]. In TAMD, dynamical auxiliary
variables z = (z1 , z2 ,..., zm ), that are harmonically coupled to CVs θ = (θ1 (x), θ2 (x),...,
θm (x)), are introduced to describe the combined motion of the [x, z] set. The time-evolution
of x and z is described by equations 2.7a and 2.7b, respectively, over the extended potential
described in equation 2.7c, where mi is the mass of xi , V(x) is the force-field, κ is the
“coupling spring-constant”, γ is the Langevin friction coefficient, η is a white-noise term
satisfying the fluctuation-dissipation theorem at the physical temperature β −1 = (kB T )−1 ,
γ̄ and m̄j , respectively, are the fictitious friction and masses of zj variables, ξ is the thermalnoise at the artificial temperature β̄ −1 = (kB T̄ )−1 , and Uκ is the extended potential.
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m
X
∂θj (x)
∂V (x)
− κ [θj (x) − zj ]
mi ẍi = −
∂xi
∂xi
j=1

− γmi ẋi + ηi (t; β)

(2.7a)

γ̄ m̄j żj = κ[θj (x) − zj ] + ξj (t; β̄)

(2.7b)

m

κX
Uκ (x, z) = V (x) +
[θj (x) − zj ]2
2 j=1

(2.7c)

In practice, TAMD algorithm requires β̄ −1 > β −1 for enhanced exploration of the freeenergy landscape defined at the physical temperature. While γ is related to the atomistic
system, γ̄ is related to the fictitious system. In addition, γ̄ should be higher than γ to ensure
that the fictitious system running at a higher temperature evolves slowly. γ and γ̄ are chosen
to guarantee adiabatic separation between the atomistic system and the fictitious system.
Moreover, the dynamics of auxiliary variables in TAMD can be described by Langevin, NoséHoover, and other related schemes [136, 137]. TAMD was originally applied to study CO
diffusion in myoglobin by Maragliano et al. [142] and since has been successfully applied to
study several biophysical problems [1, 138, 143–150].
Free-energy Surface (FES) Reconstruction: To reconstruct the free-energy landscape of gas diffusion, I used the single-sweep method [137, 142] in which mean-forces are
computed at CV positions sampled by TAMD. Specifically, it is necessary to choose distinct CV positions (in this thesis, the center-of-mass of CO), also termed unique centers,
throughout the protein matrix. Due to the rotation and translation of the protein, all TAMD
trajectories were aligned to a common reference structure for extracting centers. Out of all
CV positions sampled by TAMD, I chose a large number of unique centers (Figure 2 in
chapter 3, as an example). The centers were chosen by beginning with the first center (z1 )
and adding new centers such that the distance of each new center from all previous centers
exceeds a prescribed cutoff distance.
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A set of new MD simulations was launched to compute the mean-force at each chosen
center. The gas molecule is harmonically restrained at the chosen center, and the equation
for calculating the mean-force fk is:
t

1X
fk =
κ(θ(x(tj )) − zk )
t j=0

(2.8)

Each of these simulations was carried out until the observation of the convergence of the
mean-force (Figure C.1).
Using converged mean-forces at all centers, I globally reconstructed the free-energy
surface A(z) (equation 2.9) as a linear combination of Gaussian radial basis functions
2 /2σ 2

(ϕσ (u) = e−u

) by obtaining the optimized parameters (coefficients, ak ; and the Gaussian

width, σ) via a least square fitting procedure per equation 2.10 [137]. In equation 2.9 and/or
equation 2.10, K is the total number of chosen centers and C is a constant to adjust the
height of A(z).
A(z) =

K
X

ak ϕσ (|z − zk |) + C

(2.9)

k=1

E(a, σ) =

K
X
k=1

ak (

K
X

ak0 ∇z ϕσ (|z − zk |) + f (zk ))2

(2.10)

k0 =1

The optimized value of σ was ∼4.55 Å, and the value of the relative residual
P
((E(a, σ)/ k |fk |2 )1/2 ) was ∼0.73.
Minimum Free-energy Pathways (MFEP): I then further discovered the MFEPs
between all pairs of minima by using the reconstructed 3D-FES and the zero-temperature
string (ZTS) method [151–154]. The ZTS method defines the MFEPs as the steepest descent
paths from saddle points on the analytically reconstructed free-energy hypersurface, A(z),
to each free energy minimum. I also note that the application of the ZTS method does not
require any additional MD simulations since the analytical functional form of the 3D-FES
is available from equation 2.9.
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2.4.2

Metadynamics Simulations

Metadynamics is an advanced sampling method for faster exploration of the conformational space. Briefly, in metadynamics, a history-dependent biasing potential (Vmeta ), defined
as a sum of a set of Gaussian functions, is applied [139, 140]:
0

Vmeta (s) =

t <t
X
t0 =τG ,2τG ,...

W

N
CV
Y
i=1

exp(−

[si − si (t0 )]2
)
2δs2i

(2.11)

where, τG is the time interval, si is the current collectuve variable (CV) value, si (t0 ) is the
CV value at t = t0 , NCV is the number of CVs, W is the height of Gaussian energy packets,
and δ is the Gaussian width. Metadynamics simulations have been applied to study several
biophysical problems [155–157]. For work reported in this thesis, I applied metadynamics
method to study dimerization of two artificial channels in two different membranes (chapter
4).
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CHAPTER 3
STUDIES ON DIFFUSION NETWORK OF CO IN FEFE-HYDROGENASE

3.1

Abstract
FeFe-hydrogenase is an efficient enzyme to produce H2 under optimal conditions. How-

ever, the activity of this enzyme is highly sensitive to the presence of inhibitory gases (CO and
O2 ) that cause irreversible damage to the active site. Therefore, a detailed knowledge of the
diffusion pathways of these inhibitory gases is necessary to develop strategies for designing
novel enzymes that are tolerant to these gases. To this end, I studied the diffusion pathways
of CO in the CpI FeFe-hydrogenase from Clostridium pasteurianum. Specifically, I used
enhanced sampling and free-energy simulation methods to reconstruct a three-dimensional
free-energy surface for CO diffusion in this enzyme which revealed 45 free-energy minima
forming an interconnected network of pathways. I discovered multiple pathways of minimal
free-energy as diffusion portals for CO and found that previously suggested hydrophobic
pathways are not thermodynamically favorable for CO diffusion. I also observed that the
global minimum in the free-energy surface is located in the vicinity of the active-site metal
cluster, the H-cluster, which suggests a high-affinity for CO near the active site. Among 19
potential residues that I propose as candidates for future mutagenesis studies, 11 residues
are shared with residues that have been previously proposed to increase the tolerance of this
enzyme for O2 [1, 158]. I hypothesize that these shared candidate residues are potentially
useful for designing new variants of this enzyme that are tolerant to both inhibitory gases.
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3.2

Background
The section 1.3.1 of chapter 1 provides a brief introduction to the FeFe-hydrogenase

system. Although FeFe-hydrogenase is known to have activity in producing green fuel H2 , it
suffers from deactivation by inhibitory gases O2 and CO. Given that the active site is buried
in the protein matrix, CO and O2 entry/exit channels likely exist. Thereby, I hypothesized
that key amino acids lining these channels can be found and mutated in future to improve
the tolerance of this enzyme to inhibitory gases.
Previously, the O2 diffusion network has been studied [1, 158]. In this chapter, I describe
studies on the CO diffusion network and its comparison with the O2 diffusion network.
Specifically, I performed atomistic simulations of CO diffusion in a fully-solvated model of the
CpI FeFe-hydrogenase by judiciously combining several enhanced sampling methods. I used
the temperature-accelerated molecular dynamics (TAMD) and the single-sweep method [136,
137, 142] for obtaining a three-dimensional free-energy surface (3D-FES) for CO diffusion.
I then found the minimum free-energy pathways (MFEPs) in this free-energy hypersurface
using the zero-temperature string (ZTS) method [151–154]. The results provide detailed
information on local minima and the free-energy barriers along pathways forming a network
for CO diffusion. I also suggest several residues lining these pathways, mutations of which
could be useful in altering CO diffusion. Importantly, some of these residues are common to
residues reported earlier for mutations to alter O2 diffusion [1], and therefore can serve as
prime candidates for designing FeFe-hydrogenases tolerant to both inhibitory gases.

3.3

Methods

3.3.1

System Setup

I carried out all MD simulations and analyses using the NAMD/VMD software suite [110,
111], and used the CHARMM force-field parameters for proteins, ions, water, and metal
clusters [117,123,124], similar to a previous work [1]. I prepared a fully-solvated and ionized
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Figure 3.1: Schematic representation of the simulation domain (97 Å × 86 Å × 92 Å)
containing 70,036 atoms is shown: protein (white cartoon), solvent (gray wireframe), ions
(yellow spheres), and crystallographic water molecules (red spheres).
simulation domain (containing 70,036 atoms; Figure 3.1) using the initial coordinates for all
protein atoms from the crystal structure of the FeFe-hydrogenase (PDB code 1FEH), adding
one CO molecule (initial coordinates obtained from PDB code 1IT3), solvating with explicit
water (TIP3P) molecules, and ionizing with NaCl. After an initial energy minimization of
this system for 1000 steps, I equilibrated the box-volume by conducting a 1-ns long molecular
dynamics (MD) simulation in the NPT ensemble, where the temperature was controlled at
310 K using the Langevin thermostat and the pressure was controlled using the Nosé-Hoover
barostat. I used an integration time-step of 1 fs, periodic boundary conditions, the particlemesh Ewald summation (with a grid spacing of 1 Å) for long-range electrostatics, and a
cutoff distance of 10 Å for van der Waals interactions. For exhaustive exploration of CO
diffusion using enhanced sampling methods (vide infra), I created 22 identical initial systems
(70,036 atoms), each differing only in the initial position of CO, which was chosen to span
various locations throughout the enzyme matrix. Each of these systems was MD equilibrated
for 1 ns in the NPT ensemble using the protocol described above. The coordinates from the
end of the MD trajectories of these equilibrated systems were used as initial conditions for
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TAMD simulations (vide infra). I note that the aim of creating systems with different CO
initial locations is to explore the entire volume of the enzyme. In my study, I have observed
that 22 systems are sufficient for CO to explore all space of the enzyme.

3.3.2

TAMD Simulations

Similar to a previous study [1], I applied TAMD (section 2.4.1) for exhaustively exploring
the CO-accessible interior volume of the FeFe-hydrogenase by using the Cartesian coordinates
of the center-of-mass of CO as the three-dimensional CV-space. In TAMD simulations, I
used β̄ −1 values ranging between 2 kcal/mol and 7 kcal/mol, a spring constant κ of 200
kcal/mol·Å2 , and a fictitious friction coefficient γ̄ of 50 ps−1 . Starting from each of the 22
initial locations of CO (vide supra), I performed 30 independent 1-ns long TAMD simulations
resulting in a total of 660 ns of simulation time for exhaustive sampling of CO diffusion.
Specifically, from all TAMD trajectories, I recorded a total of 330,000 CO positions covering
the accessible volume of the FeFe-hydrogenase (Figure 3.2a).

3.3.3

Free-energy Surface (FES) Reconstruction and Minimum Free Energy

Pathways
To reconstruct the 3D-FES of CO diffusion in the FeFe-hydrogenase, I used the method
described in the section 2.4.1 [137, 142]. Out of all CO positions sampled by TAMD, I chose
635 unique centers (Figure 3.2b). The centers were chosen with a prescribed cutoff distance
of 4 Å. To compute the mean-force at each of the k centers, fk , I launched 635 new MD
simulations in which the center-of-mass of CO is harmonically restrained about the CV-value
at the chosen center, as described by equation 2.8 in section 2.4.1. These new MD simulations
used a spring constant κ of 10 kcal/mol·Å2 . Each of these simulations generally lasted for
1 ns within which I observed the convergence of the mean-force (Figure C.1A in Appendix
C), but some centers required simulations up to 5-ns long for the convergence of the meanforce (Figure C.1B in Appendix C). I show the convergence of all mean-force calculations by
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Figure 3.2: A dense cloud of all positions (330,000) of the center-of-mass of CO sampled via
TAMD simulations is shown (panel a) along with 635 unique positions/centers used for meanforce calculations (panel b). The protein backbone is shown as a white cartoon, and points
representing the center-of-mass positions of CO are colored from red to blue corresponding
to an increasing distance from the H-cluster (shown in a black space-filling representation).
plotting the histogram of the standard deviation of each mean-force calculation computed
over the last 10% of each restrained MD trajectory. This histogram reveals the behavior of
a delta function centered at the origin indicating convergence (Figure C.2 in Appendix C).
Using converged mean-forces at all centers, I globally reconstructed the free-energy surface
A(z) (equations 2.9 and 2.10 in section 2.4.1) with that the optimized value of σ was ∼4.55
Å and the value of the relative residual was ∼0.73.
I further studied the 3D-FES using the zero-temperature string (ZTS) method [151–154]
(section 2.4.1) and found MFEPs between all pairs of minima. MFEPs are the most probable
pathways between pairs of minima on A(z) and are identified as the diffusion pathways for
CO inside the enzyme.
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3.4

Results

3.4.1

Free-energy surface and minima for CO Diffusion

Figure 3.3: (a) The front and side views of the free-energy isosurfaces for CO diffusion are
shown at three different energy levels: 4 kcal/mol (red), 8 kcal/mol (green), and 12 kcal/mol
(blue). (b) The locations of 44 local minima, the global minimum (labeled G), the Xenon
cavity (labeled Xe), and the 2Fe subcluster (black sticks) are shown. The minima with the
free-energy values higher than 12 kcal/mol (cyan spheres) are also labeled. (c) Isosurfaces
at three different energy levels and associated local minima are shown: red spheres (0-4
kcal/mol), green spheres (4-8 kcal/mol), and blue spheres (8-12 kcal/mol).
I used mean-force values at 635 unique centers, chosen via exhaustive sampling through
TAMD simulations (Figure 3.2), in combination with the single-sweep method to reconstruct
the 3D-FES for CO diffusion in the FeFe-hydrogenase. In Figure 3.3a, I show isosurfaces
of the 3D-FES at three different energy levels (4, 8, and 12 kcal/mol) measured relative to
the global energy minimum. I observed that the free-energy difference between the global
minimum and the solvent space is ∼18.81 kcal/mol. In regions of the enzyme where two
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hydrophobic pathways have been suggested previously (Figure 1.3b), the 3D-FES revealed
isosurfaces with energy levels higher than 12 kcal/mol, thereby indicating that CO is unlikely
to diffuse via these hydrophobic channels.
Besides the global minimum (labeled as G in Figure 3.3b,c), I also show the locations
of 44 additional local minima in the 3D-FES along with the location of a presumed xenon
binding site (labeled as Xe). Among these minima, 10 have free-energy values below 4
kcal/mol (leftmost panel in Figure 3.3c), 14 have free-energy values between 4 kcal/mol and
8 kcal/mol (middle panel in Figure 3.3c), 15 have free-energy values between 8 kcal/mol
and 12 kcal/mol (rightmost panel in Figure 3.3c), and the remaining have free-energy values
of 12 kcal/mol or higher (labeled in cyan in Figure 3.3b). The global minimum is located
near residues A415, F417, and G422 and has a distance of 9.56 Å from the Fed of the 2Fe
subcluster of the H-cluster. The local minima 2 and 7 with free-energy values of 2.08 kcal/mol
and 2.94 kcal/mol are located at distances of 10.37 Å and 2.75 Å, respectively, from the Fed
of the 2Fe subcluster of the H-cluster. The energy values at minima 2 and 7 suggest that
CO has a higher affinity in proximity of the active site.
I observed that all 10 local minima with lower free-energy values (≤ 4 kcal/mol) are
located largely outside of the region previously suggested for two hydrophobic pathways
(Figure 1.3b). Among the 14 local minima with energy values between 4 kcal/mol and 8
kcal/mol, only the local minimum 17 is found in the vicinity of the hydrophobic pathway B
indicating that two hydrophobic pathways have regions with free-energy values higher than
8 kcal/mol. Indeed, I identified that the local minima 40, 43, and 44 (Figure 3.3b) are in
the pathway A with free-energy values higher than 12.00 kcal/mol, and the local minima
29, 35, 37, 38, and 39 (Figure 3.3c) are in the pathway B with free-energy values ranging
between 8 and 12 kcal/mol. Overall, in comparison to minima in pathway A, the minima
in pathway B have lower free-energy values. With a distance of 15.16 Å from the Fed of the
2Fe subcluster of the H-cluster, a previously proposed Xe cavity is located in the pathway
A and has a neighboring local minimum 43.
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3.4.2

Network of CO Diffusion Pathways

Figure 3.4: (a) Front and back views of MFEPs for CO diffusion are depicted on the structure
of the FeFe-hydrogenase along with the positions of all minima (indicated by spheres). (b)
The MFEPs for CO diffusion from the other local minima to the local minimum 7 are shown.
(c) The MFEPs for CO diffusion within 0-18 Å (leftmost panel), 18-25 Å (middle panel),
and over 25 Å (rightmost panel) of the local minimum 7 are shown. All local minima, the
global minimum, and the Xe cavity are labeled as in Figure 3.3. The locations of the energy
barriers are shown by transparent magenta spheres in panels b and c.
I located an MFEP for each pair of local minima using the zero-temperature string (ZTS)
method [151–153]. The ZTS-algorithm begins with an initial guess for a curve connecting
the chosen minima pair on the analytically-reconstructed 3D-FES. This initial guess is then
iteratively optimized via a discretized parameterization scheme by keeping points along the
curve equidistant on each iteration while allowing points to move on the basis of the steepest
descent on the 3D-FES. Therefore, MFEPs are the pathways of minimal free-energy for CO
diffusion in the FeFe-hydrogenase, which are assumed as the most likely diffusion channels
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for CO.
I show the network of these pathways in Figure 3.4a, where one can visualize the colorcoded free-energy values along with the MFEPs between local minima pairs (depicted as
spheres). Consistent with the 3D-FES, I found that the MFEPs of CO diffusion along
previously proposed hydrophobic pathways have high free-energy values (over 8 kcal/mol),
which are shown as blue curves. I also observed that the MFEPs interconnect multiple local
minima between the solvent-space and the H-cluster. I present a center-by-center matrix of
energy barriers between all pairs of local minima in Table S1 (see Appendix C). I find that
major energy barriers along MFEPs originating from the global minimum to neighboring
local minima are ∼10 kcal/mol, and these barriers are higher than the energy barriers of
reverse MFEPs. This suggests a preference for CO diffusion toward the global minimum.
Previous studies have suggested that CO binds the Fed of the 2Fe subcluster of the H-cluster,
thereby competing with the binding of O2 [33,34,36]. To explore the CO diffusion pathways
connecting the solvent region and the H-cluster, I present the MFEPs of CO diffusion between
the local minimum 7 (which is located in the vicinity of the Fed of the 2Fe subcluster of the
H-cluster, an area known as the geminate site) and other neighboring minima (Figure 3.4b
and 3.4c). The locations of the major energy barriers along MFEPs are indicated by magenta
spheres (Figure 3.4c).
Within 18 Å of the H-cluster, I identified 12 local minima, including the global minimum:
5 minima with the free-energy values lower than 4 kcal/mol (red/black spheres), 3 minima
with the free-energy values in the range of 4 to 8 kcal/mol (green spheres), 3 minima with
the free-energy values in the range of 8 to 12 kcal/mol (blue spheres), and 1 minimum with
a free-energy value of 18.20 kcal/mol (cyan sphere).
The energy barriers for pathways 2-7 and 5-7 are 2.45 kcal/mol and 5.23 kcal/mol, respectively. The pathways 3-7, 23-7, and 24-23-7 have energy barriers of 9.29 kcal/mol, 3.61
kcal/mol, and 7.58 kcal/mol, respectively. The pathways 17-7 and 35-7 share a part of their
MFEPs, but the major energy barriers are located at distinct positions, in the vicinity of
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the residue F328 for the pathway 17-7 vs. the residue D273 for the pathway 35-7. The
MFEP originating at the minimum 30 passes through the minimum 26 before arriving at the
minimum 7. Therefore, the pathways 30-7 and 26-7 share the same major energy barrier of
2.49 kcal/mol. The pathway 43-7 passes through the local minimum 35 as well as the global
minimum (G), and both MFEPs 43-7 and G-7 have the same major energy barrier of 14.62
kcal/mol. This suggests that a deep local minimum with high energy barriers of CO escape
could trap CO.
Within 18 to 25 Å of the H-cluster, I found 20 additional distinct local minima, most of
which are located at or near the surface of the enzyme and likely serve as local reservoirs
for CO as it enters from the solvent. The local minima 4, 6, 8, 9, and 10 have free-energy
values lower than 4 kcal/mol (relative to the global minimum). The pathways 6-7 and 9-7
share part of their MFEPs as well as the location of the major energy barrier in the vicinity
of the residue A230, but the values of the free-energy barriers for each pathway are distinct,
9.29 kcal/mol (pathway 6-7) and 8.15 kcal/mol (pathway 9-7). Also, the pathways 6-7 and
9-7, respectively, pass through the minima 3 and 23, two minima located within 18 Å of
the H-cluster (left panel; Figure 3.4c). Similarly, the pathway 4-7 passes through the local
minimum 5 and shares a part of its MFEP with the pathway 19-7 as well as the location
of the major energy barrier in the vicinity of the residue V352, but the value of the energy
barrier for each pathway is different, 5.23 kcal/mol for the pathway 4-7 (same value as for the
pathway 5-7) and 8.15 kcal/mol for the pathway 19-7. Even though the pathways from the
local minima 8, 37, 38, and 39 to the minimum 7 merge in the pathway 17-7, the locations of
the major energy barriers along the MFEPs of 8-7, 37-7, and 38-7 are different. Specifically,
the barriers along pathways 8-7, 37-7, and 38-7 are located near residues F348, I567, and
A331, respectively. The energy barrier for the pathway 39-7 is in the vicinity of residues
S323 and Q325. Since the pathway 29-7 passes through the local minimum 35, the location
of the energy barrier is same as for the pathway 35-7. Several other pathways show shared as
well as unique features: the pathways 10-7, 41-7, 32-13-7 and 18-5-7 merge into the pathway
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2-7, but the location of the energy barrier for each pathway is different, and the pathways
31-13-30-26-7, 36-26-7, 42-30-26-7, and 44-26-7 merge into the pathway 26-7, but the energy
barriers for 31-13-30-26-7 and 36-26-7 are located in the unshared parts of their MFEPs
and the energy barriers for 42-30-26-7 and 44-26-7 are located in the shared part 26-7. The
pathway 36-7 passes through the global minimum and has the same value for the major
energy barrier with the same location as the pathway G-7.
I observed 13 local minima at a distance over 25 Å from the Fed of the H-cluster, most
of which are located in the non-active-site domain of the enzyme (rightmost panel in Figure 3.4c). Among these 13 minima, two (12 and 40) are located in the solvent region near
the enzyme surface and show MFEPs reaching to the minimum 7: the pathways 12-19-5-7,
19-5-7, 4-5-7, and 5-7 all arrive at the minimum 7 and along which the major energy barrier
of 5.23 kcal/mol is shared, and the pathway 40-7 passes through the local minimum 43 as
well as the global minimum to arrive at the local minimum 7. The MFEPs of several other
minima in the non-active-site domain merge at the local minimum 2, but each MFEP has a
different location and magnitude of the energy barrier (see Table C.1 in Appendix C).

3.5

Discussion
In this study, I employed several enhanced sampling and free-energy simulation meth-

ods [137, 142, 151–154] to investigate the 3D-FES of CO diffusion within the CpI FeFehydrogenase that revealed an interconnected network of minimal free-energy pathways for
CO diffusion. The 3D-FES and the location of the global minimum within the enzyme shows
that CO prefers to diffuse into the protein matrix from the solvent space, similar to what has
been observed earlier for O2 [1, 37]. The MFEPs show that CO likely migrates via multiple
routes to reach those free-energy minima that are located in the vicinity of the active site
(e.g. the global minimum G and the local minimum 7; Figure 3.4). The local minimum 7 is
in the vicinity of the Fed of the H-cluster, a site where CO is known to bind [5,34], while the
global minimum is located in the proximity of the pathway A (Figure 1.3b). I observed that
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Figure 3.5: Locations of the minima for CO (filled spheres) and O2 (wireframe spheres)
diffusion in the CpI FeFe-hydrogenase are shown. The global minimum for both gases are
shown in black filled or wireframe spheres and are labeled (G for CO and G-O2 for O2 ).
The Xenon cavity is shown as a pink sphere and labeled as Xe. For CO, colors of other
minima are consistent with Figure 3.4: red (0-4 kcal/mol), green (4-8 kcal/mol), blue (8-12
kcal/mol), and cyan (over 12 kcal/mol). For O2 , colors of minima indicate the following
energy ranges: red (0-12 kcal/mol), green (12-16 kcal/mol), and blue (over 16 kcal/mol).
the escape of CO from the global minimum requires overcoming barriers of over 10 kcal/mol
(Table C.1 in Appendix C), which suggests that the global minimum likely serves as a CO
reservoir. The magnitudes of energy barriers for CO escape from the immediate vicinity of
the global minimum are qualitatively similar to those found for O2 [1].
CO diffusion in two hydrophobic pathways: Previous studies have suggested the
existence of two hydrophobic pathways (pathways A and B in Figure 1.3b) which have been
assumed as potential channels for diffusion of inhibitory gases [5, 31, 37–39]. However, the
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3D-FES revealed that these two hydrophobic pathways are regions of the enzyme with higher
free-energy values for CO diffusion, which indicates that CO likely migrates via other regions
of the enzyme to access the active site. These observations are consistent with a previous
finding that the mutations in the hydrophobic channels had no significant effect on the
kinetics of CO diffusion [5]. The MFEPs of CO diffusion in two hydrophobic channels also
showed requirements of overcoming relatively high free-energy barriers for CO diffusion to
the H-cluster. Previous studies on O2 diffusion in the CpI FeFe-hydrogenase showed that O2
prefers diffusion via pathway B than via pathway A [1,37]. I observed a similar phenomenon
for CO diffusion where free-energy values associated with pathway B are lower than those
with pathway A, indicating that CO and O2 may share and compete for similar pathways.
MFEPs to the active site: The MFEPs of CO diffusion from other minima to the
local minimum 7 could potentially disclose the mechanism of CO access to the active site.
In Figure 3.4, I show the MFEPs from 44 distinct minima to the local minimum 7 as well as
the locations of major barriers along MFEPs. The major energy barriers range between 2.45
kcal/mol and 16.68 kcal/mol, among which the the pathways 2-7 and 41-7 have the lowest
free-energy barriers and the pathway 28-7 has the highest free-energy barrier.
Among thermodynamically favored local minima at the surface of the enzyme (those with
free-energy values below 4 kcal/mol relative to the global minimum), the pathway 10-2-7 has
the lowest energy barrier of 4.15 kcal/mol, although the pathway 4-5-7 also has a comparable
energy barrier of 5.23 kcal/mol. However, the exit route for CO from the H-cluster requires
overcoming a barrier of at least 5.04 kcal/mol, which is the energy barrier along the reverse
MFEP 4-5-7. The lower energy barriers along the MFEP 4-5-7 for CO entry/exit from the
enzyme make this pathway a highly likely route for CO diffusion between the solvent and
the H-cluster. I note that the diffusion of a single CO molecular has been studied but in
practice multiple CO molecules are likely present within the enzyme.
Comparisons between CO and O2 diffusion in the enzyme matrix: In a previous
study of O2 diffusion in the CpI FeFe-hydrogenase, 23 minima were identified including
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the global minimum, which are shown in Figure 3.5 in a wireframe representation [1]. I
observed that two local minima of O2 partially overlapped with the local minima 2 and
5 of CO diffusion, indicating that CO and O2 may reside within the enzyme matrix at
shared locations. The global minimum for both inhibitory gases CO and O2 are located
near the active site, which suggests a high-affinity for both gases surrounding the active site.
The global minimum for CO is located near the residue F417, where F417Y mutation was
previously shown to decrease the kinetic rate constant for O2 diffusion [1, 159].
Although some common features can be found, CO diffusion and O2 diffusion in the CpI
FeFe-hydrogenase differ in many aspects. For example, no local minimum for O2 is found in
the immediate neighborhood of the H-cluster, but for CO, the local minimum 7 is situated
at a distance of 2.75 Å from the H-cluster. This suggests that CO likely has easier and faster
access to the active site than O2 , as has been previously suggested [34, 36]. This is further
reinforced by the fact that, on comparing the 3D-FES for CO in this work with that of O2
from a previous work [1], I found overall lower free-energy barriers for CO diffusion (with
respect to the global minimum for CO) than for O2 diffusion (with respect to the global
minimum for O2 ), even though the free energy difference (∆F) between the global minimum
and the solvent space for each gas are comparable, 18.81 kcal/mol (CO) and 18.5 kcal/mol
(O2 ).
However, in the regions of the enzyme with two hydrophobic pathways, I found that O2
diffusion is thermodynamically favored over CO diffusion, because five local minima (four
shown in green wireframe spheres and one shown as a red wireframe sphere near the Xe
cavity in Figure 3.5) with relatively lower free-energy values of O2 diffusion are located
along hydrophobic pathways.
Even though there exists a local minimum in the vicinity of the Xe cavity for both CO
and O2 , the Xe cavity is located in the lower free-energy region of the 3D-FES for O2 while
CO diffusion in the vicinity of the Xe cavity requires overcoming higher free-energy barriers.
The Xe cavity is surrounded by three hydrophobic residues (F493, A427, and A431) which
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may stabilize apolar gases over polar gases [5], indicating that O2 is more likely to be found
in the Xe cavity. These differences can also be explained by the observation that CO is
a polar molecule with a van der Waals volume of 16.20 cm3 /mol, while O2 is an apolar
molecule with a van der Waals volume of 13.00 cm3 /mol [160]. The effect of the size of
gases on diffusion pathways has been demonstrated in previous MD simulations of H2 and
O2 diffusion in the CpI FeFe-hydrogenase, where H2 with a smaller van der Waals radius was
shown to diffuse in a broader region of the protein matrix and on shorter timescales [37].
Furthermore, CO was shown as a better ligand for binding to electron-rich metals compared
with O2 [161]. This is consistent with the observation that CO reacts much faster than O2
with the FeFe-hydrogenase based on electrochemical studies [33, 34, 36, 162, 163].
Table 3.1: List of candidate residues for mutagenesis to increase the tolerance of the CpI
FeFe-hydrogenase for CO. The symbol X indicates that the residue has also been previously
tested/proposed [1–4] for disrupting the diffusion network of the competing inhibitor O2 in
this enzyme.
Residue
MFEP(s)
experimental computational
L191
13-2
X
C193
31-26
I197
25-2
X
A228
6-7
X
A230
9-7, 6-7
M295
44-26
X
C300
26-7
G302
42-26, 31-26
X
S323
39-7, 25-7
X
Q325
39-7, 25-7
V352
19-7, 4-7
X
K358
5-7, 4-7, 19-7, 28-7
X
T380
4-7
X
I416
41-G
V423
G-7
X
A426
29-G
X
V496
36-26, 44-26
H500
10-2
C503
2-7
Candidate residues for mutations: To prevent inhibitors (e.g. CO and O2 ) from
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binding to the Fed of the 2Fe subcluster of the H-cluster, mutagenesis of protein residues is
an approach to alter diffusion pathways. Based on the pathways and thermodynamics of CO
diffusion, I propose key candidate residues for mutations to disrupt or block the diffusion
of CO (Table 3.1). These 19 residues are located in the vicinity of the energy barriers of
the targeted MFEPs for CO diffusion. For example, the residue S323 is located near the
energy barrier for the pathway 39-7 and is along the previously proposed water pathway [5].
Similarly, the residue K358 is in the proximity of the energy barrier of the pathway 5-7,
and is also one of the residues defining the water-based proton-transfer pathway [1, 164,
165]. I hypothesize that replacing this residue with mutants having larger side-chains could
disrupt the CO diffusion along multiple MFEPs ( 5-7, 4-7, 19-7, and 28-7). The presence
of MFEPs for CO in the vicinity of the proton-transport pathway [164–166] as well as the
water pathway [5] also suggests the existence of shared pathways between water and gas
molecules [148, 167].
Among the proposed 19 residues to disrupt CO diffusion within the enzyme, 11 have been
experimentally studied or computationally proposed (marked as Xin Table 3.1) to decrease
the rate of O2 diffusion inside the CpI FeFe-hydrogenase [1,2,168]. For example, both I197 [2]
and V423 [168] have been experimentally studied to alter the diffusion rate of O2 . The other
9 residues have been proposed to block O2 diffusion [1], among which A228, M295, G302,
V352, and K358 are located in the proximity of energy barriers for O2 diffusion. This result
indicates that mutagenesis of common residues may decrease the diffusion rates of CO and
O2 in the CpI FeFe- hydrogenase. I speculate that mutations of I416, V423, and A426 may
have a weaker effect on decreasing the rate of CO diffusion because these three residues are
located in the enzyme region with higher free-energy values for CO diffusion.

3.6

Conclusion
In this study, I investigated diffusion pathways for CO in the CpI FeFe-hydrogenase by

employing TAMD simulations in combination with the single-sweep and string methods.
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I constructed a 3D-FES that revealed 45 free-energy minima forming an interconnected
network of pathways for CO diffusion. I observed a local minimum as well as the global
minimum in the vicinity of the active-site metal cluster, the H-cluster, to which CO is known
to bind. On comparing 3D-FES for CO with that of O2 , I found that even though both gases
may compete for shared diffusion pathways in some regions of the enzyme, other regions (e.g.
two hydrophobic pathways) reveal a preference for diffusion of O2 instead of CO. I also find
that out of 19 potential residues for mutations to disrupt the diffusion network of CO, 11
residues are shared with candidate residues for mutations to disrupt the diffusion network
of O2 . This suggests the possibility of designing FeFe-hydrogenase enzymes tolerant to both
inhibitory gases via mutations to residues shared among gases for diffusion along pathways
of minimal free-energy.

3.7

Publications
The work described in this chapter has been published in the following journal article:

(i) Liu, Y., Mohammadi, M., and Vashisth, H. (2018). Diffusion Network of CO in FeFeHydrogenase. J. Chem. Phys., 149(20), 204108.
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CHAPTER 4
STUDIES ON WATER TRANSPORT IN PAP CHANNELS IN
BIOMIMETIC MEMBRANES

4.1

Abstract
Peptide appended pillar[5]arene (PAP) is an artificial water channel resembling biologi-

cal water channel proteins, which has shown a significant potential for designing bioinspired
water purification systems. Given that PAP channels need to be incorporated at a high
density in membrane matrices, it is critical to examine the role of channel-channel and
channel-membrane interactions in governing the structural and functional characteristics of
channels. To resolve the atomic-scale details of these interactions, I have carried out atomistic MD simulations of multiple PAP channels inserted in a lipid or a block-copolymer
(BCP) membrane matrix. Classical MD simulations on a sub-microsecond timescale showed
clustering of channels only in the lipid membrane, but enhanced sampling MD simulations
showed thermodynamically-favorable dimerized states of channels in both lipid and BCP
membranes. The dimerized configurations of channels, with an extensive buried surface area,
were stabilized via interactions between the aromatic groups in the peptide arms of neighboring channels. The conformational metrics characterizing the orientational and structural
changes in channels revealed a higher flexibility in the lipid membrane as opposed to the BCP
membrane although hydrogen bonds between the channel and the membrane molecules were
not a major contributor to the stability of channels in the BCP membrane. I also found that
the channels undergo wetting/dewetting transitions in both lipid and BCP membranes with
a marginally higher probability of undergoing a dewetting transition in the BCP membrane.
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Collectively, these results highlight the role of channel dynamics in governing channel-channel
and channel-membrane interfacial interactions, and provide atomic-scale insights needed to
design stable and functional biomimetic membranes for efficient separations.

4.2

Introduction
In chapter 1 (section 1.3.2), I provide a brief introduction on water channels. Artificial

water channels have shown promising industrial applications over biological protein channels.
In this chapter, I focused on one of the artificial water channels-PAP channels (Figure 4.1A)
embedded in membrane matrices to investigate the channel-channel and channel-membrane
interactions. I hypothesized that these interactions can alter the conformational and functional behavior of channels.
In this chapter, I report results from four systems in which multiple PAP channels were
inserted in a 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) or a polybutadiene (PB)/
polyethylene-oxide (PEO) membrane matrix (Figure 4.1B-E). To understand channel-channel
and channel-membrane interactions in the four systems, I performed long time-scale classical
MD simulations totaling 6 µs of simulation time. Besides classical MD simulations, I employed metadynamics as an enhanced sampling method to study the dimerization propensity
of two PAP channels and to resolve the thermodynamics of channel dimerization in both
lipid and BCP membranes. I also characterized interactions between the channels and their
surrounding membrane environment. The results provide molecular-scale insights into factors that should be considered in designing membranes with a high density of channels while
maintaining their activity.
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Figure 4.1: (A) The molecular structure of the PAP channel is shown with the central pillararene ring (brown sticks) and the peptide arms (transparent gray sticks). (B, C, D, and
E) Shown are the top-views of four simulation systems in two types of membranes (panels
B and C, POPC; and panels D and E, PB-PEO). All molecules are shown in space-filling
representations: PAP (black), POPC and PEO chains (white), and PB chains (gray). Water
molecules are not shown for clarity.
4.3

Methods

4.3.1

System Setup

I studied the dynamics of PAP channels in a POPC and a PB-PEO membrane matrix.
For each type of membrane, I created two types of systems containing 2 PAP channels
(2PAP/POPC and 2PAP/PB-PEO) and 4 PAP channels (4PAP/POPC and 4PAP/PBPEO) (Figure 4.1B-E). I used the membrane builder plugin in the Visual Molecular Dynamics
(VMD) [110] software to create a square-shaped patch (90 Å × 90 Å) of the POPC membrane
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containing 215 lipids before the insertion of PAP channels. After inserting two or four
PAP channels with an initial inter-channel center of mass distance of ∼30 Å, I removed
overlapping lipids within 1.5 Å of each PAP channel. I then obtained 194 and 170 POPC
lipids in 2PAP/POPC and 4PAP/POPC systems, respectively. For the BCP membrane,
I used the PB12 PEO9 architecture which has been successfully used to incorporate PAP
channels in a previous work [66]. I placed PB-PEO chains on a grid and arranged them
in a diblock configuration over an area of 90 Å × 90 Å. After inserting two or four PAP
channels, similar to systems in the POPC membrane, I obtained 228 and 210 PB-PEO chains
in 2PAP/PB-PEO and 4PAP/PB-PEO systems, respectively. I then solvated four systems
with explicit water molecules (TIP3P) while keeping the membrane-domains free of water
molecules. Details of all systems are given in Table 4.1.
Table 4.1: Details of classical MD simulations
#
POPC
PB-PEO
2PAP 4PAP 2PAP 4PAP
PAP
2
4
2
4
POPC
194
170
PB-PEO
228
210
atoms
55867 53710 84276 83139
water
9467
9330
13692 13783
runs
3
3
3
3
length/run 0.5 µs 0.5 µs 0.5 µs 0.5 µs

4.3.2

Classical MD Simulations

I performed classical MD simulations of the four systems in three stages. In the first
stage, after performing an initial minimization of each system for 4000 steps, I performed
a brief (0.25 ns; time-step: 1 fs) MD equilibration of lipids and polymers in the NVT
ensemble. During this first stage, only POPC/PB-PEO atoms were allowed to move while
all other atoms were fixed. In the second stage, the initial coordinates of systems from the
first step were used to conduct a 0.5 ns MD equilibration of each system with a time-step
of 2 fs and in the NPT ensemble at a constant membrane area. All atoms, except those
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in PAP channels, were allowed to move while additional forces via a tcl-script were applied
to keep water molecules out of membranes. In Figure 4.1 (panels B, C, D, and E), I show
snapshots for each system after the second stage. For the final stage, I performed triplicate
MD simulations with a time-step of 2 fs in the NPT ensemble for each of the four systems,
where each trajectory was 0.5 µs long. I controlled temperature (at 303 K) using a Langevin
thermostat and pressure (at 1 atm) using a Nosé-Hoover barostat.

4.3.3

Metadynamics Simulations

To study the thermodynamics of dimerization of channels in the POPC/PB-PEO membrane matrices, I adopted the initial coordinates of 2PAP/POPC and 2PAP/PB-PEO systems from the last snapshots of the second stage of classical MD simulations. I then employed
metadynamics (equation 2.11) as an enhanced sampling method to resolve the free-energy
profiles of two PAP channels dimerizing as a function of the inter-channel distance as a
collective variable (CV). Introduction on metadynamics can be found in section 2.4.2. In
this study, I used one CV (the distance between the central pillar[5]arene rings of two PAP
channels: dCV ), spanning between 10 Å and 30 Å. I performed metadynamics simulations for
both systems with a timestep of 2 fs, W = 0.2 kcal/mol, δ = 0.05 Å, and τG = 1 ps, where
each trajectory was 0.63 µs long. Similar parameters have been successfully applied to study
several biophysical problems [155–157]. I performed all classical and enhanced sampling
MD simulations using NAMD [111], and system setup and analyses using VMD [110]. The
force-field parameters for POPC, TIP3P water, and PEO used here are from the CHARMM
force-field [117–119], and the parameters for the PAP channel and the PB block were adopted
from the literature [65, 120].

4.3.4

Metrics for Conformational and Functional Analyses

Buried Surface Area (BSA): I used the BSA as a measure to characterize channelchannel interactions. The BSA between a pair of PAP channels, a and b, was measured
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using the following equation:

BSA = SASAa + SASAb − SASAab

(4.1)

where SASAa , SASAb , and SASAab are the solvent accessible surface areas (SASAs) of channel a, channel b, and the pair of channel a and channel b, respectively. A probe radius of
1.4 Å was used to compute SASA. For systems with 2 PAP channels, I measured the BSA
between adjacent PAP channels, while for systems with 4 PAP channels, I measured the
BSA between adjacent as well as diagonally opposite pairs of PAP channels.

Distance between the Center of Mass (COM) of PAP Channels: I measured two
different distances to quantify channel-channel interactions: the distance between the allatom COM of PAP channels (dCOM ) and the distance between the central pillar[5]arene rings
(dCV ). The distance dCV was also used as a CV in metadynamics simulations, where it spans
between 10 Å and 30 Å to facilitate observation of dimerization and dissociation of a pair of
PAP channels.

Root Mean Squared Distance (RMSD): Since the peptide arms of the PAP channel
can undergo structural changes due to perturbations and constraints from each membrane, I
evaluated RMSD values of channels in each membrane to quantify conformational changes.
The RMSD calculations were based upon all atoms and the initial configuration of the PAP
channel was used as a reference.

Orientational Angle: To quantify changes in the orientation of channels, I measured the
angle of the channel axis relative to the membrane normal (θ). Initial conformations of
channels were perpendicular to the membrane plane (θ = 0◦ ).
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Two Dimensional (2D) Number Density: I characterized the dynamics of membranes
(POPC or PB-PEO) with 2D number density maps computed over the last 5 ns of each
simulation to highlight the distribution of POPC and PB-PEO atoms. By defining grids
of 0.5 Å × 0.5 Å size in the xy-plane that span the full z-axis, I counted the number of
atoms (Natom ) over the last 5 ns and used the following equation to compute the 2D number
density:
ρatom = Natom /(Nframe × V)

(4.2)

where ρatom is the 2D number density in one grid, Natom is the total number of atoms I
counted in one grid over the last 5 ns simulation, Nframe is the number of frames which is
250, and V is the volume of the chosen slab.

Hydrogen Bonds (H-bonds): I measured the number of H-bonds (NH ) between the
POPC/PB-PEO molecules and each PAP channel using VMD. I used a cutoff distance of 3
Å and a cutoff angle of 20◦ , and the acceptors of H-bonds included N, S, O, F, C, and P.

Number of Water Molecules: To quantify water transport, wetting, and dewetting characteristics of channels, I computed the number of water molecules (NW ) within PAP channels
by defining a cylindrical volume (with diameter = 5 Å and height = 12 Å) centered around
the pillar[5]arene ring of each channel.

Permeability: To measure the permeability of each PAP channel in all systems, I applied
the collective diffusion model [169] which has been used in previous studies of PAP [65, 66]
and other proteins [170]. By defining a cylindrical channel volume (3 Å in radius and 8
Å in height) centered around the pillar[5]arene ring of each channel, the mean squared
displacement of the collective displacement coordinate n(t) was obtained for each simulation
with trajectories divided into 1 ns segments, where n(0) = 0 for each segment. The diffusion
coefficient of the collective displacement coordinate (Dn ) was then used along with the
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volume of a single water molecule (vw ) to obtain the osmotic permeability of each channel
as vw Dn .

4.4

Results

4.4.1

Clustering Propensity of Channels

To understand the clustering propensity of channels in membranes, I carried out classical
MD simulations of solvated PAP channels in a POPC or a PB-PEO membrane matrix.
For each of the four systems, three independent MD simulations (each 0.5 µs long) were
carried out, thereby resulting in 6 µs of simulation data. The initial distance between
the COM of neighboring PAP channels (dCOM ) was ∼30 Å (Figure 4.2 at t = 0 ns). In
Figure 2, I show snapshots from the conformational evolution of 2PAP and 4PAP systems in
POPC (Figures 4.2A and 4.2C) and PB-PEO (Figures 4.2B and 4.2D) membranes. In the
2PAP/POPC system, I observed clustering of two PAP channels into a dimer after ∼263.5 ns
simulation (Figure 4.2A). In fact, a cluster of two PAP channels was observed only after 10
ns in another independent simulation of this system (Figure D.1A). I also observed that the
cluster size can be up to four PAP channels in the 4PAP/POPC system (Figures 4.2C and
D.1B), indicating that a higher density of PAP channels likely increases the propensity of
clustering. Compared with the clustering behavior of PAP channels in POPC, the aggregates
of PAP channels in PB-PEO (Figures 4.2B and 4.2D) were not observed in the classical MD
simulations.
Besides the visual inspection of the clustering behavior of channels, I measured the interfacial BSA between a pair of PAP channels (Figures 4.3, D.2A, D.2C, and D.3) and the
distances between their COM (Figures D.2B, D.2D, and D.4). An increase in the BSA
indicates a stronger interaction between a pair of PAP channels. I observed a significant
difference between the BSA in the POPC vs. PB-PEO membrane. Triplicate runs of the
2PAP/POPC system showed that BSA can be more than 300 Å2 (Figure 4.3A; left panel),
while the BSA in the 2PAP/PB-PEO system on similar time-scales remains around 0 Å2
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Figure 4.2: Snapshots from one of the three MD runs highlighting the evolution of each
system at different time points are shown. All panels are labeled, where panels A and B
correspond to systems with 2 PAP channels and panels C and D correspond to systems with
4 PAP channels. All PAP channels and membrane molecules are shown in black and gray
wireframe representations, respectively.
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Figure 4.3: The evolution of interfacial buried surface area (BSA) vs. simulation time
(ns) between pairs of PAP channels from three independent runs is shown. Data shown in
panels on the left correspond to systems in the POPC membrane, while that on the right
correspond to systems in the PB-PEO membrane. The pair of PAP channels for which the
BSA is reported are highlighted by filled black circles on the top left corner of each panel.
For systems with 4 PAP channels, BSA data are reported for adjacent as well as diagonally
opposite channels.
(Figure 4.3A; right panel).
In the POPC membrane, the BSA of adjacent PAP channels increased with more PAP
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channels (four channels), as larger values of BSA up to 795 Å2 were observed (Figure 4.3B;
left panel). Also, a BSA of more than 100 Å2 between a pair of diagonally opposite PAP
channels was identified (Figure 4.3C; left panel). In contrast to the POPC membrane, the
BSAs between pairs of adjacent PAP channels (Figure 4.3B; right panel) or diagonally placed
PAP channels (Figure 4.3C; right panel) were about 0 Å2 in 2PAP/4PAP systems in the PBPEO membrane. The results from other independent simulations in the PB-PEO membrane
showed similar behavior (Figures D.2 and D.3).
These results are further reinforced by measurements on distances between the COM of
pairs of PAP channels. Initially, I placed all PAP channels side by side with a dCOM of ∼30 Å.
The dCOM decreased from ∼30 Å to 23 Å when the clustering of PAP channels was observed
in the 2PAP/POPC system (Figure D.2B), and a shorter dCOM of 20 Å was observed in the
4PAP/POPC system (Figure D.4). On the contrary, in the PB-PEO membrane I observed
that the distances were sufficiently large (30 Å and 40 Å for adjacent and diagonal channels,
respectively) to keep PAP channels dissociated (Figures D.2D and D.4).

4.4.2

Conformational Flexibility of PAP Channels

I hypothesized that the conformational behavior of PAP channels may alter their functional characteristics. To probe the conformational dynamics of channels in each membrane,
I quantified the conformational metrics of the orientational angle (Figure 4.4) of the channel
axis relative to the membrane normal (θ) and the RMSD (Figure 4.5) relative to the initial
structure of the PAP channel (Figure 4.1A). These variables inform about the conformational flexibility and stabilization of the PAP channel in each membrane. For example, a
large orientational angle suggests a higher flexibility of PAP channels, which could lead to
channel insertion and burial within the surrounding membranes. It will affect the transport
characteristics of the channels.
The initial conformations of PAP channels in all simulations were perpendicular to the
membrane plane (θ = 0◦ ). During simulations, the conformations of PAP channels evolved
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Figure 4.4: Probability distributions of the data on the orientational angles (θ) of PAP
channels are shown for all four systems (panels A and B, systems in the POPC membrane;
and panels C and D, systems in the PB-PEO membrane). The distributions included data on
θ values computed from three independent runs. The traces in black indicate the Gaussian
functions fitted to describe the data in distributions.
due to interactions with the surrounding lipids or BCPs. In Figure 4.4, I show distributions of
θ for 2PAP and 4PAP systems in both POPC and PB-PEO membranes. These distributions
are based upon the data from three independent runs of each system. For the POPC systems
(Figure 4.4A and 4.4B), I observed that there were two major orientational states for PAP
channels corresponding to θ = 11◦ and θ = 23◦ . The predominant orientation of channels in
the 2PAP/POPC system was at θ = 11◦ (Figure 4.4A), while in the 4PAP/POPC system
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was at θ = 23◦ (Figure 4.4B). For the 2PAP/POPC system (Figure 4.4A), an average θ
of ∼18◦ was observed and θ spanned a range between 0◦ and 48◦ . For the 4PAP/POPC
system, the averaged θ increased to ∼22◦ , spanning a range between 0◦ and 55◦ . Contrary
to relatively wider distributions of θ in the POPC membrane, the distributions in the PBPEO membrane are sharply peaked (Figure 4.4C and 4.4D). The most probable angle was
∼12◦ for both 2PAP/PB-PEO and 4PAP/PB-PEO systems.
In Figure 4.5, I show distributions of all-atom RMSD relative to the initial structure
(Figure 4.1A) for all systems in both POPC and PB-PEO membranes. I also show snapshots corresponding to different RMSD values in Figure D.5. In the POPC membrane
(Figures 4.5A and 4.5B), I observed three major states corresponding to RMSD values of
∼5.6 Å, ∼6.1 Å, and ∼6.6 Å, except that in the 4PAP/POPC system, where I also observed
a low-populated new state with a higher RMSD value of ∼7.3 Å. The most probable RMSD
value was ∼5.6 Å for both 2PAP/POPC and 4PAP/POPC systems.
I also observed that there were three major states, corresponding to RMSDs of ∼4.8 Å,
∼5.2 Å, and ∼6.0 Å, in the 2PAP/PB-PEO system (Figure 4.5C). However, I observed an
additional low-populated state with an RMSD value of 4.5 Å in the 4PAP/PB-PEO system
(Figure 4.5D). The most probable RMSD value for channels in the PB-PEO membrane was
4.8 Å, which is smaller than the RMSD of channels in the POPC membrane (5.6 Å). In
addition, the RMSD values up to 8 Å were observed in the POPC membrane, while the
largest RMSD was ∼7 Å in the PB-PEO membrane.

4.4.3

Conformational Behavior of Lipids and BCPs

In all systems, PAP channels were inserted in the hydrophobic regions of membranes and
therefore likely affect the arrangements of hydrophobic segments of lipids or BCPs. To probe
the arrangement of lipid or BCP molecules surrounding PAP channels, I first analyzed (over
the last 5 ns in all simulations) the 2D atomic number density for the hydrophobic regions
of POPC or PB-PEO molecules. In Figure 4.6, I show color-coded atomic density maps
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Figure 4.5: Data similar to Figure 4 are shown for the distributions of RMSD of PAP channels
in all four systems. The distributions included data on RMSD values computed from three
independent runs.
for 2PAP and 4PAP systems, where blue indicates lower densities and red indicates higher
densities. For systems in the POPC membrane (Figures 4.6A and 4.6B), I observed larger
areas with uniform colors (similar densities) indicating that lipid molecules likely diffuse in a
larger volume instead of localizing in a specific region. However, in the PB-PEO membrane
(Figures 4.6C and 4.6D), I observed that the atomic density maps have many small patches
of isolated areas with yellow-to-red color indicating a higher local density of atoms. These
observations are further corroborated by measurements on radially distributed positions of
the center of mass of lipid and BCP molecules surrounding PAP channels which showed that
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Figure 4.6: The 2D number density maps for the hydrophobic tails of lipids or hydrophobic
(PB) blocks of BCP membranes are shown. Panels A and B are for systems in the POPC
membrane, respectively, and panels C and D are for systems in the PB-PEO membrane. Blue
to red color indicates lower to higher values of the number density (ranging between 0 and
150 Å−3 for the POPC membrane and between 0 and 80 Å−3 for the PB-PEO membrane).
some of the lipid molecules that were initially closer to the PAP channel diffused significantly
away (Figure D.7A) during the course of simulation, while the PB-PEO chains mostly stayed
near the channel (Figure D.7B).

4.4.4

Hydrogen-bonding Interactions

To understand the interactions of PAP channels with the lipid or BCP molecules, I
analyzed hydrogen-bonding interactions because non-covalent H-bonds are assumed as a
major contributor to structural stabilization in biological systems [171, 172]. Therefore, it
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Figure 4.7: Probability distributions of the data on the number of hydrogen bonds (NH )
between the PAP channel and the surrounding POPC or PB-PEO matrix are shown for
all four systems (panels A and B, systems in the POPC membrane; and panels C and D,
systems in the PB-PEO membrane). The distributions included data on NH averaged over
all PAP channels and three independent runs.
has been suggested that water channels could be stabilized through the formation of Hbonds between the channel and membrane molecules [70]. Specifically, I investigated the
number of hydrogen-bonds (NH ) between the PAP channel and POPC or PB-PEO molecules
(Figure 4.7). I observed NH values up to 8 for systems in the POPC membrane, although
the mean value of NH was 2 (Figure 4.7A, B). However, increased number of PAP channels
did not result in an increase in NH , which is likely because channel-channel interactions led
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to a decreased contact area between the channels and lipids. On the contrary, for systems
in the BCP membrane, I observed the highest probability for the occurrence of no hydrogen
bonds and significantly lower probabilities for 1 or 2 hydrogen bonds. Unlike systems in the
POPC membrane, this suggests that the hydrogen bonds between the PAP channel and the
PB-PEO molecules are likely not a major contributor to the flexibility and/or stability of
the channel in the BCP membrane.

4.4.5

Thermodynamic Analysis of PAP Dimerization

Figure 4.8: Free-energy profiles of channel dimerization in each membrane (panel A, POPC;
and panel B, PB-PEO) are plotted against the chosen collective variable (dCV ). The freeenergy scale is plotted to have the free-energy minimum in each profile corresponding to
a free energy value of zero. Shown also are side-view snapshots of both PAP channels at
the free-energy minima (labeled 1 and 10 ) and at the free-energy barrier (labeled 2 and 20 )
to dissociation. The central pillar[5]arene rings are colored as yellow or green spheres, the
backbone of the peptide arms of each channel is colored as cyan or magenta sticks, and the
aromatic rings in each peptide arm are colored in blue sticks. The corresponding top-views
of channel snapshots are shown in Figure D.7.
While I observed the spontaneous dimerization of PAP channels in the POPC membrane
in the classical MD simulations (Figure 4.2), I did not observe it in the PB-PEO membrane
on a 0.5 µs timescale. Therefore, I used metadynamics as an enhanced sampling method for
studying the dimerization propensity of a pair of PAP channels in each type of membrane,
where two channels were initially placed at a distance of 30 Å. In Figure 4.8, I show free62
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energy profiles as a function of the chosen CV (dCV ; see methods) as well as the snapshots
of both channels at the minima (near association) and the maxima (near dissociation).
Each profile shows a free energy minimum where stable PAP-dimers were formed in the
POPC membrane (Figure 4.8A; dCV ∼13.6 Å) and in the PB-PEO membrane (Figure 4.8B;
dCV ∼12.7 Å). The dimerized configuration of channels at each free energy minimum suggests
that two PAP channels were adjacently positioned (Figure4.8 and Figure D.7), while a further
decrease in dCV to lower values shows an increase in the free energy (Figure 4.8) and thereby
distortions in channels (Figure D.8). For the dimerized configurations, the BSA between
the channels was 1032 Å2 (POPC) and 918 Å2 (PB-PEO) which indicates an extensive
dimerization interface.
From each free energy profile, one can further infer the free energy barrier that needs to
be overcome for the dissociation of dimerized configurations. This barrier is the free energy
difference between the energy maxima observed at higher values of dCV (occurring at ∼14.6
Å in POPC, and at ∼14 Å in PB-PEO) and the minima corresponding to the dimerized
states. These barriers are ∼3 kcal/mol (in the POPC membrane) and ∼7 kcal/mol (in the
PB-PEO membrane) indicating that the dimerized channels are less likely to dissociate in
the PB-PEO membrane relative to that in the POPC membrane.

4.4.6

Water Transport Characteristics

It is of interest to understand the influence of membranes on the functional transport
behavior of PAP channels. To quantify this, I measured the averaged number of water
molecules in all PAP channels over three independent classical MD simulations. Specifically,
I counted the number of water molecules within a cylindrical volume (Figure 4.9A) centered
around the pillar[5]arene ring of each channel. When two PAP channels were inserted in each
membrane, the most probable scenario was the presence of two water molecules (Figure 4.9B).
The probability of observing states with no water molecules within the cylindrical volume
was marginally higher in the 2PAP/PB-PEO system than in the 2PAP/POPC system.
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I also observed that the increased density of PAP channels affected their water transport
characteristics. The systems with a higher density of PAP channels showed a marginally
higher probability of observing the state with no water residence (Figure 4.9C): the probability of a drying state increased from 4% to 22% for systems in the POPC membrane,
and from 10% to 18% for systems in the PB-PEO membrane. More than four fold increase
(from 4% to 22%) in the probability of no water residence in the POPC membrane indicates
that stronger channel-channel interactions in the 4PAP/POPC system in comparison to the
2PAP/POPC system may pose a blocking effect on water transport.

Figure 4.9: (A) The channel volume selected for measuring the number of water molecules
(Nw ) is highlighted as a transparent cylinder centered around the pillar-arene ring of the PAP
channel. (B and C) Probability distributions of Nw are shown for 2PAP configurations (panel
B) and 4PAP configurations (panel C) in each membrane. The distributions were computed
from data averaged over all PAP channels and from three independent MD simulations.
Furthermore, I measured the osmotic water permeability of individual PAP channels
in each system for each simulation (Figure 4.10). I observed an averaged permeability of
2.99 × 10−14 cm3 /s/channel in the 2PAP/POPC system (Figure 4.10A), while the averaged
permeability slightly decreased to 2.89 × 10−14 cm3 /s/channel in the 4PAP/POPC system
(Figure 4.10B). The averaged permeability for the 2PAP/PB-PEO system was 2.72 × 10−14
cm3 /s/channel (Figure 4.10C) and decreased to 1.70 × 10−14 cm3 /s/channel the 4PAP/PBPEO system (Figure 4.10D). While these permeability values are of the same order of mag64
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Figure 4.10: Permeability of each PAP channel in both POPC (panel A, 2PAP/POPC; and
panel B, 4PAP/POPC) and PB-PEO (panel C, 2PAP/PB-PEO; and panel D, 4PAP/PBPEO) membranes. The permeability values for each channel are reported from three independent simulations.
nitude as observed in a previous study of a single PAP channel in both membranes [66], individual PAP channels showed significant differences in permeability values: the lowest and
the highest permeability values respectively were 0.58 ×10−14 cm3 /s and 8.77 ×10−14 cm3 /s
(2PAP/POPC), 0.55 ×10−14 cm3 /s and 9.78 ×10−14 cm3 /s (4PAP/POPC), 0.45 ×10−14
cm3 /s and 7.14 ×10−14 cm3 /s (2PAP/PB-PEO), and 0.24 ×10−14 cm3 /s and 5.42 ×10−14
cm3 /s (4PAP/PB-PEO). Correspondingly, I also observed in each membrane that the PAP
channel with a higher permeability has a lower mean RMSD, while the one with a lower permeability has a higher mean RMSD (Figure D.9), thereby suggesting a correlation between
the channel flexibility and its permeability.
Furthermore, I observed wetting/dewetting transitions in PAP channels in both membranes, where fully transitioning from a dewetting state to a wetting state required less than
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3 ns (Figure 4.11). Such transitions have been explained as capillary condensation switching
with capillary evaporation, as observed in AQPs and AWCs [173, 174]. These observations
highlight that water molecules in PAP channels are likely in a metastable state. The transport characteristics of the PAP channel can be further affected by the membrane molecules.
Unlike a previous study in which it was observed that a lipid chain could enter the PAP
channel and block its pore [65], in the simulations I did not observe that the entrances/exits
of PAP channels were completely blocked by lipid molecules or the PB-PEO chains, although
I observed that the entrance of each PAP channel was partially or transiently blocked by the
flexible arms of the channel itself or the hydrophilic regions of lipids or polymer chains.

4.4.7

Conformational Metrics and Water Transport Characteristics in Larger

Systems
To test the effect of the membrane-size on conformational metrics and water transport
characteristics of PAP channels, I further studied two larger systems, 2PAP/POPC (85423
atoms) and 4PAP/POPC (83766 atoms), with increased number of POPC lipids (383 and
363 lipids, respectively). I conducted two independent simulations for each system with each
simulation trajectory of 300 ns (2PAP/POPC) and 100 ns (4PAP/POPC), respectively.
In both systems, I observed clustering of PAP channels (Figures D.10A, D.11A) with the
interfacial BSA up to 400 Å2 (Figures D.10B, D.11B). With an increased density of PAP
channels, I observed that the distributions of conformational metrics (θ and RMSD) became
more wider (panels C, D in Figure D.10 vs. Figure D.11) and the range of values explored
for both metrics were consistent with the data from systems with lower number of lipids
(panels A, B in Figures 4, 5). I further measured water permeability of each PAP channel
in both systems and report an averaged permeability of 1.61 × 10−14 cm3 /s with a range
between 1.03 × 10−14 cm3 /s and 2.05 × 10−14 cm3 /s in the 2PAP/POPC system, and an
averaged permeability of 1.50 × 10−14 cm3 /s with a range between 0.71 × 10−14 cm3 /s and
2.54 × 10−14 cm3 /s in the 4PAP/POPC system.

66

4.5. DISCUSSION

Figure 4.11: Snapshots of wetting/dewetting states of a single PAP channel are shown in
the POPC membrane (panel A; wetting states: 105.92 ns and 121.12 ns, and the dewetting
state: 110.92 ns) and in the PB-PEO membrane (panel B; wetting states: 472.08 and 475.48
ns, and the dewetting state: 473.48 ns). In all snapshots, depicted are PAP channels via
gray/magenta sticks, lipids/BCP molecules via gray lines, neighboring water molecules via
cyan spheres, and water molecules inside channels in van der Waals representations (oxygen
atoms in red and hydrogen atoms in white).
4.5

Discussion
In this study, I incorporated multiple PAP channels in a lipid or a polymeric mem-

brane and employed classical MD simulations and enhanced sampling methods to investigate channel-channel and channel-membrane interactions. The results show clustering of
PAP channels in the POPC membrane in classical MD simulations. The clustering phe-
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nomenon was highlighted in a recent study, in which it was suggested that the aggregates
were stabilized by hydrogen bonds between neighboring PAP channels [65]. I observed that
the interaction between PAP channels initially occurred through the aromatic rings of the
peptide arms in channels. Therefore, I note that the π-π stacking of aromatic rings from
neighboring channels also contributes to the stabilization of aggregates.
Moreover, an increased density of channels could result in stronger interfacial interactions
between PAP channels, thereby subsequently leading to a large-size cluster, as seen in this
study where a cluster of four PAP channels was formed, and in a recent work [65] where the
size of a PAP cluster in lipids could be up to 13 PAP channels. The interfacial BSA between
the channels in the 2PAP/POPC system was up to 300 Å2 vs. 795 Å2 in the 4PAP/POPC
system which suggests that a higher density of PAP channels leads to interfacial channelchannel interactions over a larger area.
I also note that the timescale of 0.5 µs was not sufficient for observing via classical
MD simulations the clustering of channels in the PB-PEO membrane, as the observation of
clustering of PAP channels likely requires overcoming higher free energy barriers. However,
the free energy profiles resolved via enhanced sampling metadynamics simulations showed
that the dimerized states of PAP channels exist in both POPC and PB-PEO membranes.
While the dissociation of a PAP dimer requires overcoming a barrier of ∼3 kcal/mol in the
POPC membrane, up to ∼7 kcal/mol is required for the dimer dissociation in the PB-PEO
membrane.
I observed that the increased density of PAP channels could also affect the orientation of
channels in the POPC membrane while a little effect was observed in the BCP membrane.
A previous study of a single PAP channel in the POPC/PB-PEO membrane suggested that
the tile-angle (θ) of the axis of the PAP channel, relative to the membrane normal, was
∼15◦ [66]. In this study, the averaged tilt-angles were found higher when two or four PAP
channels were inserted in the POPC membrane: 18◦ in the 2PAP/POPC system and 22◦ in
the 4PAP/POPC system. I also observed that the tilt-angle distributions of channels in the
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POPC membrane became broader when the number of channels was increased from two to
four. However, in the PB-PEO membrane, the averaged tilt-angle for channels was ∼12◦ and
no significant changes in tilt-angles were observed when the channel density was increased
from two to four.
Furthermore, based upon all-atom RMSD calculations, I found that the channels were
more flexible in the POPC membrane than in the PB-PEO membrane and increasing the
channel density in the POPC membrane led to higher RMSD values. A previous study of a
single PAP channel demonstrated that the RMSD values in PAP channels are mostly contributed by the flexible peptide arms [66], which suggests that the peptide arms in channels
were more stable in the PB-PEO membrane relative to the POPC membrane. This is potentially useful for the design of PAP-based biomimetic membranes where it is desired to
enhance the stability of channels while maintaining their functional (permeability/selectivity) characteristics.
Unlike the studies on carbon nanotubes (CNTs) in lipids where the surrounding lipid
molecules adopted a layered and annular structure [175], I did not observe any organized pattern from the analysis of two-dimensional atomic densities of POPC or PB-PEO molecules.
This observation is consistent with the viewpoint that the flexibility and roughness of the
outer wall of a biological/synthetic channel plays a vital role in lipid distributions and
the increased flexibility of the outer wall may deteriorate the organization of membrane
molecules [70, 176–180]. The arms of the PAP channel are flexible without a well-defined
shape unlike the rigid structure of a CNT, indicating that the perturbations on membranes
due to the PAP channel are likely smaller than those by a CNT [70]. Moreover, multiple
clustered channels as a single assembly may further increase the surface roughness, thereby
affecting the organization of lipid or BCP molecules.
I also identified that the probability of observing a dewetting state in the PAP channel
is marginally higher than in the PB-PEO membrane compared to the POPC membrane.
This is consistent with a previous study showing that the permeability of PAP channels
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in the PB-PEO membrane was slightly lower than in the POPC membrane, although the
value of the channel permeability in each membrane was of the same order of magnitude
(∼ 108 molecules/s/channel) [66]. Furthermore, I observed a higher probability of observing
a dewetting state when the channel density was higher. Specifically, an increase of up to
∼20% in the probability of observing a dewetting state was found in both 4PAP/POPC
and 4PAP/PB-PEO systems. A previous study also suggested that from a set of 25 PAP
channels inserted in the POPC membrane, on average, only 40% of the channels were filled
with water [65]. The single-channel osmotic permeability measurements for individual PAP
channels (Figure 4.10) further revealed differences in their water permeability characteristics,
which correlated well with the flexibility of the channel in that the channels with higher/lower
permeability values had lower/higher RMSD values (Figure D.9), respectively.
These observations mean that the PAP channel, like other hydrophobic nanopores, likely
functions via a gating mechanism and switches between an open and a closed state [59,181].
This nanopore confinement effect leads to perturbed diffusive and dielectric behavior of
water molecules [173, 182, 183], and thereby leads to a wetting/dewetting transition in the
channel. While water orientation and interactions with the channel interior are factors
leading to a dewetting state, other factors could be the blockage of the channel pore by
membrane molecules [65]. Collectively, these results reveal several atomic-scale details of
channel-channel and channel-membrane interactions [184, 185] that govern the functional
behavior of channels and are therefore key factors to consider in the design of biomimetic
membranes with a high density of channels.

4.6

Conclusions
I employed MD simulations to study channel-channel and channel-membrane interactions

of AWCs in lipid and BCP membranes. Specifically, I incorporated multiple PAP channels
in a POPC or a PB-PEO membrane matrix to investigate interfacial interactions between
channels and membranes. Although classical MD simulations on a 0.5 µs timescale showed
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spontaneous clustering of channels only in the POPC membrane, enhanced sampling simulations showed that it is thermodynamically favorable for channels to dimerize in both
POPC and PB-PEO membranes. I found that the free-energy barrier for the dissociation of
dimerized channels was ∼4 kcal/mol higher in the PB-PEO membrane relative to the POPC
membrane. I quantified that the dimerized configurations have ∼1000 Å2 of surface area
buried between the channels and the neighboring channels are stabilized by π-π interactions
between the aromatic groups in the peptide arms of each channel. The measurements on
the tilt-angle of the channel axis and the RMSD relative to the initial structure showed that
the channels were more flexible in the POPC membrane relative to the PB-PEO membrane.
I also found that the hydrogen bonds between the channel and the membrane molecules
were not a major contributor to channel stability in the PB-PEO membrane. Furthermore,
I report on wetting/dewetting transitions in the PAP channel in both POPC and PB-PEO
membranes and found that the probability of observing a dewetting state was marginally
higher at a higher channel density and for channels in the PB-PEO membrane.

4.7
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The work described in this chapter has been published in the following journal article

(highlighted on journal cover; Figure D.12):
(i) Liu, Y. and Vashisth, H. (2019). Conformational Dynamics and Interfacial Interactions
of Peptide-appended pillar[5]arene Water Channels in Biomimetic Membranes. Phys.
Chem. Chem. Phys., 21(41), 22711-22721.
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CHAPTER 5
STUDIES ON ALLOSTERIC COMMUNICATION PATHWAYS IN RGS
PROTEINS

5.1

Abstract
RGS proteins play a central role in modulating signaling via G-protein coupled receptors

(GPCRs). Specifically, RGS proteins bind to activated Gα-subunits in G-proteins, accelerate the GTP hydrolysis, and thereby rapidly dampen GPCR signaling. Therefore, covalent
molecules targeting conserved cysteine residues among RGS proteins have emerged as potential candidates to inhibit the RGS/Gα protein-protein interaction and enhance GPCR
signaling. While these inhibitors bind to conserved cysteine residues among RGS proteins,
it has been previously suggested that their potencies and specificities are related to differential protein dynamics among RGS proteins [95]. Using data from all-atom molecular
dynamics simulations, I reveal these differences in RGS dynamics by partitioning the protein structural space into a network of communities that allow allosteric signals to propagate
along unique pathways originating at inhibitor binding sites and terminating at the RGS/Gα
protein-protein interface.

5.2

Introduction
In the section 1.3.3 of chapter 1, I provide a brief introduction to RGS proteins and TDZD

inhibitors. In this chapter, I aim to reveal how internal motions in homologous RGS proteins
form allosteric networks and what pathways exist through which the allosteric perturbations
from covalent binding sites are conveyed to the RGS-Gα protein-protein interface. To address
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these questions, I have studied here five RGS proteins (RGS4, RGS8, RGS9, RGS17, and
RGS19) through dynamic allostery analysis of long timescale MD simulations. This analysis
has revealed differences in allosteric pathways originating at the conserved cysteine residues
(termed source residues) located on the α4-helix of each RGS protein and arriving at each
of the six key residues (termed sink residues) in the RGS/Gα protein-protein interface.

5.3

Methods

5.3.1

System Preparation and Simulation Details

I used the NAMD [111] software to perform MD simulations using the CHARMM forcefield [117–119] and the VMD [110] software to visualize and analyze data. I used the initial
coordinates from the protein data bank entries 1AGR, 2ODE, 1FQI, 6AM3, and 1CMZ
for RGS4, RGS8, RGS9, RGS17, and RGS19, respectively. I solvated all systems with
TIP3P water molecules and charge-neutralized with NaCl. The final simulation domains
were comprised of 28160 atoms (RGS4), 30731 atoms (RGS8), 30777 atoms (RGS17), 29369
atoms (RGS17), and 29560 atoms (RGS19). After an initial energy minimization (500 cycles)
of all systems, I optimized box volumes in the NPT ensemble for ∼100 ps using a time-step
of 2 fs. The pressure was set at 1 atm and controlled using the Nosé-Hoover barostat and the
temperature was controlled at 310 K using the Langevin thermostat. I then conducted long
time-scale MD simulations of all systems in the NVT ensemble. Each system was subjected
to a 2 µs long MD simulation with a time-step of 2 fs. The periodic boundary conditions
were applied in all simulations. I also analyzed simulation data on RGS4, RGS8, and RGS19
from previous studies on RGS proteins [95].

5.3.2

Residue Fluctuations and Salt-bridge Analyses

I analyzed Cα-based root mean squared fluctuation (RMSF) per residue to identify flexible residues (Figure E.4) and to compare differences in dynamics among RGS proteins. I
also analyzed a network of conserved and non-conserved salt-bridges formed between charged
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Figure 5.1: Structural similarities and key residues in RGS proteins (A) Shown are the
front and back views of the overlay of structures of five RGS proteins: RGS4 (PDB code
1AGR), RGS8 (PDB code 2ODE), RGS9 (PDB code 1FQI), RGS17 (PDB code 6AM3), and
RGS19 (PDB code 1CMZ). The alignment is based on the Cα -atoms of the α4-helix. (B)
Sequence similarity between RGS proteins is highlighted. The similarity between a pair of
RGS proteins was computed based upon the sequence alignment (Figure E.2) and residues
52 to 178 (RGS4), 46 to 172 (RGS8), 289 to 414 (RGS9), 74 to 200 (RGS17), and 80 to
206 (RGS19). Shown also are cartoon representations of all RGS proteins, classified by their
subfamily, and highlighting the conserved cysteine residues (cyan spheres) that are targeted
by covalent inhibitors. Six key residues of each RGS protein that participate in the RGS/Gα
protein-protein interface are shown by colored spheres and labeled. The structures of three
known RGS/Gα complexes are shown in Figure E.3.
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amino acids. A salt-bridge was considered stable if the distance between the nitrogen atoms
of basic residues and any of the oxygen atoms of acidic residues forming the salt-bridge was
within 3.2 Å.

5.3.3

Dynamic Network Analysis

To infer correlated residues and allosteric networks in proteins, several approaches based
upon protein sequence and dynamics have been developed [186,187]. The sequence based approaches make use of multiple sequence alignment and the coevolution principle for identifying evolutionarily conserved residues that can be combined into allosteric groups and sectors
in proteins [188, 189]. The dynamics based approaches rely on data from MD simulations
and include principle component analysis [190], mutual information between residues [191],
timing correlations [192], interaction correlations [193], and community network analysis [85].
I used the method developed by Sethi et al. [85] to conduct community and allosteric
pathway analyses, which has been successfully applied in extensive studies of allostery in
protein kinases [87–92]. Based on MD simulations of each protein, I first performed the
cross correlation analysis using Carma [134] by setting the Cα-atoms of residues as nodes.
The pairwise correlations are defined by the equation 2.5. The correlation maps are provided
in Figure E.5.
An edge is formed between two nodes when the two nodes are within a cutoff distance
of 4.5 Å for at least 75% time of an MD trajectory [85]. A length of an edge (lopt ) is defined
in the equation 2.6. I then can find the optimal pathway from a source node to a sink node
which has the shortest length lopt (Figures 3 and 4). The edge betweenness is then defined
as the number of shortest pathways crossing that edge.
To identify communities, I used the Girvan-Newman algorithm [85, 135] which removes
the edge with the highest betweenness until the last node. Then the optimal community
structure is chosen using a largest modularity value which measures difference in the probability of intra- and inter-community edges. The modularity value has a maximum value of 1.
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Generally, the modularity values are in the range of 0.4-0.7 [194]. For RGS systems studied
here, the modularity values are ∼0.58. In a community network, there may exist several
edges connecting any two communities. These edges are termed as critical edges, and the
nodes forming these edges are termed as critical nodes (Figure E.7).

5.4

Results
For work described in this chapter, I aim to evaluate differences in structure and dy-

namics of five distinct RGS proteins (RGS4, RGS8, RGS9, RGS17, and RGS19), especially
allosteric communication pathways originating at conserved cysteine residues and ending at
the protein-protein interface between RGS proteins and Gα subunits of G-proteins. I first
highlight a comparison of sequences and structures of all five RGS proteins, followed by
per residue fluctuations as observed from initial structures and subsequent MD simulations.
I then discuss conserved salt-bridging interactions among various helical structural motifs,
allosteric community network, and allosteric pathways.

5.4.1

Sequence and Structural Comparison

I have studied five RGS proteins from three different subfamilies: the R4 subfamily (RGS4
and RGS8), the R7 subfamily (RGS9), and the RZ subfamily (RGS17 and RGS19). I report
sequence similarity among pairs of RGS proteins in Figure 5.1B and the sequence alignment
for all proteins in Figure E.2. For the same subfamily, I observed a sequence similarity of
56.25% among RGS4 and RGS8, and of 68.75% among RGS17 and RGS19, while sequence
similarities are lower (∼33-48%) between RGS proteins from different subfamilies. Contrary
to the variation among their sequences, the structures of RGS proteins are highly similar with
each protein containing 9 α-helices (Figure 5.1A) and a highly conserved cysteine residue on
the α4-helix (labeled in cyan in Figure 5.1C and highlighted in cyan in Figure E.2). The
canonical RGS-Gα protein-protein interface mainly has three structural motifs on Gα termed
as the switch regions (switch I, II, and III; Figure E.3) that contact residues of RGS proteins
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buried within the interface (Figure 5.1C). I aim to understand allosteric coupling between
the conserved cysteine residues on the α4-helix, that are sites of inhibitor binding [101], and
key residues in the RGS-Gα interface. The comparison of sequences and structures alone is
limited in gaining insights into these allosteric couplings. Therefore, I report below metrics
aimed at differentiating dynamical features among RGS proteins.

5.4.2

Root Mean Squared Fluctuations (RMSF)

I report RMSF values per residue based upon the initial structures of all RGS proteins
as well as from their subsequent MD simulations (Figure 5.2). On comparing experimental
structures of other RGS proteins (RGS8, RGS9, RGS17, and RGS19) with RGS4, a canonical
member of this family, higher RMSF values for residues in the α4-α5 interhelical loops were
observed for all other RGS proteins, with the highest values in this loop of RGS9 which is
likely due to the presence of a glycine (G341) residue (Figure 5.2). In comparison to other
RGS proteins, higher RMSF values for residues in the α5-α6 and α6-α7 interhelical loops
and in the α3-helix (Figure 5.2A; magenta trace) were observed for RGS19, and for residues
in the α6 and α7 helices of RGS9 and RGS17 (Figure 5.2A; red and green traces).
I further calculated RMSF values based on MD simulations of RGS structures (Figure 5.2B) and observed that residues in the α6-α7 loops showed higher fluctuations in all
RGS proteins except in RGS17. Also, the RMSF values for residues in the α3-α4 loop of
RGS9 were higher than in other RGS proteins. Importantly, the structural motifs showing
higher flexibility are either located in the RGS/Gα protein-protein interface (e.g. residues
in the α3-α4 and α5-α6 loops) or in the proximity of cysteine residues (e.g. residues in
the α4-α5 and α6-α7 loops) accessed by allosteric inhibitors of RGS proteins. I hypothesize that these differences in conformational fluctuations of residues in the loop motifs of
RGS proteins potentially contribute to differences in potencies and selectivities of inhibitory
compounds [95, 102].
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Figure 5.2: The root mean squared fluctuations (RMSF) per residue are shown based upon
experimental structures (panel A) and MD simulations (panel B). The residue numbers on
the x-axis are for RGS4 (52-178) that correspond to the following residues in other RGS
proteins: 46 to 172 (RGS8), 289 to 414 (RGS9), 74 to 200 (RGS17), and 80-206 (RGS19).
5.4.3

Correlation between Salt-bridges and RGS Dynamics

Previous studies have shown that the mutations in residues forming salt-bridges in RGS4,
RGS8, and RGS19 alter their dynamics and correlate with inhibitor potency [195]. Therefore,
I further analyzed salt-bridging interactions between charged residues in all RGS proteins,
as changes in these interactions may perturb the conformational flexibility of helical motifs
and may play a role in allosteric communication.
I observed eight salt-bridges conserved across all five RGS proteins, four of which connect
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different helices or loops (Figure 5.3A), while the remaining four reside within the same helix
or a loop (Figure E.4). In Figure 5.3A, I show four conserved salt-bridges for RGS4 that
connect two different helices or a helix with a loop: E83-R167 links the α3-α4 interhelical loop
with the α8-helix, E87-K125 links the α4-helix with the α5-α6 interhelical loop, E97-K110
links the α4-helix with the α5-helix, and K99-D150 links the α4-helix with the α7-helix. The
percentage occupancy of each of the four conserved salt-bridges across all five RGS proteins
is shown in Figure 5.3B.
These results suggest the following: (i) the E77-R161 salt-bridge in RGS8, corresponding
to E83-R167 in RGS4, is marginally stronger than in other four RGS proteins; (ii) saltbridges homologous to E87-K125 in RGS4 show stronger interactions in RGS4, RGS17, and
RGS19 than in RGS8 and RGS9; (iii) among salt-bridges homologous to E97-K110 in RGS4
as well as among three other conserved salt-bridges, the D119-K132 salt-bridge in RGS17
shows the highest occupancy; and (iv) the K99-D150 salt-bridge in RGS4, that connects the
α4-helix and the α7-helix, shows a stronger connection in the R7 subfamily (RGS9) and the
RZ subfamily (RGS17 and RGS19) than in the R4 subfamily (RGS4 and RGS8)
Overall, salt-bridge analyses reveal differences in the interhelical interactions between
the α4-α5 and α4-α7 pairs of helices (Figure 5.3A). Importantly, the salt-bridges affecting
the conformational flexibility of the α4-α5 helical pair will lead to allosteric perturbations
since one of these salt-bridges is located near the conserved cysteine residue recognized by
covalent inhibitors (e.g. E97-K110; Figure 5.3) and the other salt-bridge is located near the
protein-protein interface (e.g. E87-K125; Figure 5.3). I further analyzed many unique and
non-conserved salt-bridges across all RGS proteins (see Appendix E and Figure E.5).
5.4.4

Community Network in RGS Proteins

By using data from MD simulations spanning 10 µs, I obtained residue-residue correlation
maps for all RGS proteins (Figure E.6). I then used the Girvan-Newman algorithm [135] to
find communities of correlated residues, thereby revealing the underlying community network
(Figure 5.4). In this algorithm (see methods), the community structure is probed based on a
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Figure 5.3: Conserved salt-bridges in RGS proteins. (A) Four salt-bridges conserved across
5 RGS proteins are highlighted on the structure of RGS4, a canonical member of the RGS
family. The conserved cysteine residue is highlighted as a cyan sphere and labeled C95.
Three key helices connected via inter-helical salt-bridges are also colored uniquely in cartoon
representations: α4 (yellow), α5 (green), and α7 (magenta). (B) Shown is the percentage
occupancy of conserved salt-bridges computed based on fractional time of the simulation
trajectory during which a given salt-bridge was intact based on a distance criterion. The
subscript “L” in salt-bridge labels for helices indicates a loop connecting two helices. For
example, (α3 /α4 )L signifies the loop connecting the α3 and α4 helices.
key metric termed “edge betweenness” of an edge, which is the number of shortest pathways
between pairs of vertices that run along it; the edge is a bridge between two nodes/vertices in
a network. By definition, the edge betweenness for intercommunity nodes is higher because
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Figure 5.4: Community network in RGS proteins. The network of communities and their
schematic community maps in RGS proteins, as organized by their subfamily memberships.The Cα -atoms of residues forming each community are uniquely colored and mapped
on respective protein structures. The communities are labeled 1 through 7 or 8 in corresponding community schematic maps. The cumulative edge betweenness is represented as
the width of intercommunity links. Additional details about critical nodes and listing of
residue memberships for each community are shown in Tables E.1-E.5.
of the existence of unique shortest pathways and lower for intracommunity nodes because
many alternative pathways [135, 196]. I further hypothesized that intercommunity communication can be established through bridging via critical nodes leading to the propagation of
perturbations originating at the shared cysteine residue to residues in the RGS-Gα interface.
I highlight such intercommunity connections in schematic maps shown in Figure 5.4, where
a thicker line indicates a stronger connection between communities.
I observed that RGS proteins from the same subfamily partition into the same number of
communities, 7 communities for the R4 subfamily and 8 communities for the RZ subfamily.
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Moreover, RGS9, a member of the R7 subfamily, partitions into 7 communities similar to the
R4 subfamily. However, the composition of various communities varies across proteins from
the same family or different family: (i) the community 1 (C1) contains the α1 helix in all five
RGS proteins, but additionally the α2 helix in RGS4, RGS9, and RGS19, and the α9 helix
in RGS8; (ii) the community 2 (C2) contains the α4-helix in all five RGS proteins, while it
may also involve parts of the α5-helix, as seen in RGS17, or the α7-helix, as seen in RGS4,
RGS8, RGS9, and RGS19; (iii) the community 3 (C3) only contains the α6-helix in all five
RGS proteins; (iv) the community 4 (C4) is composed of the α3-helix, the α8-helix, and/or
the α9-helix, as seen in RGS4, RGS8, RGS9, and RGS17, but it contains fewer residues
on the α8 and α9 helices in RGS19; (v) the community 5 (C5) contains the flexible α5-α6
interhelical loop located near the RGS/Gα interface, as seen in the R4 subfamily (RGS4 and
RGS8) and in the RZ subfamily (RGS17 and RGS19). However, in RGS9, C5 is distinct and
it contains residues from the terminal α9-helix; (vi) the community 6 (C6) contains parts
of the α7-helix, the α8-helix, and/or the α9 helix in RGS proteins. For example, in the
RZ subfamily members, C6 contains the α7-helix in RGS17 but also includes the α8 and
α9 helices in RGS19; (vii) the community 7 (C7) mainly contains the α5-helix in all RGS
proteins except in RGS17; (viii) the community 8 (C8) is only observed in the RZ subfamily
members, where in RGS17 it contains the terminal α9-helix, and in RGS19 it contains only
one residue (P172) on the α6-α7 interhelical loop.
To understand the allosteric perturbations originating at the binding site of covalent
inhibitors, it is useful to examine the links of the community C2 to other communities since
the conserved cysteine residue on the α4-helix is located within C2. Particularly significant
are links of C2 to communities harboring residues located in the RGS/Gα protein-protein
interface (e.g. C3 through C7). I observed a stronger communication between communities
C2 and C3 in all RGS proteins except in RGS9, suggesting that the perturbations originating
in C2 can be directly transmitted to C3 in the R4 and RZ subfamily members (RGS4, RGS8,
RGS17, and RGS19). In RGS9, C2 can communicate with C3 via the C4-C6 bridge or via
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the C7-C6 bridge. I also observed in all RGS proteins that C2 communicates with C4 or C6
to a varying extent. Compared to RGS4 and RGS19, a stronger communication between C2
and C4 can be found in RGS8, RGS9, and RGS17. Similarly, C2 and C6 have a stronger
communication in the R4 subfamily (RGS4 and RGS8), one member of the RZ subfamily
(RGS19), but not in other members of the RZ (RGS17) and R7 (RGS9) subfamilies. A direct
communication between C2 and C5 in all RGS proteins is weak or not observed. Importantly,
the community C2 serves as a hub of connectivity with several other communities in all RGS
proteins.
5.4.5

Allosteric Communication Pathways

Using the network of communities, I further analyzed allosteric pathways originating at
the conserved cysteine residue in each RGS protein (termed as a source residue) and ending
at six different residues in the RGS/Gα interface (each termed as a sink). Among these six
residues (Figure 5.1B and Figure E.3), one residue (Y84 in RGS4, F78 in RGS8, F321 in
RGS9, Y106 in RGS17, and Y112 in RGS19) resides on the α3-α4 loop and contacts the
switch I region of the Gα subunit; three residues (V127, N128, and S131 in RGS4 and counterparts in other RGS proteins; Figure E.2) are located in the α5-α6 loop interacting with
the switch II (residues V127 and N128 in RGS4) or switch III (residue S131 in RGS4) regions
of Gα; and the remaining two residues, residing on the α7-helix and α8-helix, contact the
switch I region of Gα (Figure 5.1B and Figure E.3) [101]. These residues are key participants
in the RGS-Gα interface because they directly contact the Gα subunit (Figure E.3) [197,198].
Importantly, mutations in Y84, N128, L159, and R167 in RGS4 significantly decreased the
GAP activity of RGS4 [197]. In addition, I also found that N128 and L159 in RGS4, N122
and L153 in RGS8, I363 in RGS9, and S150 in RGS17 are critical nodes (Tables E.1-E.5)
which are of importance for intercommunity communication.
Employing the method developed by Sethi et al. [85] which transforms the residue-residue
correlation data (Figure E.6) to the length of a pathway (see methods), I discovered allosteric
pathways from the source to sink residues and their corresponding lengths (Figures 5.5
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Figure 5.5: Allosteric pathways between source and sink residues. Shown are optimal pathways from the conserved cysteine residue (cyan sphere) to six sink residues. Panels A-F
depict each of the six pathways on the structure of RGS4 along with the details of residues
for each pathway in all RGS proteins, where the first residue serves as a source residue and
the last residue serves as a sink residue. See also Figure E.7. Additional pathways originating
at a second cysteine residue conserved only among RGS4 and RGS8 are shown in Figure E.8
and discussed in Appendix E.
and E.7). Given that there is one source residue (the conserved cysteine at the α4-helix;
Figure 5.1B) and six sink residues (each located in the protein-protein interface; Figure 5.1B),
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I have obtained six unique pathways (termed P1-P6) for each RGS protein that originate
at the source residue and terminate at each of the sink residues. I examined and concluded
that the allosteric pathways cannot be predicted by trivial physical distance analysis, which
predicts the order of pathways (shortest to longest) as P2 < P3 < P5 < P4 < P1 < P6, but
the shortest allosteric pathway is P5 and the longest is P3 (RGS8, RGS9, and RGS19) or
P4 (RGS4 and RGS17) (Figure E.7). I briefly describe all allosteric pathways below.
Among allosteric pathways, a shorter pathway length indicates that the sink residue is
easily affected by the source residue. Based on the pathway length analysis, the rankings for
pathways from the shortest to longest in five RGS proteins are: (i) RGS17 < RGS8 < RGS9
< RGS19 < RGS4 (P1); (ii) RGS19 < RGS8 < RGS4 < RGS17 < RGS9 (P2); (iii) RGS4 <
RGS17 < RGS9 < RGS19 < RGS8 (P3); (iv) RGS19 < RGS4 < RGS8 < RGS9 < RGS17
(P4); (v) RGS9 < RGS8 = RGS17 < RGS4 < RGS19 (P5); and (vi) RGS9 < RGS8 = RGS17
< RGS4 < RGS19 (P6). Examining these rankings for the fastest allosteric perturbation
pathway (shortest pathway length) originating at the conserved cysteine residue, which is the
source residue and the binding site of covalent inhibitors, reveals that the fastest pathway to
any of the sink residues located in the protein-protein interface is distinct in each of the three
subfamilies of RGS proteins. For the pathways P1, P2 or P4, the fastest perturbations will
be in the RZ subfamily, for the pathway P3 the fastest perturbations in the R4 subfamily,
and for the pathways P5 or P6 the fastest perturbations will be in the R7 subfamily.
These observations suggest that allosteric perturbations propagate: (i) in the R4 subfamily via P3 that connects the source cysteine residue (C95 in RGS4) to a sink residue on
the α5-α6 loop (N128 in RGS4); (ii) in the RZ subfamily via P1 which connects the source
cysteine residue (C117 in RGS17) to a sink residue on the α3-α4 loop (Y106 in RGS17)
or via P2 and P4 which connect the source cysteine residue (C123 in RGS19) to two sink
residues on the α5-α6 loop (V155 and S159 in RGS19); and (iii) in the R7 subfamily via P5
or P6 which connect the source cysteine residue (C332 in RGS9) to sink residues on the α7helix (L395 in RGS9) or on the α8-helix (R403 in RGS9). Since the preferred pathways for
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each subfamily terminate at distinct structural motifs in RGS proteins that contact distinct
regions in Gα subunits (the α3-α4 loop contacts switch I, the α5-α6 loop contacts switch III,
and α7/α8 helices contact switch I/II; Figure E.3), a differential inhibitory effect is expected
due to binding of covalent molecules at conserved cysteine residues.
5.5

Discussion
In this work, I have studied differences in dynamical features of five RGS proteins from

three subfamilies including the R4 subfamily (RGS4 and RGS8), the RZ subfamily (RGS17
and RGS19), and the R7 subfamily (RGS9). I highlight differences in sequences, structures, residue fluctuations, salt-bridging interactions as well as in allosteric communities and
pathways. I hypothesize that collectively these differences in dynamics of RGS proteins are
correlated with the differential inhibitory effect observed in binding of covalent inhibitors at
a conserved cysteine residue on the α4-helix of each RGS protein (Figure 5.1).
I observe key differences in dynamics of a bundle of helices (α4, α5, α6, α7) that are
connected by three flexible loop motifs (the α4-α5, α5-α6, and α6-α7 loops). Importantly,
two of these loop motifs (α4-α5 and α6-α7) are located near the conserved cysteine residue,
that serves as the binding site for covalent inhibitors, while the third loop motif (α5-α6) is
located in the RGS/Gα protein-protein interface and therefore directly contacts the Gα subunit. These helices and loops are held together by several conserved salt-bridges (Figure 5.3)
and differential strength of these salt-bridges underlie the flexibility of each RGS protein. For
example, the salt-bridges connecting the α4-α5 helical pair and the α6-α7 helical pair have
a higher occupancy in proteins of the R7 or RZ subfamilies (RGS9, RGS17, and RGS19) in
comparison to proteins of the R4 subfamily (RGS4 and RGS8).
Within the same subfamily (e.g. the R4 subfamily), I identified two non-conserved saltbridges (D136-K155 and R139-E151) connecting the α6-helix and the α7-helix in RGS4, while
no similar salt-bridge pair was found in RGS8 (Figure E.5). However, in a different subfamily
(e.g. the RZ subfamily), I identified again two non-conserved salt-bridges (K168-D178 and
K168-D179) connecting the α6-helix and the α7-helix in RGS19 (Figure E.5). The differential
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flexibilities of these helical and loop motifs due to distinct salt-bridging interactions in RGS
proteins are consistent with differential inhibitory effect [75,95,98,99] due to variability in the
exposure of the side-chains of conserved cysteine residues, as reported in a previous work [95].
As an example, it has been shown in a previous work that introducing a negative charge
(L111D) on the α4 helix of RGS19 resulted in a new salt-bridging interactions with the
α5-α6 loop that increased the thermal stability of RGS19 and decreased inhibitor potency
by several fold, likely due to difficulties in inhibitor access to the side-chain of conserved
cysteine residue on the α4-helix [195].
I also compared pairs of RGS proteins across all three subfamilies using a difference
cross-correlation analysis (Figure E.9). On comparing proteins from the same subfamily, for
example the R4 subfamily (RGS8 vs. RGS4), in RGS8 I observed a decreased correlation
between the α6-α7 loop and the α4/α7 helices, while an increased correlation between the
α6-α7 loop and the α6 helix. Similarly, comparing proteins of the RZ subfamily showed
in RGS19 a decreased correlation between the α4-α5 and α6-α7 loops. Among different
subfamily members (RGS9/RGS17/RGS19 vs. RGS4), I observed increased correlations
between the α6 and α7 helices in RGS9, no significant change in correlations for RGS17,
and decreased correlations between the α4-α5 and α6-α7 loops in RGS19. However, using
the R4 subfamily member RGS8 as a reference, I found increased correlations between the
α6 and α7 helices in RGS9, increased correlations between the α4-α5 and α6-α7 loops in
RGS17, and no significant change in correlations for RGS19.
From the residue-residue correlation data (Figure E.6), I also observed that the motions in the α4-helix and the α7-helix are highly correlated in all RGS proteins although
this correlation is weaker in RGS19. The observation of weaker correlations in the α4/α7
helical pair of RGS19 relative to other RGS proteins is consistent with the higher hydrogendeuterium exchange (HDX) rates in these motifs of RGS19 and lower HDX rates of these
motifs in other RGS proteins (e.g. RGS4 and RGS8), as reported in a previous work [95].
Furthermore, weaker correlations and higher HDX rates in the α4/α7 helical pair of RGS19
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suggest easier accessibility of the conserved inhibitor binding cysteine residue located on the
α4 helix, which is consistent with the observation that RGS19 is more potently inhibited
by CCG-50014 than RGS4/RGS8 [95]. Collectively, these differences highlight that due to
differential dynamics in helical and loop motifs surrounding the inhibitor binding sites, the
access to inhibitors is distinct among RGS proteins of the same or different subfamilies and
as a result, the inhibitory effect is distinct.
The analyses of a network of communities within RGS proteins further revealed that
the community C2, which harbors the inhibitor binding site (a conserved cysteine residue),
forms a hub of connectivity with many other communities in RGS proteins. For example, the
community C2 and C3 had stronger connectivity in the R4 and RZ subfamilies but not in the
R7 subfamily. Moreover, a stronger communication between C2 and C4 was found in at least
one protein member of each subfamily (RGS8 in the R4 subfamily; RGS9 in the R7 subfamily;
and RGS17 in the RZ subfamily), while I did not observe any direct communication between
C2 and C5. Furthermore, the analyses of allosteric pathways highlighted unique pathways
along which allosteric perturbations propagate from the inhibitor binding site to residues in
the protein-protein interface. For the pathways P1, P2, or P4, the fastest perturbations are in
the RZ subfamily, for the pathway P3 in the R4 subfamily, and for the pathways P5 or P6 in
the R7 subfamily. These differences suggest that the binding of covalent inhibitors to RGS
proteins differentially perturbs distinct regions (switch I, II, and III) in the Gα subunit,
thereby resulting in distinct inhibitory effect. Briefly, I also point out that although the
community partitioning based on MD simulations can vary among independent simulations
and analyses based on different cut-off distances, the allosteric pathways and their lengths
remain largely preserved (Figures E.10, E.11, and E.12).
Additionally, besides the conserved cysteine residue that serves as a binding site of allosteric inhibitors in RGS proteins, I found that two more conserved residues that lined most
of the pathways may be important for allosteric regulation: F91 and W92 in RGS4, F85 and
W86 in RGS8, F328 and W329 in RGS9, F113 and W114 in RGS17, and F119 and W120 in
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RGS19. This observation is consistent with the previous NMR data that showed significant
perturbations in the residue F91 in RGS4 on CCG-50014 binding [101]. However, the importance of these two residues may vary in different RGS proteins. For instance, four optimal
pathways in RGS8 (P1, P3, P5, and P6) crossed the residue W86, while four optimal pathways in RGS19 (P2, P3, P4, and P5) crossed the residue F119. Since both of these residues
are located away from the RGS/Gα protein-protein interface, targeting them (potentially
using non-covalent compounds) may provide an alternative route to achieve allosteric modulation in RGS proteins. It is supported by the fact that a binding pocket for inhibitors has
been proposed near the phenylalanine residue previously [100]. Moreover, previous study
have shown that non-covalent analogues of TDZD compounds can dock and stably reside in
the vicinity of these two residues [94]. Therefore, the findings are potentially useful in future
design of inhibitors with enhanced selectivity among protein members of the RGS family.
It is of importance to note that different force fields can lead to different results, as
seen in a previous study [93]. The discrepancy is expected given different protocols of
parameterization in different force-fields. In this study, I also employed the AMBER force
field (ff14SB) to do all-atom MD simulations of five RGS proteins [199]. I observed that the
community structures of different simulations vary to some extent (Figure E.13). However,
the allosteric pathways are highly similar using the same force field (Figure E.14). Similarly,
I also found that the community structures are not consistent with the community structures
using the CHARMM force-field. Interestingly, I observed that the allosteric optimal pathways
are highly similar regardless of different force-field, different PDB, or different runs. It
indicates that the method developed by Sethi et al. [85] is reliable for allosteric optimal
pathways analysis. Although the community structures vary in different simulations, I believe
that this discrepancy is due to insufficient simulation time in comparison with time-scale of
experiments.
5.6

Conclusions
I have studied differences in dynamics of five RGS proteins (RGS4, RGS8, RGS9, RGS17,
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and RGS19) from three subfamilies (R4, R7, and RZ) with an aim to probe their differential
inhibition by covalent inhibitors that target a conserved cysteine residue located on the
α4-helix in each protein. Via analyses of residue fluctuations, salt-bridging interactions,
allosteric communities and pathways, I highlight differences in dynamics of helical and loop
motifs surrounding the inhibitor binding site and near the RGS/Gα protein-protein interface.
The results reveal that preferred allosteric pathways exist among RGS members from distinct
families that allow propagation of allosteric signals from the inhibitor binding site to distinct
regions in the RGS/Gα protein-protein interface. I also suggest another pair of conserved
residues on the α4-helix (a Phe and Trp residue) as potential docking sites for non-covalent
inhibitors given that these two residues lined several allosteric pathways.
5.7

Publications
The work described in this chapter has been submitted as the following journal article:

(i) Liu, Y. and Vashisth, H. (2020). Allosteric Pathways Originating at Cysteine Residues
in Regulators of G-protein Signaling Proteins. Biophys. J. Under Review.
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CHAPTER 6
STUDIES ON RGS8/INHIBITOR INTERACTIONS

6.1

Abstract
Covalent inhibitors are promising therapeutic modalities given their higher potency, site

specificity, and prolonged duration of binding. Although covalent inhibitors bind to a specific residue, multiple similar residues can be found in proteins which makes it difficult to
resolve the inhibitory mechanism. To understand the role of site specificity for covalent inhibitors, I have employed the Regulator of G-protein Signaling Protein 8 (RGS8) as a model
protein, which has two cysteine residues targeted by allosteric covalent-linking compounds
that inhibit a protein-protein interaction (PPI) between RGS8 and a G-protein. Based
on the atomistic modeling data, I observed synergistic inhibitory effects from simultaneous
binding of inhibitors to both cysteine residues in comparison to inhibitor binding to each
cysteine alone. With both cysteine residues bound to TDZD inhibitors, I observed differences in structural perturbations in RGS8 in that the inhibitor with the aliphatic side-chains
(termed I1) largely perturbs the PPI through covalent binding to site C89 while the inhibitor
with aromatic side-chains (termed I2) does the same via binding to site C142.

6.2

Introduction
Covalent inhibitors that bind with high site-specificity to specific moieties on proteins are

gaining an increasing interest in drug discovery [15–18]. Although toxicity remains a concern
for covalent inhibitors, there are several benefits of a covalent-linking inhibitory approach
including: (i) a strong affinity for the target protein; (ii) a higher potency; (iii) a prolonged
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duration of binding at a lower dose [15–18]. In fact, several marketed drugs are covalently
binding small molecules [200, 201]. Although covalent inhibitors have a high site specificity,
both target and non-target proteins often have multiple similar residues where inhibitors can
bind. The most common residue targeted by covalent inhibitors is a cysteine residue. Since
inhibitor binding to one site can potentially interfere with binding to a different site (for
example, two different cysteine residues in a protein), dissecting the role of each binding site
is critical to gain mechanistic insights.
Thiadiazolidinone (TDZD) based inhibitors are covalent inhibitors, which bind to cysteine residues in Regulators of G-protein Signaling (RGS) proteins and allosterically inhibit
the protein-protein interaction (PPI) between an RGS protein and the binding partner, an
activated Gα-subunit of a G-protein [100,202,203]. Allosterically targeting cysteine residues
in RGS proteins has proven a feasible strategy to inhibit the function of RGS proteins in
deactivating signaling via G-protein coupled receptors (GPCRs). As a result, the inhibition
of this PPI enhances signaling via GPCRs [10, 94, 95, 101].
Although the structural folds of the box domain in RGS proteins are highly conserved
and consist of nine α-helices (Figure 6.1A) [10, 204], TDZD inhibitors (Figure 6.1B) show
different potencies and selectivities for various RGS proteins [100]. Protein dynamics have
been suggested as a key factor affecting the potency due to the accessibility of cysteine
residues in RGS proteins [94, 95, 101]. Besides protein dynamics, the number of cysteine
residues is also an important factor underlying the potency and selectivity of a given TDZD
inhibitor [100, 203], because multiple cysteine residues are found in some RGS proteins. For
example, RGS8 has two cysteine residues with one cysteine residing at the α4-helix and the
other residing at the α6-α7 interhelical loop. It is expected that targeting one of these two
sites may lead to different allosteric perturbations in the RGS8/Gα interface. Therefore,
dissecting the role of each cysteine is critical to assess differences in perturbations due to
inhibitor binding originating at each of the two cysteines. In addition, inhibitor binding to
both cysteine residues on RGS8 may result in enhanced perturbations due to a synergistic
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effect arising from each binding site and thereby an enhanced inhibitory effect on the PPI.
Besides different functions of each binding site, TDZD inhibitors may show distinct potency and selectivity due to their sizes, structures, or chemical compositions. For example,
the TDZD inhibitor CCG-203769 (designated inhibitor 1, I1) has two aliphatic side-chains,
while the inhibitor CCG-50014 (designated inhibitor 2, I2) has two aromatic side-chains
(Figure 6.1B). Understanding the effectiveness of these two TDZD inhibitors will potentially
facilitate discovery of improved inhibitors to block the RGS8/Gα PPI.
In this study, I chose the RGS8 protein (with two cysteine residues) and two TDZD
inhibitors (I1 and I2) as the model systems to probe the role of each binding site in inhibitor
recognition and the inhibition of the RGS8/Gα PPI. Specifically, I employed MD simulations
at the atomistic scale to characterize allosteric structural perturbations on inhibitor binding
at each cysteine residue on wild-type RGS8 (designated RGSWT ) and two RGS8 mutants
(designated RGSC89 and RGSC142 ), each retaining a single cysteine residue.

6.3

Methods

6.3.1

Molecular Dynamics Simulations

I created all systems using the VMD [110] software and performed atomistic MD simulations using the NAMD software [205]. The details on all systems are given in Table 6.1. I
used the CHARMM36 force field [206] for proteins, solvents, and ions. I parameterized both
inhibitors employing the Multipurpose Atom-Typer for CHARMM (MATCH) tool [122], as
done in the previous work [94, 95].

Table 6.1: Details of MD simulations
#
CCG-203769 (I1)
CCG-50014 (I2)
total atoms
water molecules
runs
length/run

WT
30731
9524
3
2 µs

Mutants
C89S
C142S
30734
30734
9525
9525
3
3
2 µs
2 µs

C89S
X
27141
8319
3
5 µs
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Single Docked
C142S
C89S
X
X
23962
27116
7260
8308
3
3
5 µs
4 µs

C142S
X
23934
7248
3
4 µs

Doubly Docked
WT
WT
X
X
26490
28288
8093
8687
3
3
2 µs
2 µs
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Figure 6.1: (A) Front and back views of the RGS8 structure (PDB code 2ODE) are shown.
(B) Chemical structures of TDZD inhibitors are shown. (C) I1 docked RGS8 systems (left
panel: RGS8C89/I1 , RGS8C142/I1 , and RGS8WT/I1 ) and I2 docked RGS8 systems (right panel:
RGS8C89/I2 , RGS8C142/I2 , and RGS8WT/I2 ).
I first prepared three systems without inhibitors: wild type RGS8 (RGS8WT ) (PDB code
2ODE, Figure 6.1A) and two mutant forms of RGS8 (C89S-RGS8 retaining C142: RGS8C142
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and C142S-RGS8 retaining C89: RGS8C89 ). In each mutant construct, I mutated one of
the two cysteine (C) residues to a serine (S) residue. To understand the effect of binding of
TDZD inhibitors (I1 and I2, Figure 6.1B), I then prepared docked systems (Figure 6.1C), four
single-docked systems: I1-docked RGS8C89 (RGS8C89/I1 ), I1-docked RGS8C142 (RGS8C142/I1 ),
I2-docked RGS8C89 (RGS8C89/I2 ), and I2-docked RGS8C142 (RGS8C142/I2 ), and two doubly
docked systems: I1-docked RGS8WT (RGS8WT/I1 ) and I2-docked RGS8WT (RGS8WT/I2 ). For
covalent docking to C89, which is buried within the RGS8 structure, I first identified cysteineexposed conformations of RGS8 with largest solvent accessible surface areas (SASAs) for
cysteine residues from simulations of RGS8C89 , RGS8C142 , and RGS8WT , as also successfully
done for other RGS proteins in previous work [94, 101].
I solvated all systems using explicit TIP3P water molecules and neutralized them with
NaCl. I then energy minimized each system via 500 cycles of steepest-descent minimization,
optimized the volume of simulation domain in the NPT ensemble by conducting a short (∼80
ps) MD simulation with a time-step of 2 fs, and finally performed triplicate µs-timescale MD
simulations in the NVT ensemble. I employed the Langevin thermostat with a damping
coefficient of 5 ps−1 to control the temperature (at 310 K) and the Nosé-Hoover barostat
to control the pressure (at 1 atm). A cut-off distance of 10 Å and a smooth switching
of 8 Å were applied to account for the non-bonded interactions, while the Particle Mesh
Ewald (PME) method was used to calculate long-range electrostatic interactions. Periodic
boundary conditions were applied in all simulations.

6.3.2

Conformational Metrics for Analyses

Root mean squared fluctuation (RMSF): To measure the effect of inhibitor binding
to RGS8 at each cysteine residue, I calculated RMSF values per residue based on the Cα
atoms and RMSF differences (∆RMSF) between systems. The initial conformation of each
system was set as a reference for RMSF calculations, while ∆RMSF calculations were carried
out by setting as reference the RMSF values in each system before mutating or inhibitor-
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binding.
Dynamics Cross-correlation (DCC) Analysis: I calculated the normalized Cα-Cα
correlation values using the Carma software [134] to understand allosteric communication
between various structural motifs in RGS8. I used three independent MD simulations for
each system to carry out DCC analyses. I also computed the correlation differences (∆DCC)
between pairs of systems to understand the effect of mutations and binding of inhibitors.
The pair correlation function used is defined by equation 2.5 in chapter 2.
Community network and optimal pathway analyses: While several approaches
based on protein structures or dynamics exist to study allostery in proteins [87–89, 187],
I have used the approach developed by Sethi et al. [85] to carry out community network
and allosteric pathway analysis. This approach has been successfully applied to several
systems [207–209]. In this approach, each residue is defined as a node. When two nodes are
within a cutoff distance of 4.5 Å for at least 75% time in a trajectory, the nodes form an
edge [85]. The length of an edge is defined by −log(|Cij |), which becomes 0 when |Cij | → 1,
while the length goes to infinitely large when |Cij | → 0. The optimal pathway is then defined
as the pathway of the shortest length from a source residue node to a sink residue node. The
edge betweenness is defined as the number of shortest pathways crossing that edge.
The partitioning of the protein structure into a network of communities was based on
the Girvan-Newman algorithm [135]. Each community division can be measured by the
modularity score. The optimal community partitioning corresponds to the largest modularity
value. The modularity values for the systems were in a range of 0.5-0.6, which are within the
general suggested range of 0.4-0.7 although the maximum value can be 1 [85, 194]. Nodes
connecting two different communities are termed as critical nodes. For the optimal pathway
analysis, I chose each cysteine residue in RGS8 (C89 and C142) as a source residue and as
sink residues I chose six residues (F78, V121, N122, F125, L153, and R161) that are located
in the RGS8/Gα interface [197, 210]. The pathway with the shortest allosteric length is the
optimal pathway. I carried out community network and optimal pathway analyses using the
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NetworkView plugin in VMD.
Buried Surface Area (BSA): I used the BSA to measure the opening between a pair
of structural motifs in RGS8. A small BSA indicates a larger opening which can facilitate
inhibitor binding. I calculated the BSA as previously described [211]:

BSA = SASA1 + SASA2 − SASA12

(6.1)

where SASA1 , SASA2 , SASA12 are the SASAs of motif 1, motif 2, and of combined motifs
1 and 2. Here, I measured the BSA values for two pairs of motifs: the BSA between the
α4-α5 interhelical loop and the α6-α7 interhelical loop, and the BSA between the α6-helix
and the α7-helix. I also measured the SASA of each inhibitor to characterize the insertion of
surface-docked inhibitors within the RGS8 structure. A small SASA suggests that a larger
part of the inhibitor entered the RGS8 structure.

6.4

Results
In this work, I focus on assessing structural and dynamical differences in mutant/WT

RGS8 constructs due to inhibitor binding at each of the two cysteine residues. Using MD
simulations, I first evaluate comparisons of per residue fluctuations and dynamic cross correlation between inhibitor-docked RGS8 and apo/mutant RGS8. I then highlight a comparison
of the community network for mutant/WT RGS8 as well as allosteric pathways originating
at each cysteine residue and ending at the RGS/Gα interface. I show the results for RGS8WT
in Figure 6.2 and mutant RGS8 in Figure 6.3, while I focus on inhibitor-bound systems in
the following analyses and discussions.

6.4.1

Residue Fluctuations and Dynamic Cross-Correlation

I calculated RMSF values per residue for each system and their differences from MD
simulations. I show the difference RMSF (∆RMSF) and cross-correlation (∆DCC) maps
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A

B

C

D

Figure 6.2: (A) Correlation map of RGS8WT ; (B) Community partition of RGS8WT ; (C)
Optimal paths from the source C89 to the six sinks for RGS8WT ; (D) Optimal paths from
the source C142 to the six sinks for RGS8WT .
in Figures 6.4 and 6.3A and the RMSF values and DCC maps in Figures 6.2 and F.1.
Although I observed increased fluctuations in the α6-α7 interhelical loop after mutagenesis
(Figures F.1 and 6.3), the RGS8 mutants remain stable with well maintained residue-residue
cross-correlations.
The key observations from RMSF and DCC calculations include: (i) the inhibitor I1
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Figure 6.3: (A) The calculated difference of RMSF(∆RMSF) and cross-correlation (∆DCC)
maps for RGS8 mutants with the reference of RGS8WT . The color bar values from -1 to
1 indicate more decreased correlations (darker blue color) to more increased correlations
(darker red color) (B) Community network for RGS8 mutants.
bound RGS8 mutants do not show significantly increased fluctuations except at the termini,
which is consistent with the marginally changed DCC values (light blue or red colors); (ii)
RGS8C89/I2 shows significantly increased fluctuations in the α4-α5 and α6-α7 interhelical
loops, corresponding to the observation of an uncorrelated motion between the α6-helix and
the α7-helix (highlighted in a dotted-box); (iii) RGS8C142/I2 does not show significant change
in comparison with RGS8C142 ; and (iv) the dual-occupancy of RGS8WT , with inhibitors
bound at both cysteines, shows significantly increased fluctuations in the α4-α5 and α6-α7
interhelical loops on inhibitor binding. While the inhibitor I1 shows a higher effect on the
α4-α5 loop, the inhibitor I2 shows a higher effect on the α6-α7 loop. The RGS8WT/I2 also
shows significantly decreased correlations between the α6-helix and the motifs of the α4, α5,
and α7-helices.
These results suggest that: (i) the inhibitors may have a limited inhibitory effect on
RGS8 mutants, while they may show a synergistic effect with higher inhibitory effect for
RGS8WT ; (ii) the inhibitor I2 binding to RGSC89 decreased the correlations between the α6helix and the α7-helix and increased the fluctuations of the α6-α7 loop, thereby suggesting
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Figure 6.4: Shown are difference RMSF (∆RMSF) and cross-correlation (∆DCC) maps:
aliphatic inhibitor I1 (left panel) or aromatic I2 (right panel) binding to RGS8 mutants and
dual inhibitor occupancy RGS8WT with their corresponding reference structures. The color
bar values from -1 to 1 indicate more decreased correlations (darker blue color) to more
increased correlations (darker red color).
the exposure of the second cysteine residue at the α6-α7 loop; and (iii) the inhibitor I1 may
disrupt the interaction between the α4-helix and the α7-helix of RGS8WT , while the inhibitor
I2 may disrupt the interaction between the α6-helix and the α7-helix.

6.4.2

Community Network

Employing the Girvan-Newman algorithm [135], I transformed residue-residue correlation
data from MD simulations into a community network (Figures 6.2, 6.3, and 6.5). Nodes
within one community are strongly interconnected with each other, while these nodes have
weaker connections with nodes from another community. Critical nodes (Figure F.3) link
communities with different edge betweenness, represented by the width of connecting lines
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Figure 6.5: Shown are the networks of communities and their schematic community maps
for inhibitor I1 (left panel) and I2 (right panel) binding RGS8 mutants and dual inhibitor
occupancy RGS8WT . The communities are labeled 1 through 7, 8, or 9 in the schematic
maps. The width of the intercommunity links denotes the cumulative edge betweenness.
The communities where inhibitors located are labeled with an asterisk. Community network
of other systems are shown in Figures 6.2 and 6.3. Critical nodes connecting communities
are shown in Figure F.3, and residue memberships are shown in Tables F.1- F.9.
in the schematic maps (Figures 6.2, 6.3, and 6.5), where a thicker line suggests a stronger
interaction.
I observed that the inhibitor-bound systems partition into 7 to 9 communities: 7 communities for RGS8C89/I2 , RGS8C142/I1 , and RGS8WT/I1 ; 8 communities for RGS8C89/I1 and
RGS8WT/I2 ; and 9 communities for RGS8C142/I1 . Since the binding sites for two inhibitors
I1 and I2 are two cysteine residues, it is important to locate the communities within which
these residues reside. I found that C89 belongs to community 2 (C2) for all inhibitor-bound
systems. While C142 is part of the community 3 (C3) for all I1-bound systems and for
RGS8C142/I2 , but it belongs to community 5 (C5) for RGS8C89/I2 and RGS8WT/I2 .
Since cysteine residues that serve as inhibitor binding sites are located within a bundle of 4
helices (α4, α5, α6, α7; Figure 6.2A) in RGS proteins, previous studies have shown [94, 101]
that inhibitors perturb and/or disrupt interhelical interactions and thereby the protein101
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protein interface. Therefore, via community analysis on inhibitor-bound mutant/WT RGS8,
I focus on α4 through α7 helices where the results suggest that: (i) residues from helices α4
and α7, neighboring cysteines, formed the community C2 in RGS8C142/I1 , RGS8C89/I2 , and
RGS8C142/I2 , indicating a stronger interaction among these two helices in inhibitor-bound
mutant proteins and thereby a lower likelihood of structural perturbations by inhibitors; (ii)
although the community C2 in RGS8WT/I1 also involves residues from helices α4 and α7, the
residues on the α7-helix that form C2 are located away from the cysteine residues, indicating
that the RGS8WT can be perturbed by the inhibitor I1; (iii) the α4, α6, and α7 helices of
RGS8WT/I2 formed three distinct communities C2, C3, and C5, which have weak interactions
among each other. It indicates that the inhibitor I2 which contains the larger aromatic side
chains may easily perturb interhelical interactions and thereby the RGS8WT /Gα interaction;
(iv) the community 6 (C6) of RGS8C89/I1 is comprised of residues from the α6 and α7 helices,
indicating a stronger interaction between these two helices. In contrast, the corresponding
community C5 in RGS8C89/I2 has weak interactions with other communities, which may
facilitate the exposure of the cysteine residue located near the α6-α7 loop; and (v) strong
interaction between the communities C3 and C6 in RGS8C89/I1 and between the communities
C2 and C3 in RGS8C142/I1 and RGS8C142/I2 suggest that the inhibitors may not perturb the
interhelical interactions between the α6-helix and the α7-helix.

6.4.3

Allosteric Pathways

Using the defined edge length (see section 6.3.2), I was able to find the shortest pathways
from the cysteine residues (termed as source residues) to six key residues (termed as sink
residues) in the RGS8/Gα protein-protein interface (Figures 6.2, 6.6, and F.2). These six
residues directly contact the Gα subunit, mutations of which can significantly affect the
activity of RGS proteins [197, 210]. I computed all optimal pathways for each system (Figures 6.2 and F.2). Here, I focus on the most differential pathways between two inhibitors
in the inhibitor-bound systems (Figure 6.6), while other pathways have a higher similarity
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Figure 6.6: Shown are significantly different optimal pathways originating from each cysteine residue to sink residues for inhibitor-bound systems: (A) pathway P4 (C89-F125)
of inhibitor-bound RGS8C89 , (B) pathway P3 (C142-N122) of inhibitor-bound RGS8C142 ,
(C) pathway P4 of dual inhibitor occupancy RGS8WT (source residue C89 to sink residue
F125;left panel), and pathway P4 of dual inhibitor occupancy RGS8WT (source residue C142
to sink residue F125; right panel).
(Figure F.2).
For the inhibitor-bound RGS8C89 , the most differential optimal pathway between two
inhibitors is the pathway P4 (C89-F125) originating at the source residue C89 and ending
at the sink residue F125 (Figure 6.6A), while for the inhibitor-bound RGS8C142 , the most
differential optimal pathway is pathway P3 (C89-N122) originating at the source residue
C89 and ending at the sink residue N122 (Figure 6.6B). However, for the inhibitor-bound
RGS8WT , I have analyzed pathways originating at each cysteine residue, and the pathway 4
(C89/C142-F125) in each case is the optimal pathway which ends at the sink residue F125
(Figure 6.6C).
The key observations from the pathway comparison include the following: (i) the pathway
P4 of RGS8C89/I1 (blue arrows in Figure 6.6A) crossed residues from the α5 (A105 and F109)
and α6 (R128) helices, while the pathway P4 of RGS8C89/I2 (red arrows in Figure 6.6A)
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crossed the α5-α6 loop (V121 and I123); (ii) the pathway P3 of RGS8C142/I1 (blue arrows in
Figure 6.6B) crossed residue from the α4 and α7 helices, while the pathway P3 of RGS8C142/I2
(red arrows in Figure 6.6B) only involves the residues from the α6-helix; (iii) the pathway P4
of RGS8WT/I1 with C89 as the source residue (blue arrows in Figure 6.6C) crossed residues
from the α4-helix and the α5-α6 loop, while the corresponding pathway for RGS8WT/I2 (red
arrows in Figure 6.6C) crossed residues from the α5 and α6 helices. Both pathways are
different from unliganded RGS8WT which involves residues from the α7-helix (Figure 6.2C);
and (iv) the pathway P4 of RGS8WT/I1 with C142 as the source residue (blue arrows in right
panel of Figure 6.6C) only crossed two residues from the α7-helix, while the corresponding
pathway P4 of RGS8WT/I2 (red arrows in right panel of Figure 6.6C) crossed the residues
from the α6-α7 loop before crossing the residues from the α7-helix.
These observations indicate a differential perturbation mechanism for binding and sitespecificity of TDZD inhibitors: (i) inhibitor I1 binding to C89 of RGS8C89 leads to a higher
correlation between residues from helices α4 and α5, while binding to C142 does not significantly alter the pathway P3 of the RGS8C142 ; (ii) in contrast, the inhibitor I2 shows the
opposite effect in that the binding to C142 of RGS8C142 showed a significant change in the
pathway P3 while binding to C89 of RGS8C89 does not change the pathway P4; (iii) both
pathways P4 (originating at C89 as the source residue) for inhibitors binding to RGS8WT
are significantly different from the pathway P4 in unliganded RGS8WT , indicating that both
inhibitors can decrease the correlation between the α4-helix and the α7-helix; and (iv) the
pathway P4 of RGS8WT/I1 (with C142 as the source residue) shows direct connection between
the α6-helix and the α7-helix, suggesting a higher correlation. In contrast, the pathway P4
of RGS8WT/I1 does not show the same feature, indicating that the inter helical interaction
between the α6-helix and the α7-helix can be disrupted and may facilitate the insertion of
the inhibitor I2 within the helical bundle of RGS8.
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Figure 6.7: (A) Snapshots of RGS8 highlighting the interhelical loops (α4-α5 and α6-α7),
the α6-helix, and the α7-helix. (B) top panel: BSA between the interhelical loops α4-α5
and α6-α7. bottom panel: BSA between the α6-helix and the α7-helix. Vertical lines are
BSAs from the crystal structure. The plots are shown both for the probability values (P) in
distributions and for cumulative values of P.
6.4.4

Buried Surface Area

There are two pairs of structural motifs in RGS8 (Figure 6.7A) which likely play key roles
in inhibitor binding , the α4-α5 and the α6-α7 interhelical loops, and the pair of helices α6-
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helix and α7. Therefore, I further probed any disruptions in these interactions by computing
buried surface area between interhelical loops and helices.
The analyses of BSA between the α4-α5 interhelical loop and the α6-α7 interhelical loop
with/without inhibitor-bound suggests: (i) I1 can lead to lower BSAs in RGS8C142/I1 and
RGS8WT/I1 than I2 (Figures 6.7B, F.4A and F.4C); and (ii) a lower BSA for dual-inhibitor
occupancy in RGS8WT/I1 in comparison to single inhibitor bound mutants (RGS8C89/I1 and
RGS8C142/I1 ) indicates a synergistic effect for I1 bound systems. The computed BSAs between the α6-helix and the α7-helix show: (i) lower BSAs are caused by I2 binding than
I1 binding in RGS8C142 , RGS8C89 , and RGS8WT (Figures 6.7B and F.5A-C); and (ii) the
RGS8C89/I2 and RGS8WT/I2 systems show lower BSAs than the RGS8C142/I2 , indicating that
I2 binding to the C89 disrupts the interhelical interaction between helices α6 and the α7.

6.4.5

Solvent Accessibility of Inhibitors

The above analyses suggest that the inhibitor binding to each cysteine residue may have a
variable effect on the RGS8/Gα PPI. I further analyzed the SASA of inhibitors to understand
this variable effect. A low SASA of an inhibitor when bound to RGS8 indicates a strong
interaction between the inhibitor and the protein and thereby a high perturbation and likely
a strong effect on function. I observed that SASA of inhibitors binding to C89 (RGS8C89/I1
and RGS8C89/I2 ; Figure 6.8) were lower than binding to C142 (RGS8C142/I1 and RGS8C142/I2 ;
Figure 6.8).
In addition, I observed a synergistic inhibitory effect on binding of inhibitors to WT
RGS8 over binding to RGS8 mutants from SASA calculations (Figure 6.8). For I1 bound
systems, I observed that I1 shows a higher probability for a lower SASA for inhibitor binding
to C89 in the RGS8WT/I1 than in the RGS8C89/I1 , although the probability distribution of
SASA of I1 binding to C142 showed less change between the RGS8WT/I1 and RGS8C142/I1
(Figure 6.8). This also indicates that I1 exerts its effect via structural perturbations in RGS8
largely through binding to C89.
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Figure 6.8: Probability distributions of solvent accessible surface area of inhibitors I1 (panel
A) and I2 (panel B). Snapshots highlight significant differences between single inhibitorbinding and dual inhibitor-binding. Residues on the RGS8/Gα interface are depicted as a
pink surface, other residues are depicted as a white surface. Docked molecules are depicted
in space-filling representations.
In contrast, I observed that the SASA of I2 binding to C142 decreases significantly
in RGS8WT/I2 in comparison with RGS8C142/I2 , while the SASA of I2 binding to C89 in
RGS8WT/I2 did not change much in comparison with RGS8C89/I2 (Figure 6.8). It indicates
that I2 perturbs the structure of wild type RGS8 largely through binding to C142. Although
the mechanisms for I1 and I2 are different, the BSA of inhibitors were significantly decreased,
indicating that the inhibitors efficiently inserted within the RGS8 structure and caused
increased perturbations in RGS8WT than in RGS8 mutants. It is therefore expected to lead
to a higher inhibitory effect on the RGS8/Gα PPI.
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6.5

Discussion
In this work, I conducted MD simulations to investigate the inhibitory mechanisms of

TDZD inhibitors for the RGS8/Gα PPI. I highlight the difference in dynamics of mutant
and WT forms of RGS8 via calculations on residue fluctuations, community network, allosteric pathways, BSA of RGS8 motifs, and SASA of inhibitors. I hypothesize that the site
specificity, structural effect of inhibitors, and synergistic effect together lead to differential
inhibitory behavior in TDZD inhibitors.
I observed key differences in structural dynamics for inhibitor binding to different cysteine
residues. For instance, inhibitor I2 binding to RGS8C89 leads to increased fluctuations in the
α4-α5 and α6-α7 loops, uncorrelated motion between the interhelical loops, and a lower BSA
between the α6 and α7 helices, while I2 singly binding to RGS8C142 does not show similar
features. In addition, inhibitors insert themselves within the helices in RGS8 through binding
to C89 rather than binding to C142, as seen by the SASA calculation on inhibitors for the
inhibitor-bound RGS8 mutants.
The structural differences among inhibitors (Figure 6.1B) can lead to different perturbations in the protein structure and thereby a different potency, as seen in previous studies [94, 95, 203]. In this study, the two TDZD inhibitors are different in their side chains in
that the inhibitor I1 has two aliphatic chains while the inhibitor I2 has two aromatic chains.
While I2 binding to RGS8C89 leads to formation of a new residue community (C5) and increased fluctuations in the α6-α7 loop, I1 binding to the same site has no such feature. The
distinct allosteric pathways originating at each cysteine residue further support differential
inhibitory effect of TDZD compounds.
In addition, the BSAs between the α4-α5 interhelical loop and the α6-α7 interhelical
loop in the RGS8C142/I1 and RGS8WT/I1 systems are much lower than in the RGS8C142/I2
and RGS8WT/I2 systems, while I2 can lead to lower BSAs between the α6 and α7 helices
in RGS8C89 , RGS8C142 , and RGS8WT/I2 than I1. I also observed that I1 binding to C89
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causes higher perturbations in RGS8, while I2 binding to C142 causes higher perturbations
in RGS8.
The analyses of MD simulations suggested the existence of a synergistic effect where dual
inhibitor occupancy in RGS8 has a higher potency than binding at single cysteine sites.
Compared to single site binding, dual occupancy binding leads to higher residue fluctuations
in RGS8, lower correlations between α4 and α7 helices and between α6 and α7 helices, lower
BSAs between the α4-α5 interhelical loop and the α6-α7 interhelical loop and between α6
and α7 helices, and enhanced insertion of inhibitors within the RGS8 structure.
This synergistic inhibitory effect originates from a structural change after inhibitor binding to one cysteine residue which likely facilitates inhibitor binding to the other cysteine
residue. It thereby leads to higher perturbations and a higher potency of inhibition of the
RGS8/Gα PPI. For instance, the RGS8C89/I1 showed a higher perturbation in the α6-α7
interhelical loop where the second cysteine residue C142 resides. Similarly, RGS8C89/I2 displayed a higher perturbation in the α6-α7 interhelical loop, a new community (C5) formed
in that loop, and lower correlations between the α6/α7 helical pair (Figures 6.4C and F.1C).
These changes increased the exposure of the other cysteine residue and facilitated inhibitor
binding.

6.6

Conclusion
In this study, I integrated 84 µs of MD simulation data to study the inhibitory effect

of two TDZD inhibitors (CCG-203769, I1; CCG-50014, I2) on the RGS8/Gα PPI. I constructed nine systems with and without inhibitors for simulations. I carried out RMSF
calculations, correlation analysis, community partitioning, allosteric optimal pathway analysis, and SASA computations to reveal the differential perturbations in RGS8 on binding
of inhibitors. I found that I1 and I2 perturbed RGS8 through two different mechanisms in
that the perturbation by I1 mostly originate from binding at C89, while perturbations by I2
mostly originate from binding at C142. I1 can efficiently enter the gap between the α4-α5
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interhelical loop and the α6-α7 interhelical loop, while I2 can lead to a significant decreased
correlation between the α6-helix and the α7-helix and thereby facilitate it entering the gap
between the two helices. I also observed a synergistic inhibitory effect for both inhibitors
in that the dual inhibitor occupancy in RGS8, as opposed to single site occupancy, showed
higher perturbations and thereby a stronger inhibitory effect on the RGS8/Gα PPI. Since
many RGS proteins have multiple cysteine residues for inhibitor binding, this study highlights the significance of differences among binding sites as well as a synergistic effect that
can arise from inhibitor binding at multiple sites. I believe that the work described here
serves as a good example to study other systems with multiple inhibitor binding sites.

6.7

Publications
The work described in this chapter is under preparation and will be submitted as a

journal article:
(i) Liu, Y., Shaw, V., Neubig, R., and Vashisth, H. (2020). Synergistic Inhibitory Effect
Arising from Covalent Binding of Allosteric Inhibitors to Regulatory Signaling Proteins.
To be submitted.
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CHAPTER 7
STUDIES ON DYNAMICS OF GAF DOMAINS IN CONE
PHOSPHODIESTERASE 6

7.1

Abstract
In this chapter, I discuss MD studies of the GAF domains of cone phosphodiesterase 6

(PDE6) with/without the ligand cGMP. This work was carried out in collaboration with
Dr. Rick Cote’s group at UNH. I only describe the MD simulation part which includes the
stability of the crystal structure of the GAFab homodimer, and asymmetric and allosteric
communication in apo and cGMP-liganded GAFab. Other details can be found in our
collaborative publication [212].

7.2

Introduction
In chapter 1 (section 1.3.4), I provide a brief introduction on PDE6. For work reported

in this chapter, I employed MD simulations of the crystal structure of GAFab and structural
models of apo GAFab of cone PDE6 that were refined via chemical cross-linking studies by
the Cote group [212]. The primary aim was to study the stability of the crystal structure of
GAFab and allosteric communication in apo GAFab and cGMP-docked GAFab using MD
simulations.
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7.3

Methods

7.3.1

System Setup and Simulation Details

I used the VMD [110] software to prepare all systems and analyze simulation trajectories. All simulations were performed using the NAMD software [111] with three different
structures of GAFab: The x-ray structure and the structural models (consisting of residues
42-458) of the unliganded (apo) and cGMP-bound GAFab states. I note that the X-ray structure PDE6 does not contain a portion of the GAFb β1/β2 flexible loop (residues 286-310),
whereas the two cross-link refined structural models include this loop. In the cGMP-bound
structural model, a cGMP molecule was docked in each GAFa binding site based on the
atomic coordinates of cGMP reported for the published chicken cone GAF structure (PDB
ID: 3DBA) [213].

#
X-ray
apo
cGMP-bound

atoms
113990
104728
104792

Table 7.1: Details of
water molecules
33856
30533
30531

MD simulations
length runs
box size
500 ns
3
87 Å × 131 Å × 107 Å
360 ns
3
88 Å × 120 Å × 107 Å
360 ns
3
88 Å × 120 Å × 107 Å

The three structures were solvated with TIP3P water molecules and the systems were
neutralized with NaCl and MgCl2 . After 500 steps of conjugate-gradient minimization, I
equilibrated the volume of the simulation domain for each system by conducting a short 1 ns
MD simulation in the NPT ensemble, after which I conducted three independent long timescale MD simulations of each system (Table 7.1). In all simulations, I used a time-step of 2 fs
and the CHARMM force-field [117–119] for all molecules. The temperature was maintained
(at 310 K) using a Langevin thermostat and the pressure (at 1 atm) using a Nosé-Hoover
barostat.

7.3.2

MD Conformational Metrics

Root Mean Squared Deviation/Fluctuation (RMSD/RMSF): To understand the
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domain-level flexibility of PDE6 in various states (crystal structure, apo, and cGMP-bound
states), I computed the RMSD as a metric based on the Cα atoms, where RMSD was
measured relative to the initial structure in each simulation. A higher RMSD relative to
the initial structure would indicate increased flexibility and vice-versa. The probability
distributions of RMSDs of various domains of PDE6 are shown in Figures 7.1-7.3. To quantify
the conformational flexibility of each residue, I further computed RMSF per residue for each
subunit of PDE6. The RMSF calculations were based on all atoms in each residue. The
RMSF data are shown in Figures 7.1-7.3.
Buried surface area (BSA): To characterize interfacial area between a pair of domains
within PDE6, I calculated BSA between domains using the following equation:

BSA = SASAa + SASAa0 − SASAaa0

(7.1)

where SASAa , SASAa0 , and SASAaa0 are the solvent-accessible surface areas (SASA) of each
domain individually or both domains taken together. I used a probe radius of 1.4 Å for
SASA calculations.
Dynamic Cross Correlation (DCC) Analysis: I also carried out residue-residue
(Cα-Cα) DCC analysis for different states of PDE6. Details can be found in Section 2.3.2.

7.4

Results
To evaluate the conformational dynamics, subunit asymmetry, and allosteric communi-

cation of the cone PDE6 GAFab homodimer, I carried out three independent long time-scale
MD simulations (see Section 7.3 and Table 7.1) of the GAFab crystal structure as well as
of the refined (based on cross-linking data) structural models of the GAFab in the apo and
cGMP-liganded states. These MD simulations of the GAFab homodimer permitted analysis of the flexibility of individual sub-domains (RMSD) and individual amino acid residues
(RMSF), changes in buried surface area (BSA), and correlated motions (dynamic residue-
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residue cross correlation; DCC).

7.4.1

Stability of X-ray structure of GAFab

Figure 7.1: Dynamics and stability of the crystal structure of the PDE6 GAFab homodimer
as characterized by various conformational metrics. (A) Cartoon representation of the X-ray
structure with color scheme for the subdomains [N-terminal region of GAFa (N-GAFa or
α1, residues 55-74), GAFa (residues 75-224), long helix-1 (LH1, residues 225-255), GAFb
(residues 256-443), and long helix-2 (LH2, residues 434-453)] characterized in panels B-D.
(B) Root mean squared fluctuation (RMSF) per residue for each subunit, color-coded to
correspond with the representation in panel A; (C) the probability distributions of the root
mean squared deviation (RMSD) for individual domains of each subunit; (D) the distributions of the buried surface area (BSA) between various domains of the homodimer. Vertical
lines marked on distributions correspond to mean values of the RMSD data from simulations
(panel C) and the BSA values (panel D) observed in the crystal structure.
In Figure 7.1, I report data on conformational metrics based on simulations of the crystal
structure of the GAFab homodimer (without β1/β2 loops in GAFb). The RMSF and RMSD
results (panels B and C in Figure 7.1) show that the region preceding the GAFa domain
as well as the GAFa and LH1 subdomains in each subunit (Figure 7.1A) are least flexible,
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whereas the GAFb and LH2 subdomains show bimodal RMSD distributions reflecting two
distinct conformational states; the higher flexibility of the LH2 subdomain (RMSD values
of 0-10 Å) may be due in part to the GAFab regulatory domains not being attached to the
catalytic domains of cone PDE6. Figure 7.1 shows that the highest BSA occurs between
the LH1 (∼1100-1500 Å2 ), LH2 (∼500-1300 Å2 ) and the N-terminal helix (∼300-800 Å2 )
motifs, and likely accounts for the major interactions stabilizing dimer formation. From
these results one can conclude that the overall subdomain folds and interfacial contact areas
between subdomains in the GAFab crystal structure (Fig. 2A) are stably maintained in
solution states of GAFab explored by MD simulations.

7.4.2

Asymmetry and Allosteric Communication in apo and cGMP-liganded

GAFab
In comparison to the high degree of structural similarity of the two GAFab subunits in
the x-ray structure, MD simulations of both apo and cGMP-bound GAFab (Figures 7.2, 7.3,
and 7.4) provide evidence that the conformational dynamics in the GAFab homodimer evolve
in an asymmetric manner for the two subunits. As seen in the ∆RMSF plots in Figure 7.2,
differences in the conformational dynamics of the two subunits of apo GAFab (Figure 7.2A)
or cGMP-liganded GAFab (Figure 7.2B) are observed in the flexible loop regions, particularly
the GAFb β1/β2 and β4/β5 loops, whereas the secondary structural elements are appear
symmetrical in the two subunits. These atomistic simulations illustrate that the unstructured
loops can exist in multiple conformations (Figure 7.5).
A further examination of changes in the BSA profiles for the apo and cGMP-bound atomistic simulations (Figures 7.3D and 7.4D) reveal a change from a bimodal to a unimodal
profile upon cGMP binding to the GAFab homodimer. The analysis of each subdomain
indicates that the increases in BSA upon cGMP binding occur primarily in the N-terminal
helix region preceding the GAFa domain as well as in the LH2 region that normally links
GAFb to the catalytic domains of PDE6 (Figures 7.3D and 7.4D). The changes in BSA
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Figure 7.2: MD simulations of the apo and cGMP-bound states of GAFab. Differences in the
root mean squared fluctuations (∆RMSF) per residue were analyzed separately for each subdomain of GAFab to identify differences in protein dynamics of the apo and cGMP-bound
states for each subunit. Any regions that differed more than 0.5 Åare highlighted in black
on the accompanying structure. A and B. Evaluation of asymmetry in protein dynamics of
the two GAFab subunits in the apo (panel A) and cGMP-bound (panel B) state. C and D.
Changes in protein dynamics upon cGMP binding to each subunit of GAFab were evaluated
by plotting the ∆RMSF per residue for the apo and cGMP-bound states for subunit A (panel
C) and subunit B (panel D).
further support the idea that cGMP binding to its GAFa binding pocket is predicted to
induce conformational changes in several loop regions in both GAF domains, and also implicate cGMP-dependent perturbations of two helical elements that represent a portion of
the “backbone” of the GAFab dimerization interface.

116

7.4. RESULTS

Figure 7.3: Conformational metrics highlighting dynamics of the apo-state of the PDE6
GAFab homodimer. For the apo-state of PDE6 (A), data similar to Figure 7.1 are highlighted
in panels B-D.
I further focused on the flexible lid (residues 156-178) in the GAFa domain and loop
(residues 286-310) in the GAFb domain. In Figure 7.5, I show conformational snapshots of
GAFab with highlighted lid and loop at different time-points during the simulation. Although
the lid and loop are highly flexible in both apo and cGMP-liganded GAFab states, the loop
in the GAFb domain is more flexible than the lid in both states. It suggested that the
allosteric communication between two GAF domains probably depends upon the β1/β2
loop in the GAFb domain. The RMSD calculation further highlighted the flexibility of two
motifs (Figure 7.6). Although the difference in RMSD values of lid/loop for two chains in
apo GAFab is very small, I observe big difference in RMSD values for the loop in two chains
(10.87 Å vs. 19.27 Å in Figure 7.6). This result also highlights the asymmetric evolution of
two chains.
In Figure 7.7, I report the differences in residue-residue correlations between apo and
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Figure 7.4: Conformational metrics highlighting dynamics of the cGMP-bound state of the
PDE6 GAFab homodimer. For the cGMP-bound state of PDE6 (A), data similar to Figure 7.1 are highlighted in panels B-D.

A

B

run1

run2

run3

run1

run2

run3

Figure 7.5: The flexible LID (residues 156-178) and LOOP (residues 286-310) indicated
by snapshots of structures of (A) apo-state GAFab and (B) cGMP-bound GAFab. Initial
coordinates and end coordinates are colored as green and red, respectively. The middle states
are colored as cyan and purple. cGMP structures are shown as blue sticks.
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Figure 7.6: The mean RMSD values for lid and loop. RMSD values: Lid of chain A (6.57 apo
vs 6.41 cGMP-bound GAFab); Loop of chain A (12.87 for apo vs. 12.74 for cGMP-bound
GAFab); Lid of chain B or Lid’ (7.68 for apo vs 7.13 for cGMP-bound GAFab); Loop of
chain B or Loop’ (10.87 apo vs 19.27 cGMP-bound GAFab).

Figure 7.7: Difference dynamic cross-correlation (∆DCC) analysis of the differences in correlated motions between the apo and cGMP-bound states of GAFab for chain A (left) and
chain B (right). Heat map bar indicates the range of correlations from -1 (highly decreased
correlation) to 0 (no change in correlation) to +1 (highly increased correlation).
cGMP-liganded states (chain A and chain B). It further showed signatures of asymmetric
behavior in two chains and correlated motions between several structural elements upon
cGMP binding. For example, upon cGMP binding one subunit (labeled chain A) showed
a strong pattern of increased coordinated movements between the GAFa domain and the
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N-terminal region, the LH1 helix connecting GAFa to GAFb, and the LH2 region (attached
to the catalytic domain of the intact PDE6 catalytic subunits). The other subunit (chain B)
exhibited a very different ∆DCC map, with an alternating pattern of increased and decreased
correlated motions between the GAFb β1/β2 loop and the rest of the GAFb domain as well
a strong decrease in correlated movements between the GAFa domain and the GAFb β1/β2
loop.

7.5

Discussion
In this study of MD simulations on cone PDE6 GAFab, I examined the stability of

the x-ray structure and studied conformational dynamics and cGMP-induced changes in
the GAFab structure. I observed that the lid (α2/3 region, β4/α4 loop, and α4 helix)
of GAFa and the β1/β2 loop and β4/β5 loop of GAFb showed conformational changes
after cGMP bound. However, such conformational changes do not necessarily indicate the
allosteric communication between GAFa and GAFb. Instead, the sites at the interface of two
domains, such as the GAFa α2/3 region with the GAFb β6/α5 loop, and the GAFa β1/β2
loop with the GAFb β4/β5 and β6/α5 loops, are highly likely responsible for allosteric
signaling transfer.
In the systems I studied, the catalytic domains and the Pγ are absent. The allosteric
communication from GAF domains to the catalytic domains cannot be speculated from
current MD simulations. A future direction of this work is to carry out MD simulations and
dynamic network analysis with the presence of the catalytic domains and the Pγ subunits.
Although current MD simulations cannot tell the allosteric communication pathway from
GAF domains to the catalytic domains, the speculations, in analogy to PDE2, are available
in the published paper [212].
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7.6. CONCLUSION

7.6

Conclusion
Collectively, MD simulations provided evidence for the stability of the solution state fold

of the PDE6 conformation observed in the crystal structure, differences in the conformational
dynamics of the two subunits, and highly coordinated allosteric perturbations on cGMP
binding.

7.7

Publications
The work described in this chapter has been published in the following journal article:

(i) Gupta, R., Liu, Y., Wang, H., Nordyke, C.T., Puterbaugh, R.Z., Cui, W., Varga,
K., Chu, F., Ke, H., Vashisth, H., and Cote, R.H., (2020). Structural Analysis of
the Regulatory GAF Domains of cGMP Phosphodiesterase Elucidates the Allosteric
Communication Pathway. J. Mol. Biol., 21(432), 5765-5783.
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CHAPTER 8
FUTURE WORK

In this chapter, I provide suggestions on future research directions based on the systems
I studied.
In chapter 3, I studied the CO diffusion network in FeFe-hydrogenase and provided
candidate residues for mutagenesis to block CO and O2 diffusion towards the active site.
Therefore, one possible future research topic could be testing the effect of mutating these
residues and understanding the increased tolerance of FeFe-hydrogenase towards inhibitory
gases. This can be investigated by a combination of MD simulations and experiments. The
other research topic I would like to suggest is to understand how CO/O2 react with the
H-cluster. This can be done using the QM/MM methods that employ quantum mechanical calculations for understanding the interaction between inhibitory gases and the active
site, while the dynamics of other parts of the enzyme can be understood using molecular
mechanics.
In chapter 4, I studied conformational dynamics and interfacial interactions of PAP channels in POPC/PBPEO membranes. Practically, other BCP membrane or mixed membrane
matrices can be used for the integration of PAP channels. Therefore, one possible research
topic could be parametrizing new BCP membranes and studying the dynamics of PAP channels in these new or mixed membranes. In addition, water dynamics in the PAP channels
or newly developed channels could be another interesting research topic.
In chapters 5 and 6, I studied the dynamics of apo and TDZD inhibitor-bound RGS
proteins. In drug discovery, the purpose of TDZD inhibitors is to interrupt the RGS-Gα
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protein protein interaction. Therefore, one important research topic I would like to suggest
is to understand the dynamics of the RGS-Gα complex with/without inhibitors. In addition,
finding potential new pockets for inhibitor-docking in RGS proteins is another important
topic.
In chapter 7, I studied the dynamics of cone GAFab homodimer with/without cGMP.
However, the GAFab homodimer does not contain the C-terminal catalytic domain and the
inhibitory PDE6γ subunit. Therefore, understanding dynamics of the complete cone PDE6
is an important research topic for future studies. In addition, understanding differences in
the dynamics between cone PDE6 and rod PDE6 can be helpful in drug discovery targeted
at phototransduction pathways.
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APPENDIX A
NAMD INPUT FILES AND SCRIPTS

A.1 Typical NAMD Configuration File
This sample script shows a typical NAMD configuration file for simulations in the N P T
ensemble. For the N V T ensembles, one can remove the “Constant Pressure Control” part.
1

#############################################################

2
3

set input

ionized_1fqi

4
5
6

structure
coordinates

$input . psf
$input . pdb

set outputname
set temperature

nvt
310

# continuing a run
# set inputname
# binCoordinates
# extendedSystem

npt . restart ;# only need to edit this in one place !
$inputname . coor ;# coordinates from last run ( binary )
$inputname . xsc
;# cell dimensions from last run

firsttimestep

0

7
8
9
10
11
12
13
14
15
16
17
18
19
20

#############################################################
## SIMULATION PARAMETERS
##
#############################################################

21
22
23
24
25

# Input
paraTypeCharmm
parameters
parameters

on
par_all36_prot . prm
t o p p a r _ w a t e r _ i o n s _ n a m d . str

temperature

$temperature

COMmotion

no

26
27
28
29
30
31
32
33
34
35
36
37

# Force - Field Parameters
exclude
scaled1 -4
1 -4 scaling
1.0
cutoff
10.
switching
on
switchdist
8.
pairlistdist
12

38
39
40
41
42
43

# Integrator Parameters
timestep
2.0
rigidBonds
all
nonbondedFreq
1
fu ll El ec tF re qu en cy 2
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44

stepspercycle

20

45
46
47
48
49
50
51

52
53

# Periodic Boundary Conditions
if {1} {
cellBasisVector1
71.01
0.
0.
cellBasisVector2
0.
65.77
0.
cellBasisVector3
0.
0.
70.85
cellOrigin
1 .29 79 81 73 90 44 18 95 -3.478576421737671
2 .90 61 80 85 86 12 06 05
}
wrapAll
on

54
55
56
57
58
59

# PME ( for full - system periodic electrostatics )
PME
yes
PMEGridSizeX
72
PMEGridSizeY
66
PMEGridSizeZ
70

60
61
62
63
64
65

# Constant Temperature Control
langevin
on
;# do langevin dynamics
langevinDamping
5
;# damping coefficient ( gamma ) of 5/ ps
langevinTemp
$temperature
langevinHydrogen
off
;# don ’ t couple langevin bath to hydrogens

66
67
68
69
70
71

# Constant Pressure Control
if {1} {
useGroupPressure
yes ;# needed for 2 fs steps
useFlexibleCell
no ;# no for water box , yes for membrane
useConstantArea
no ;# no for water box , yes for membrane

72
73
74
75
76
77
78

langevinPiston
langevinPistonTarget
langevinPistonPeriod
l an g e vi n P i st o n De c a y
la ng ev in Pi st on Te mp
}

on
1.01325 ;# in bar -> 1 atm
200.
50.
$temperature

79
80
81
82
83
84
85
86

# Output
outputName
restartfreq
dcdfreq
outputEnergies
outputPressure
xstFreq

$outputname
10000
10000
10000
10000
10000

87
88
89

minimize
reinitvels

500
$temperature

90
91

run

1000000000

A.2 Typical Metadynamics Configuration File
This sample script gives a typical metadynamics simulation file with a pre-defined CV file.
1
2
3

#############################################################
## ADJUSTABLE PARAMETERS
##
#############################################################

4
5
6
7

structure
coordinates
outputName

22 _popcw . psf
22 _popcw . pdb
met1

set temperature

303

8
9
10
11

# Continuing a job from the restart files
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12
13
14
15

16
17

if {0} {
set inputname
fix_eq2
binCoordinates
$inputname . restart . coor
binVelocities
$inputname . restart . vel ;# remove the " temperature "
entry if you use this !
extendedSystem
$inputname . restart . xsc
}

18
19

firsttimestep

0

20
21
22
23

#############################################################
## SIMULATION PARAMETERS
##
#############################################################

24
25
26
27
28
29
30
31

# Input
paraTypeCharmm
parameters
parameters
parameters
parameters
parameters

on
par_all36_lipid . prm
par_all36_prot . prm
p a r _ a l l 3 6 _ c g e n f f _ k a r l . prm
p a r _ w a t e r _ i o n s _ j e j o o n g . str
jejoong_mid . str

32
33
34

# NOTE : Do not set the initial velocity temperature if you
# have also specified a . vel restart file !

35
36

temperature

$temperature

37
38
39
40
41
42
43
44
45

46
47
48

# Periodic Boundary Conditions
# NOTE : Do not set the periodic cell basis if you have also
# specified an . xsc restart file !
if {1} {
cellBasisVector1
98
0.
0.
cellBasisVector2
0.
98
0.
cellBasisVector3
0.
0.
80
cellOrigin
-0.017971962690353394 0 . 0 3 7 9 3 1 9 7 8 7 0 2 5 4 5 1 6 6
-0.03922014310956001
}
wrapWater
on
wrapAll
on

49
50
51
52
53
54
55
56

# Force - Field Parameters
exclude
scaled1 -4
1 -4 scaling
1.0
cutoff
12.
switching
on
switchdist
10.
pairlistdist
13.5

57
58
59
60
61
62
63

# Integrator Parameters
timestep
2.0
rigidBonds
all
nonbondedFreq
1
fu ll El ec tF re qu en cy 2
stepspercycle
20

;# 2 fs / step
;# needed for 2 fs steps

64
65
66
67
68
69
70
71
72

# PME ( for full - system periodic electrostatics )
if {1} {
PME
yes
# PMEGridSizeX
56
# PMEGridSizeY
56
# PMEGridSizeZ
65
PMEGridSpacing
1
}

73
74
75

# Constant Temperature Control
langevin
on
;# do langevin dynamics
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76
77

langevinDamping
langevinTemp

1
;# damping coefficient ( gamma ) of 5/ ps
$temperature

78
79
80
81
82
83
84

# Constant Pressure Control ( variable volume )
if {1} {
useGroupPressure
yes ;# needed for 2 fs steps
useFlexibleCell
yes ;# no for water box , yes for membrane
useConstantArea
no ;# no for water box , yes for membrane
useConstantRatio
yes ;

85
86
87
88
89
90
91

langevinPiston
langevinPistonTarget
langevinPistonPeriod
l an g e vi n P i st o n De c a y
la ng ev in Pi st on Te mp
}

on
1.01325 ;# in bar -> 1 atm
200.
50.
$temperature

92
93
94
95
96
97

restartfreq
dcdfreq
xstFreq
outputEnergies
outputPressure

1000
1000
1000
1000
1000

;# 1000 steps = every 2 ps

98
99
100
101
102
103
104
105
106

# Fixed Atoms Constraint ( set PDB beta - column to 1)
if {0} {
fixedAtoms
on
fixedAtomsFile
fix . pdb
fixedAtomsCol
B
fixedAtomsForces
on
}

107
108
109
110

#############################################################
## EXTRA PARAMETERS
##
#############################################################

111
112
113

# Put here any custom parameters that are specific to
# this job ( e . g . , SMD , TclForces , etc ...)

114
115
116
117
118
119
120
121
122

# eFieldOn yes
# eField 0 0 -0.155
# metadynamics
colvars
on
colvarsConfig input . in
#############################################################
## EXECUTION SCRIPT
##
#############################################################

123
124
125
126
127
128

# Minimization
if {1} {
minimize
reinitvels
}

4000
$temperature

129
130

run 200000000 ;# 400 ns

The CV file “input.in” is shown below:
1
2

colvarsTrajFrequency
colvarsRestartFrequency

500
1000

3
4
5

colvar {
name distance1

6
7

lowerBoundary 20
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upperBoundary 30
lowe rWall Consta nt 40
uppe rWall Consta nt 40
width 0.05
distance {
group1 {
atomnumbersrange {35615 -36349}
}
group2 {
atomnumbersrange {36350 -37084}
}
}

8
9
10
11
12
13
14
15
16
17
18
19
20
21

}

22
23
24
25
26
27
28
29
30
31

metadynamics {
name
meta - distance
colvars distance1
hillWeight
0.2
newHillFrequency
500
d ump Fr ee En er gy Fi le
yes
writeHillsTrajectory
on
hillwidth
1.0
}

A.3 Preparation of System Files
The psfgen plugin tool was used to generate the PDB and PSF files.
1

# psfgen file to generate correct PDB and PSF files

2
3
4
5
6

package require psfgen
topology topp ar_wat er_ion s . str
topology top_all36_prot . rtf
topology top_all36_na . rtf

7
8
9
10
11

# Alias of residues and atoms NOT properly defined in the original PDB
files
# Alias for proteins
pdbalias residue HIS HSD
pdbalias atom ILE CD1 CD

12
13
14

pdbalias atom HOH O OH2
pdbalias residue HOH TIP3

15
16
17

segment A { pdb chainA2_xray . pdb }
coordpdb chainA2_xray . pdb
A

18
19
20
21
22

# patch CY35 G :1
guesscoord
writepdb chainA2 . pdb
writepsf chainA2 . psf

23
24

exit

Another sample script using psfgen:
1

package require psfgen

2
3
4

readpsf chainA1 . psf
coordpdb chainA1 . pdb

5
6
7

readpsf chainA2 . psf
coordpdb chainA2 . pdb
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8
9
10

readpsf chainB1 . psf
coordpdb chainB1 . pdb

11
12
13

readpsf chainB2 . psf
coordpdb chainB2 . pdb

14
15
16
17

writepsf GAFAB . psf
writepdb GAFAB . pdb
exit

The preparation of solvated systems was carried out with the following code (solvate.tcl)
which can be run in a shell script interface: vmd -dispdev text -e solvate.tcl > solvate.log.
1
2
3
4

# solvate . tcl
package require solvate
solvate 2 odemu1 . psf 2 odemu1 . pdb -x 12 -y 12 -z 12 + x 12 + y 12
2.4 -o solvated
exit

+ z 12 -b

After solvation, the ionization step was done with the following code (ionization.tcl) which
can be run as: vmd -dispdev text -e ionization.tcl > ionization.log.
1
2
3
4

# ionization . tcl
package require autoionize
autoionize - psf solvated . psf - pdb solvated . pdb -o ionized_2odemu1 - sc 0.05
exit

To extract the size and center of the system, one can use the following code (size.tcl) in a
shell script interface: vmd -dispdev text -e size.tcl > size.log.
1
2
3

# size . tcl
# Determine size of simulation box and center of box
mol load pdb ionized_2odemu1 . pdb psf ionized_2odemu1 . psf

4
5
6
7
8
9
10
11
12
13
14
15

set outfile [ open data . dat w ]
set sel [ atomselect top " all "]
set a [ measure minmax $sel ]
set a1 [ lindex $a 0]
set a2 [ lindex $a 1]
set size [ vecsub $a2 $a1 ]
puts $outfile " MIN : $a1 "
puts $outfile " MAX : $a2 "
puts $outfile " SIZE : $size "
set b [ measure center $sel ]
puts $outfile " CENTER : $b "

16
17
18

close $outfile
exit

A.4 Post-processing Files
To process the trajectory data (file.dcd in NAMD), I usually remove water molecules and
ions from the trajectory file if they are not critical to analysis. I used the catdcd tool to
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process the trajectory file: catdcd -o dry.dcd -i select.ind npt.dcd. The “select.ind” file
can be generated using the following Tcl script.
1
2

mol new ionized_2odemu1 . pdb
mol addfile ionized_2odemu1 . psf

3
4
5
6
7
8
9

set sel [ atomselect 0 " all and protein "]
set ind [ $sel get index ]
set output [ open " select . ind " w ]
put $output $ind
close $output
exit

I then align the new trajectory file with a reference configuration using the following script
to generate a new trajectory file “align.dcd”.
1
2
3

mol new 2 odemu1 . pdb
mol new dry . dcd waitfor all
mol addfile 2 odemu1 . psf

4
5
6
7
8
9
10
11

set nf [ molinfo 1 get numframes ]
set nff [ expr $nf -1]
proc fitframes { molid seltext } {
set ref [ atomselect 0 $seltext ]
set sel [ atomselect $molid $seltext ]
set all [ atomselect $molid all ]
set n [ molinfo $molid get numframes ]

12

for { set i 0} { $i < $n } { incr i } {
$sel frame $i
$all frame $i
$all move [ measure fit $sel $ref ]
}
return

13
14
15
16
17
18
19

}

20
21
22
23

fitframes 1 " all "
animate write dcd align . dcd beg 0 end $nff waitfor all
exit

Finally, I can start to analysis the trajectory file “align.dcd” using Tcl scripts.
Root Mean Squared Deviation (RMSD):
1
2
3
4
5

mol
mol
set
set
set

new 2 odemu1 . psf
addfile align . dcd waitfor all
outfile [ open rmsd . dat w ]
nf [ molinfo top get numframes ]
Pr [ atomselect top " all "]

6
7
8

set a4align1 [ atomselect top " protein and name CA "]
set a4align [ atomselect top " protein and name CA "]

9
10
11

set i 0
$a4align1 frame [ expr { $i }]

12
13
14
15

for { set i 0 } { $i < $nf } { incr i } {
$Pr frame [ expr { $i }]
$a4align frame [ expr { $i }]
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16
17
18

set movematrix [ measure fit $a4align $a4align1 ]
$Pr move $movematrix

19
20
21
22
23

puts $outfile " $i [ measure rmsd $a4align $a4align1 ]"
}
close $outfile
exit

Root Mean Squared Fluctuation (RMSF):
1
2

mol new ./ rgs9_nvt . dcd waitfor all autobonds off
mol addfile ./ ionized_1fqi . psf

3
4
5
6
7
8

set
set
set
set
set

outfile [ open rmsf_rgs9 . dat w ]
nf [ molinfo top get numframes ]
all [ atomselect top " all "]
CA1 [ atomselect top " chain A and name CA "]
CA2 [ atomselect top " chain A and name CA "]

9
10
11
12
13
14
15
16
17
18
19
20

$CA1 frame 0
for { set i 1 } { $i <= $nf } { incr i } {
$CA2 frame [ expr { $i }]
$all frame [ expr { $i }]
set movematrix [ measure fit $CA2 $CA1 ]
$all move $movematrix
}
set CA [ atomselect top " chain A and name CA "]
puts $outfile "[ measure rmsf $CA ]"
close $outfile
exit

Solvent Accessible Surface Area (SASA) and Buried Surface Area (BSA):
1
2

mol new ./ aligndry . dcd
mol addfile ./1 fqi . psf

waitfor all autobonds off

3
4
5

set outfile1 [ open BSA_alph45 . dat w ]
set outfile2 [ open BSA_alph47 . dat w ]

6
7
8
9
10
11

12

set
set
set
set
set

nf [ molinfo top get numframes ]
a4 [ atomselect top " protein and resid 324 to
a5 [ atomselect top " protein and resid 340 to
a7 [ atomselect top " protein and resid 386 to
a4a5 [ atomselect top "( protein and resid 324
resid 340 to 354) "]
set a4a7 [ atomselect top "( protein and resid 324
resid 386 to 399) "]

13
14
15
16
17
18
19
20
21
22
23
24

set dt 0.02
for { set i 0 } { $i <= $nf } { incr i } {
$a4 frame [ expr { $i }]
$a5 frame [ expr { $i }]
$a7 frame [ expr { $i }]
$a4a5 frame [ expr { $i }]
$a4a7 frame [ expr { $i }]
set sasaA4 [ measure sasa 1.4 $a4 ]
set sasaA5 [ measure sasa 1.4 $a5 ]
set sasaA7 [ measure sasa 1.4 $a7 ]
set sasaA45 [ measure sasa 1.4 $a4a5 ]
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25
26
27
28
29
30
31

1
2

set sasaA47 [ measure sasa 1.4 $a4a7 ]
puts $outfile1 "[ expr " $i * $dt "] [ expr " $sasaA4 + $sasaA5 - $sasaA45 "]"
puts $outfile2 "[ expr " $i * $dt "] [ expr " $sasaA4 + $sasaA7 - $sasaA47 "]"
}
close $outfile1
close $outfile2
exit
mol new ./ rgs9_nvt . dcd waitfor all autobonds off
mol addfile ./ ionized_1fqi . psf

3
4

set outfile [ open sasa_cysHS . dat w ]

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

set nf [ molinfo top get numframes ]
set pro [ atomselect top " all and chain A "]
set resCYS [ atomselect top " all and index 740 741"]
set dt 0.02
for { set i 0 } { $i <= $nf } { incr i } {
$resCYS frame [ expr { $i }]
$pro frame [ expr { $i }]
$resCYS update
$pro update
set sasa1 [ measure sasa 1.4 $pro - restrict $resCYS ]
puts $outfile "[ expr " $i * $dt "] $sasa1 "
}
close $outfile
exit

For permeability calculations in PAP channels, I used the Tcl scripts written by Mr. D.
Ryan Barden. The scripts can be found in his thesis (Appendix B.11) [214].
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I used the MATLAB scripts to reconstruct the Free-energy surface (FES) using radial
basis functions [136] and to calculate the minimum free-energy pathways (MFEPs) using the
Zero-Temperature String method [151]. These scripts can be found in Dr. Mohammadjavad
Mohammadi’s thesis (Appendix A) [158].
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Figure C.1: Convergence of typical mean-force calculations in a 1 ns (A) and a 5 ns (B) MD
simulation is shown. Traces are shown for the x, y, and z-components of forces.

Figure C.2: Histogram of the standard deviation of each mean-force over the last 10% of
each mean-force simulation. Data are from mean-force simulations for all 635 unique centers.
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G
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44

13.99
12.6
12.42
16.05
11.93
11.76
11.67
13.7
10.97
6.5
12.53
11.86
12.51
12.44
13.09
12.51
11.47
12.49
12.38
13.12
12.53
13.09
10.95
6.5
12.59
11.66
12.43
11.63
5.73
11.67
6.54
11.62
12.57
0.61
5.48
1.46
11.66
6.63
11.62
6.07
12.59
8.06
0.45
11.53

G
15.47
11.35
11.32
10.47
11.16
10.16
11.34
10.86
9.68
9.78
6.15
6.06
6.15
6.12
0.22
4.55
11.08
5.76
10.37
2.21
1.17
1.48
9.36
5.01
0.3
13.36
5.49
8.16
13.83
12.16
8.5
6.15
2.21
3.07
14.58
9.78
11.81
11.16
10.68
15.42
0.18
8.56
15.37
13.35

1
14.68
11.95
9.29
7.77
7.66
7.64
2.24
8.28
7.64
4.15
6.06
7.76
5.13
6.06
13.91
7.63
2.71
5.13
7.65
11.93
13.27
13.96
7.65
6.53
6.6
2.49
5.12
8.22
14.6
2.48
4.14
5.12
7.63
14.59
6.2
4.12
2.97
3.67
4.85
14.59
2.07
2.44
14.6
2.49

2
14.69
11.95
9.48
6
6.3
5.67
8.62
4.53
5.62
9.47
8.16
4.01
7.48
6.49
12.01
5.8
4.28
5.31
1.03
7.24
11.42
13
1.88
5.81
5.69
8.61
5.48
5.56
6.87
8.62
8.58
5.31
5.82
14.43
6.42
14.66
4.87
4.9
3.37
6.87
8.09
8.61
14.57
11.25

3
18.63
11.57
8.26
6.3
2.76
2.13
5.04
6.05
2.73
8.26
7.42
1.74
8.26
6.47
12.43
2.49
3.39
5.55
2.31
3.96
12.25
10.91
2.74
4.83
6.06
5.02
5.5
3.23
13.26
8.12
8.17
3.05
2.49
14.35
13.27
14.49
3.42
5.72
3.36
14.63
8.22
8.22
14.56
4.96

4
14.62
11.95
8.26
6.72
2.87
2.87
5.03
8.41
7.35
8.26
8.23
6.52
8.25
6.49
11.92
5.83
3.39
5.58
1.04
5.73
11.98
11.72
0.87
4.79
8.07
5.02
5.53
3.21
13.5
6.09
8.19
3.21
5.83
14.59
5.88
5.19
4.93
3.67
4.62
14.61
8.26
5.81
14.62
4.89

5
14.67
11.59
8.26
6.3
2.46
2.76
8.62
6.29
2.73
8.2
9.05
1.74
8.22
6.5
13.06
2.49
6.3
5.55
2.31
6.84
7.06
12.11
2.73
2.73
5.24
8.58
5.49
3.31
6.25
5.25
8.21
3.01
2.47
13.97
13.82
14.64
6.26
6.7
6.26
14.64
5.23
7.12
14.04
13.83

6
14.62
11.58
2.45
9.29
5.23
5.23
9.29
8.29
8.15
4.15
6.06
5.23
5.13
7.07
13.96
7.63
2.71
8.19
5.23
11.88
13.02
11.9
3.61
7.58
6.59
2.49
5.13
5.56
16.68
2.49
6.27
5.13
7.51
14.62
5.88
3.18
2.92
3.65
2.71
14.62
2.45
2.49
14.62
2.49

7
16.68
11.95
9.18
5.24
6.45
8.7
5.67
8.32
5.67
9.16
8.56
4.72
7.55
10.08
12.09
6.32
4.89
8.55
2.56
6.3
11.74
12.17
7.14
6.1
8.19
8.32
7.62
6.78
6.86
8.31
8.22
7.81
7.8
16.23
7.69
8.24
5.03
5.05
4.91
7.53
7.86
10.45
8.28
4.96

8
14.4
11.61
8.26
6.3
3.57
8.19
3.24
8.68
6.25
12.35
9.03
3.54
8.22
9.1
13.15
6.86
6.12
5.59
3.56
6.07
6.77
12.25
0.03
2.04
5.24
8.14
3.36
8.26
13.12
8.23
8.2
8.04
6.84
14.26
13.82
14.29
8.61
7.55
6.12
14.37
5.24
8.18
14.66
8.58

9
10.38
12.17
5.94
9.29
7.74
7.65
7.62
5.94
8.27
11.17
7.6
7.99
6.66
7.54
11.98
9.65
9.55
6.65
5.92
13.97
11.83
11.92
7.64
6.52
7.2
4.16
6.65
9.05
10.33
4.19
1.92
6.66
13.62
10.13
10.33
1.46
9.5
12.22
9.5
5.28
5.92
7.83
10.32
3.8

10
14.63
8.88
8.19
8.07
9.06
8.15
11.16
8.18
8.28
11.15
7.93
8.55
0.56
4.51
8.88
3.87
8.21
4.66
9.2
4.13
9.13
8.87
11.17
11.16
8.87
2.97
0.53
3.77
14.59
2.53
3.69
2.24
3.86
11.4
8.16
9.08
8.42
8.05
10.94
12.48
8.83
2.47
14.52
2.98

11
14.56
8.88
8.25
6.05
3.47
8.14
3.14
5.57
6.05
3.36
8.6
7.62
7.96
6.49
11.51
2.5
3.73
7.91
1.34
3.96
11.84
10.27
3.47
4.85
4.75
7.99
2.79
3.23
6.85
7.96
7.95
7.42
2.5
10.55
11.51
8
3.39
6.19
4.06
6.03
5.82
8
5.87
5

12
14.65
8.88
8.19
8
8.21
8.19
8.14
8.19
8.28
11.17
7.93
1.49
9.16
4.51
12.12
5.46
8.22
4.66
8.23
8.86
11.94
8.87
8.16
8.17
6.69
2.97
4.65
3.77
14.55
2.52
3.69
2.8
3.88
11.69
8
9.02
8.36
8.04
8.08
12.51
7.83
2.51
14.58
2.97

13
14.61
8.88
8.19
9.61
9.29
9.19
9.29
10.38
12.49
10.79
7.93
5.69
7.58
5.69
9.74
5.55
11.13
5.68
8.66
5.64
8.88
9.25
9.74
8.19
5.56
7.32
5.59
3.21
9.61
7.29
5.01
2.2
5.62
9.89
8.15
8.96
9.09
10.89
5.33
9.69
8.88
7.31
14.55
9.74

14
14.58
4.54
13.37
11.25
11.46
11.13
11.8
13.36
11.57
11.34
9.92
6.15
8.77
9.61
6.92
4.56
13.34
5.1
11.16
4.54
4.5
3.77
9.26
5.73
4.5
11.5
5.83
7.97
14.33
11.57
4.89
6.14
4.53
3.74
14.59
11.12
13.33
13.36
10.84
10.12
4.54
8.46
14.21
10.8

15
15.66
8.88
11.35
9.34
5.73
8.95
5.71
9.53
8.95
9.25
13.16
5.46
4
6.12
5.33
8.88
8.94
3.07
5.3
3.96
12.3
11.09
5.64
9.24
4.8
11.12
2.95
3.07
13.9
6.05
8.29
3.06
0.54
14.38
8.93
11.33
8.94
8.94
8.9
14.58
4.78
6.11
14.6
9.51

16
14.74
11.95
7
6.22
7.18
7.07
7.49
6.14
8.29
7.06
8.63
6.76
5.18
6.37
6.46
13.92
7.07
7.06
6.16
7.06
11.89
11.5
7.08
7.57
6.98
5.89
7.06
6.05
7.98
6.13
6.16
6.08
7.07
14.62
5.93
6.14
2.92
3.72
1.26
6.04
7
10.42
6.06
11.85

17
14.61
8.87
9.18
9.2
8.92
8.94
9.05
9.81
9.19
9.04
7.93
7.06
8.84
6.13
4.86
8.88
3.87
9.2
9.19
3.87
11.38
8.87
8.92
11.14
6.76
6.1
0.08
2.83
14.43
6.04
6.12
2.75
3.87
14.56
9.18
6.1
9.19
9.19
11.2
14.51
6.55
6.12
14.57
9.08

18
14.67
11.58
8.26
5.73
6.72
5.33
6.39
5.12
6.02
6.7
5.88
7.68
4.01
5.78
7.44
12.2
5.32
4.39
5.29
4.78
12.65
10.98
5.3
5.3
8.26
5.03
6.97
3.72
6.87
5.06
6.11
5.3
4.01
14.63
13.7
5.01
3.39
5.7
3.37
12.86
8.02
5.54
8.6
3.5

19
14.61
7.83
11.34
8.78
8.47
8.95
9.75
11.27
8.94
9.24
12.78
6.44
6.75
7.8
6.38
7.87
5.25
8.93
4.85
7.47
7.78
1.7
9.24
9.1
7.82
11.32
4.84
4.78
14.13
7.8
7.79
6.28
0.05
9.85
11.23
11.54
11.08
8.94
9.18
13.34
7.81
7.76
14.53
11.33

20

14.62
6.99
12.9
11.22
11.51
11.21
11.44
12.5
10.8
10.65
10.1
6.91
10.77
8.29
6.91
6.88
8.22
11.18
7.42
11.86
6.99
6.92
5.96
5.93
6.65
12.51
6.92
10.63
13.68
13.37
9.96
8.28
6.98
3.3
14.29
10.44
12.47
14.36
11.56
13.75
6.8
11.56
14.65
14.31

21

Table S1: Major energy barriers (kcal/mol) along MFEPs between minima pairs (locations are shown in Fig. 3 and MFEPs are shown in Fig. 4) . The
value on the entry i j is the free energy barrier of the rate-limiting step from the local minima i to the local minima j.
22
14.58
7.85
13.36
12.37
10.08
11.34
10.77
11.3
11.08
10.39
10.09
7.83
8.26
7.83
8.17
5.81
7.85
11.31
7.84
10.04
2.45
7.85
9.19
7.81
7.85
13.28
7.84
7.83
18.72
13.2
11.58
7.83
7.66
9.79
14.5
10.39
11.26
11.31
11.05
13.68
10.13
10.98
14.47
11.41

APPENDIX C. SUPPORTING INFORMATION FOR CHAPTER 3

153

G
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44

24
14.57
11.59
12.51
7.82
7.52
7.41
7.19
8.62
7.82
6.68
12.43
12.48
7.5
12.5
12.84
12.28
6.85
8.52
8.18
7.41
12.01
6.7
12.3
6.56
4.81
14.61
8.07
8.81
14.4
12.56
12.32
12.47
7.68
14.38
14.37
14.39
13.45
14.17
8.61
14.39
4.8
13.83
14.41
14.4

23
18.9
12.02
8.26
7.56
6.25
6.13
5.08
8.62
7.55
4.57
8.26
9.05
6.25
8.23
8.23
11.99
5.32
6.13
6.11
6.13
5.81
11.79
12
4.45
5.24
9.34
6.13
6.13
14.56
8.23
8.24
8.13
6.85
14.38
13.96
14.47
8.63
6.87
6.12
14.66
8.21
8.19
14.65
8.61

14.69
7.08
11.35
11.23
10.61
11.16
10.59
11.34
11.29
10.08
12.92
7.07
10.43
8.29
8.72
7.03
7.34
11.35
8.24
11.39
7.08
6.81
7.08
9.7
5.01
13.37
7.77
10.67
14.2
14.78
13.35
8.29
7.25
3.05
14.58
12.44
11.78
11.24
11.49
14.51
0.15
12.97
14.6
13.47

25

Continued (Table S1)
26
14.61
13.97
8.76
9.29
8.26
7.88
8.65
7.9
8.29
8.71
8.64
7.11
8.13
6.18
7.07
13.94
8.7
7.77
6.16
7.88
11.94
12.94
13.84
8.61
14.6
8.76
6.16
8.22
14.6
0.21
6.18
6.15
6.15
12.33
7.89
3.08
7.89
7.88
7.87
12.51
8.76
0.74
14.59
0.87

27
14.59
8.88
9.18
9.33
9.04
8.95
9.03
9.14
8.91
6.88
7.93
4.86
5.37
6.12
4.76
8.88
3.87
9.2
2.02
8.18
3.86
8.94
8.88
8.94
10.73
4.8
6.1
2.83
13.56
6.13
4.86
4.78
3.87
10.964
9.19
6.07
9.14
9.17
5.22
14.43
8.87
4.86
14.52
8.98

28
14.62
11.95
9.2
11.98
9.35
9.21
9.09
11.3
12.49
9.4
9.11
8.24
7.61
7.32
6.51
11.93
5.71
11.21
4.9
7.63
5.62
11.76
11.91
9.45
9.19
9.13
11.54
4.9
11.12
8.85
7.35
0.4
5.69
14.5
11.14
8.72
11.21
11.05
5.47
11.01
9.1
9.09
11.05
10.68

29
14.43
13.54
14.29
13.3
12.89
13.13
11.08
14.15
13.28
12.72
14.3
14.27
13.27
14.29
13.86
14.23
13.54
13.54
14.03
13.28
13.79
13.86
13.95
14.18
14.29
14.09
14.28
13.26
13.56
14.27
14.25
13.93
12.99
14.16
1.2
14.27
6.69
6.66
10.31
12.3
14.28
14.29
1.18
2.57

30
14.61
15.83
8.79
9.3
9.17
9.17
8.26
7.9
8.42
8.73
8.67
7.13
8.58
6.2
7.09
13.88
6.1
7.88
6.08
8.39
9.8
13.25
13.97
8.73
8.76
9.23
0.67
6.13
8.98
14.54
6.11
5.98
6.13
12.26
7.9
2.76
7.89
7.87
8.56
12.49
8.12
0.75
14.67
0.88

31
11.22
12.22
9.12
10.69
10.81
10.94
9.07
10.13
10.03
9.08
7.33
8.76
10.22
7.83
8.7
11.43
7.83
10.01
7.82
10.48
11.46
12.14
12.23
9.09
8.92
9.1
7.83
8.75
7.85
12.49
7.88
7.83
8.73
11.04
9.46
7.21
9.41
10.06
11.05
7.3
7.73
7.83
12.46
10.41

32
14.61
10.97
10.38
9.62
9.32
9.21
9.3
10.27
11.25
10.21
8.58
7.69
8.62
7.32
6.47
10.95
5.71
11.25
4.9
9.21
7.48
11.94
10.41
10.28
10.34
7.32
7.29
7.57
1.38
8.57
7.17
7.32
7.5
12.49
8.43
7.26
11.22
14.43
5.2
9.69
7.32
7.3
14.6
10.54

33
14.71
8.69
11.35
9.35
8.08
8.95
8.06
11.16
8.71
9.24
11.53
6.44
6.35
6.44
6.38
8.67
4.85
8.94
4.85
6.35
3.07
8.65
8.5
9.23
9.44
4.85
6.09
4.85
4.84
13.36
6.08
6.44
6.29
13.24
9.46
9.52
9.19
8.94
6.65
14.55
9.153
6.42
14.48
6.04

34
11.35
12.33
12.53
12.4
11.8
11.63
11.48
11.72
13.68
10.97
11
10.82
11.23
11.09
10.76
11.57
12.51
11.66
12.43
12.38
12.28
6.75
11.58
11.32
11.32
5.53
11.02
10.89
11.65
11.21
10.89
11.05
11.18
11.04
11.37
11.09
11.62
11.29
11.31
11.2
12.47
11.04
11.34
11.3

35
14.3
14.39
14.91
13.3
12.96
13.99
13.47
13.73
15.51
13.48
14.44
14.78
16.74
14.69
13.9
14.23
13.98
13.53
13.95
15.73
14.46
14.21
14.22
13.65
14.23
14.32
13.73
13.96
13.57
3.31
13.72
13.76
13.47
14.45
14.41
18.83
12.01
6.63
13.71
6.04
14.42
13.63
0.09
2.36

36
12.67
12.18
10.58
12.66
12.53
9.97
12.62
9.72
9.68
12.53
8.79
8.77
9.98
8.72
8.64
12.44
10.56
9.71
7.52
9.68
13.88
8.76
11.72
12.58
12.66
9.65
4.31
7.48
9.35
12.64
4.31
10.86
7.46
8.77
12.55
12.65
10.2
12.66
9.02
5.29
10.02
4.31
12.37
2.61

37
14.63
13.17
12.61
12.37
12.06
11.94
12.33
11.7
11.66
11.63
10.76
11.69
10.32
11.7
10.07
13.93
11.9
8.27
11.88
9.34
12.39
12.96
13.1
11.69
15.68
12.49
11.67
11.8
11.56
9.72
11.7
15.84
11.57
11.87
17.91
8.27
13.17
8.25
8.27
11.27
12.61
4.43
16.6
11.64

38
18.38
13.92
13.34
13.13
13.12
12.74
16.16
12.46
12.43
16.25
18.02
12.55
12.42
13.18
12.04
16.56
12.73
9.11
12.71
13.1
12.72
17.98
16.73
16.14
18.34
13.14
15.43
12.68
12.04
9.72
12.43
15.42
12.09
12.73
18.26
7.59
18.84
9.02
9.04
7.61
13.34
12.09
7.64
11.4

39
14.61
11.95
11.29
11.1
10.8
10.69
11.07
10.43
10.41
10.68
10.34
11.47
9.12
10.51
12.08
11.92
10.66
7.02
10.33
7.77
10.65
11.78
11.8
10.68
10.41
11.26
10.4
10.74
8.92
7.99
10.6
11.43
8.65
9.44
14.55
10.39
12.47
7
7
11.73
11.23
10.36
10.31
12.04

40
18.91
18.83
18.85
13.3
18.83
18.79
18.85
18.87
15.9
18.87
14.24
18.85
15.62
18.87
17.33
15.54
18.86
12.51
18.86
17.09
18.82
18.79
18.67
18.86
18.86
18.79
18.8
18.63
15.65
16.44
18.8
14.22
17.34
18.78
18.88
8.08
6.92
10.48
8.08
16.17
18.86
14.19
0.52
2.33

41
15.45
12.09
13.37
11.27
11.43
11.34
10.63
13.37
11.09
10.12
13.35
12.04
10.95
9.76
12.09
12.09
7.73
13.36
8.26
11.25
12.08
11.96
12.09
11.4
5.47
5.28
13.37
12.08
10.92
15.42
11.57
8.44
8.58
12.07
13.34
14.53
12.8
13.39
13.39
13.35
15.43
11.58
15.45
13.04

42
16.42
14.09
13.52
12.33
13.5
13.39
13.28
12.67
16.29
13.46
11.73
11.39
12.91
10.46
10.45
14.07
10.45
13.9
10.45
12.9
14.07
13.81
14.03
13.47
14.87
13.12
7.25
11.38
9.31
15.57
6.81
10.46
10.44
11.38
15.45
12.5
7.25
7.58
12.27
7.15
7.69
11.72
7.18
12.79

43
18.8
18.7
18.79
18.34
18.4
18.43
17.8
18.6
15.45
18.78
18.79
18.75
15.44
18.75
18.42
18.73
18.79
15.42
18.75
16.15
18.75
18.8
18.68
18.77
18.8
18.77
18.79
18.75
15.25
9.74
18.44
18.73
18.43
18.78
18.79
7.65
18.79
15.82
7.61
15.38
6.04
18.79
14.2
2.4

44
22.55
19.65
19.05
19.41
18.55
18.34
20.34
18.18
19.56
18.17
17.25
16.92
18.52
16
15.81
18.94
19.04
14.75
18.31
17.46
18.99
20.9
19.58
18.17
21.12
19.03
12.77
18.2
17.57
14.12
12.77
12.77
13.95
15.94
22.58
11.82
11.66
11.64
16.13
12.04
9.75
18.71
12.19
4.3
-
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Figure D.1: Snapshots from a second set of independent MD simulations highlighting the
clustering phenomenon in PAP channels for the 2PAP/POPC system (panel A; t = 10 ns)
and the 4PAP/POPC system (panel B; t = 5 ns). Coloring scheme is identical to Figure 4.2.

Figure D.2: The time-evolution traces for the conformational metrics of BSA and dCOM (see
methods) are shown from three independent simulations of 2PAP channels in the POPC
membrane (panels A and B) and in the PB-PEO membrane (panels C and D).
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Figure D.3: For the systems with 4PAP channels, the time-evolution traces for the BSA are shown from all possible pairs of
adjacent and diagonally-positioned PAP channels from three independent simulations in the POPC membrane (top row) and
in the PB-PEO membrane (bottom row).
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Figure D.4: For the systems with 4PAP channels, data similar to Figure D.3 are shown for the inter-channel distance metric
dCOM (see Section 4.3).
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Figure D.5: Shown are the snapshots highlighting the conformation of the PAP channel
corresponding to various RMSD values. The RMSD values are corresponding to peaks in
the distributions shown in Figure 4.5. The upper (yellow) and lower (green) parts of the
central pillar[5]arene rings are shown in space-filling representations, the peptide arms are
shown in cyan sticks, and the aromatic side chains in the peptide arms are shown in blue
sticks.

Figure D.6: Shown are the top-views highlighting the locations of the center of mass of those
POPC (panel A) and PB-PEO (panel B) molecules that were initially in the vicinity of the
PAP channel (shown in a black space-filling representation). The locations are higlighted
in color: t = 0 µs (red spheres), 0.25 µs (green spheres), and 0.5 µs (blue spheres). To
highlight the diffusion of lipid/BCP molecules away from the channel, three concentric rings
are marked at different radial distances relative to the center of mass of the PAP channel.
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Figure D.7: The top-views of dimerized PAP channels corresponding to Figure 4.7 are shown.

Figure D.8: Shown are the side-view (panels A and C) and the top-view (panels B and D)
snapshots highlighting structural distortions in channels (panels A and B, POPC; panels C
and D, PB-PEO). The configurations correspond to dCV = 10 Å and are higher in the free
energy relative to the dimerized configurations shown in Figure 4.7.

159

APPENDIX D. SUPPORTING INFORMATION FOR CHAPTER 4

Figure D.9: The RMSD distributions of the PAP channel corresponding to simulations in
which the lowest and the highest permeability was observed in each membrane: (A) in the
POPC membrane corresponding to the lowest permeability (0.55×10−14 cm3 /s; Figure 4.10B,
channel 3, run1) and the highest permeability (9.78 × 10−14 cm3 /s; Figure 4.10B, channel 4,
run3); and (B) in the PB-PEO membrane corresponding to the lowest permeability (0.24 ×
10−14 cm3 /s; Figure 4.10D, channel 3, run1) and the highest permeability (7.14×10−14 cm3 /s;
Figure 4.10C, channel 2, run2).
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Figure D.10: Results from a larger 2PAP/POPC system with 383 POPC lipids and 85423
atoms: (a) snapshots highlighting channel-channel interactions; (b) traces of the BSA vs.
simulation time (ns) from two independent simulations; and (c and d) distributions of conformational metrics (tilt-angle and RMSD) computed from data based on two independent
simulations.
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Figure D.11: Data similar to Figure D.10 are shown for a larger 4PAP/POPC system with
363 lipids and 83766 atoms.
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Non-conserved Salt Bridges

I also observed many unconserved salt-bridging residue pairs between different helices or
loops in RGS proteins (Figure E.5A-E). In the R4 subfamily, I observed that the K77/K125D90 and K155-D130 in RGS4, and R71/R119-E84 and K149-D124 in RGS8, are shared saltbridges (Figure E.5B-C). While in RGS4 there is only one salt-bridge (K77-D90) connecting
the α3-helix and the α4-helix, four salt-bridges (R71-E84/E80, K75-E80, and K64-E90) were
identified in RGS8. Additionally, I identified two salt-bridges (D136-K155 and R139-E151)
connecting the α6-helix and α7-helix in RGS4, while no salt-bridge pair was found in RGS8.
Similarly, I identified two salt-bridges (K168-D178 and K168-D179) connecting the α6-helix
and the α7-helix in RGS19 (Figure E.5E), which potentially explains the observation that
several allosteric pathways crossed residues on the α6-helix (Figure E.7E). In RGS9 (Figure E.7C), I identified strong salt-bridging interactions (R292-D306 and R292-E302) between
the α1-helix and the α2-helix. Also, the E345/E348-K378 salt-bridges in RGS9 keep the
α5-helix and the α6-helix together. In RGS17, I observed that the salt-bridge K123-D165
connects the α4-α5 interhelical loop with the α6-α7 interhelical loop. In both RGS17 and
RGS19, I identified the formation of salt-bridges between the α5-α6 loop and the α5-helix
or α6-helix (Figure E.5D-E), which is different from the R4 subfamily proteins (RGS4 and
RGS8) where the salt-bridges between the α4-helix and the α5-α6 loop are formed (Figure E.5A-B).
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Pathways for additional shared cysteine between RGS4 and RGS8

I also analyzed allosteric pathways for the additional shared cysteine between RGS4 and
RGS8 (Figure E.8). The physical distances between the common source residue (C148 in
RGS4 and C142 in RGS8) and six sink residues in both RGS proteins showed an order
(shortest to longest): P2 < P4 < P3 < P5 < P1 < P6, which is distinct from allosteric
pathway analysis that revealed P5 as the shortest pathway in both proteins. I further
observed that the pathways P1, P4, P5, and P6 are similar in both proteins. Also, the
pathway P2 in RGS8 crossed the node (residue F85) on the α4-helix, indicating that the
α4 and α7 helices are highly correlated which is consistent with the finding of the pathway
P4 from the other cysteine residue (C89) in RGS8 (Figure E.7B). For the pathway P3, I
found that it crossed the residue L153 in RGS8 (C142-D144-Q147-V150-L153-N122) rather
than directly link the sink N122 with V150, as observed in RGS4. I also observed that all
pathways in both proteins crossed an aspartate residue (D150 in RGS4 and D144 in RGS8)
residing on the α7-helix, which suggests that targeting this residue may be an alternate
potential route to allosterically perturb the RGS/Gα protein-protein interface.
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Figure E.1: Chemical structures of TDZD inhibitors of RGS proteins (CCG: Center for
Chemical Genomics).
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Figure E.2: Sequence alignment of RGS proteins is shown (RGS4: residues 51-178; RGS8:
residues 46-174; RGS9: residues 288-416; RGS17: residues 73-202; RGS19: residues 79206). Highly conserved residues are highlighted in red except cysteine residues which are
highlighted in cyan. Other residues highlighted in blue boxes are conserved across at least
two RGS proteins.
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Figure E.3: The structures of three known RGS/Gα complexes are shown: (A) RGS4/Gα;
(B) RGS8/Gα; and (C) RGS9/Gα. Highlighted in these structures are cysteine residues
of RGS proteins (cyan spheres), switch regions of Gα subunits (colored and labeled), and
residues of RGS proteins involved in the protein-protein interface (shown in stick representations, colored and labeled). The Gα-subunit in each complex is shown as a transparent
white surface and each RGS protein as a blue transparent ribbon.
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Figure E.4: Shown are residue pairs forming intrahelical salt-bridges conserved across RGS
proteins (RGS4, RGS8, RGS9, RGS17, and RGS19). (A) The Cα -atoms of salt-bridge
forming residues are mapped on the structure of RGS4 along with the highly conserved
cysteine residue (labeled C95), and (B) tabulated are eight salt bridges conserved among all
RGS proteins. See also Figure 5.3.
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Figure E.5: Unique and non-conserved salt-bridges in RGS proteins. (A-E) Salt-bridges that
are not conserved across five RGS proteins but are identified uniquely for each RGS protein
are highlighted. Residues highlighted in blue are positively charged and in red are negatively
charged.
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Figure E.6: The Cα -Cα residue-residue correlation maps: (A) RGS4, (B) RGS8, (C) RGS9,
(D) RGS17, and (E) RGS19. The horizontal and vertical black lines in each map indicate
the location of a common and conserved cysteine residue in each RGS protein. The color bar
values from 0 to 1 indicate uncorrelated motions (lighter colors) to highly correlated motions
(darker colors).

171

APPENDIX E. SUPPORTING INFORMATION FOR CHAPTER 5

Figure E.7: Allosteric pathways between source and sink residues. Shown are optimal pathways from the conserved cysteine residue shared by five RGS proteins to sink residues: (A)
RGS4, (B) RGS8, (C) RGS9, (D) RGS17, and (E) RGS19. Shown also are details of residues
for each pathway in all RGS proteins with the first residue as a source residue and the last
residue as a sink residue. The numbers in parenthesis indicate the length of each pathway.
See also Figure 5.5.
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Figure E.8: Pathways for an additional shared cysteine residue between RGS4 and RGS8.
Allosteric pathways between a second shared cysteine residue (C148 in RGS4 and C142 in
RGS8), and six sink residues. Other details are similar to Figure E.7.
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Figure E.9: Shown are difference cross-correlation (∆DCC) maps: (top row) maps for RGS8,
RGS9, RGS17, and RGS19 with RGS4 as a reference; (middle row) maps for RGS9, RGS17,
and RGS19 with RGS8 as a reference; (bottom row) maps for RGS17 and RGS19 with
RGS9 as a reference, and for RGS19 with RGS17 as a reference. Red indicates an increased
correlation, blue a decreased correlation, and white no change in correlation.
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Figure E.10: Shown are communities and pathways computed from an additional simulation
(2 µs each) for RGS4 (PDB 1EZT), RGS8 (PDB 2IHD), RGS9 (PDB 1FQI), and RGS17
(PDB 6AM3). See also Figures 5.4 and E.7.
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Figure E.11: The effect of changing the cut-off distance (4.5 Å, 5 Å, 6 Å, 7 Å) for computing
communities and pathways is highlighted for RGS9. See also Figures 5.4 and E.7.

176

APPENDIX E. SUPPORTING INFORMATION FOR CHAPTER 5

Figure E.12: Data similar to Figure E.11 are shown for RGS17. See also Figures 5.4 and E.7.
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Figure E.13: Shown are communities computed from additional simulations using the Amber
force-field (ff14SB) (2 µs each) for RGS4 (PDB 1AGR and 1EZT), RGS8 (PDB 2ODE and
2IHD), RGS9 (PDB 1FQI for three runs), and RGS17 (PDB 6AM3 for three runs), and
RGS19 (PDB 1CMZ). See also Figure 5.4.
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Figure E.14: Shown are allosteric optimal pathways computed from additional simulations
using the Amber force-field (ff14SB) (2 µs each) for RGS4 (PDB 1AGR and 1EZT), RGS8
(PDB 2ODE and 2IHD), RGS9 (PDB 1FQI for three runs), and RGS17 (PDB 6AM3 for
three runs), and RGS19 (PDB 1CMZ). See also Figure E.7.
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community #
C1
C2
C3
C4
C5
C6
C7

residue membership
51-52; 53-59 (α1); 60-62; 63-68 (α2); 69; 70-74 (α3);
87-100(α4); 127; 145-149; 150-154, 156 (α7);
129-130; 131-140 (α6); 141-144;
75-82 (α3); 83-86; 164, 166-168 (α8); 169-171; 172-175 (α9); 176-178;
122, 124, 126, 128;
155,157-162 (α7); 163; 165 (α8);
101-106;107-118 (α5);119-121, 123, 125;

critical nodes
L63, I67, A74
E87, D90, F91, W92, Y98, F149, I156
T133, T137, P144
K77, E86, S164
Q122, E126, N128
K155, F157, L159, M160, E161
L107, F118, S120

Table E.1: Residue memberships in communities and critical nodes for RGS4 (PDB: 1AGR (residue 51-178): 53-59 (α1); 63-68
(α2); 70-82 (α3); 87-100 (α4); 107-118 (α5); 131-140 (α6); 150-162 (α7); 164-168 (α8); 172-175 (α9)). Tabulated are data
corresponding to Figure 5.4.
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community #
C1
C2
C3
C4
C5
C6
C7

residue membership
46; 47-52 (α1); 55; 166, 169-174 (α9); 175, 176;
80-92 (α4); 93-96; 142, 143; 144-148, 150 (α7);
123, 124; 125-134 (α6); 135-139, 141;
64-66, 68-76 (α3); 77-79; 158, 160-164 (α8); 165; 167, 168 (α9);
120, 122;
53, 54, 56; 57-61 (α2); 62, 63; 67 (α3); 149, 151-156 (α7); 157; 159 (α8);
97; 98-112 (α5); 113-119, 121; 140;

critical nodes
D55, D170
L83, F85, T95, F143
R128, T131, L135
R71, L74, F162, M167
E120, N122
L153, M154, Y159
K100, A105, I108, V113, P118

Table E.2: Residue memberships in communities and critical nodes for RGS8 (PDB: 2ODE (residue 46-176): 47-52 (α1); 5761 (α2); 64-76 (α3); 80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)). Tabulated are data
corresponding to Figure 5.4.

APPENDIX E. SUPPORTING INFORMATION FOR CHAPTER 5

180

community #
C1
C2
C3
C4
C5
C6
C7

residue membership
290, 292, 294, 295 (α1); 296-299; 300-304 (α2); 305, 306; 307, 310 (α3); 401 (α8);
323; 324, 325, 327-334, 336 (α4); 337, 338; 385; 389 (α7);
366; 367-376 (α6); 377-382, 384;
308, 309, 311-319 (α3); 320-322; 326 (α4); 400; 402-405 (α8); 406, 407;
289; 291, 293 (α1); 408-416 (α9); 417-420;
365; 383; 386-399 (α7);
335 (α4); 339; 340-354 (α5); 355-364;

critical nodes
R295, V296, F300, I304
F328, W329, L385, Q389
T369, T373, V384
L326, S400, S407
M291, V293, K411
I365, D386, H391, I392, Y393, M396, K397
I350, I363, A387

Table E.3: Residue memberships in communities and critical nodes for RGS9 (PDB: 1FQI (residue 289-420): 290-295 (α1);
300-304 (α2); 307-319 (α3); 324-336 (α4); 340-354 (α5); 367-376 (α6); 386-399 (α7); 401-405 (α8); 408-416 (α9)). Tabulated
are data corresponding to Figure 5.4.
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community #
C1
C2
C3
C4
C5
C6
C7
C8

residue membership
72-74; 75-80, 82, 83 (α1);
109, 112, 113, 115-120 (α4); 121-125; 126-140 (α5); 141-143, 145, 147, 149; 168, 171;
151, 152; 153-163 (α6); 164-166, 170;
85 (α2); 97-104 (α3); 105-108; 111 (α4); 183 (α7); 185; 186-191 (α8); 192, 193; 195 (α9);
144, 146, 148;
89 (α2); 110, 114 (α4); 150; 167, 169; 172-182, 184 (α7);
81 (α1); 84; 86-88, 90 (α2); 91; 92-96 (α3);
194, 196-203 (α9); 204-206;

critical nodes
V78, S80, S82
F113, L115, E118, Y137, S142, V149
L151, I159, N160
F85, L111, S186, F187, L191
L144, E148
W114, S150, A174, Y179, M182
W81, D86, K87, R95
Y196, F199

Table E.4: Residue memberships in communities and critical nodes for RGS17 (PDB: 6AM3 (residue 72-206): 75-83 (α1); 85-90
(α2); 92-104 (α3); 109-120 (α4); 126-140 (α5); 153-163 (α6); 172-184 (α7); 186-191 (α8); 194-203 (α9)). Tabulated are data
corresponding to Figure 5.4.
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community #
C1
C2
C3
C4
C5
C6
C7
C8

residue membership
79, 80; 81-87 (α1); 88-90; 92-95 (α2); 96, 97; 98-102 (α3); 117 (α4); 193 (α8); 205;
114; 115, 116,118-128 (α4); 155; 177; 178-182, 184 (α7);
147, 149, 157-159; 160-168 (α6); 169-171, 173-176;
103, 105-111 (α3); 112, 113; 199; 201, 203 (α9);
150, 152, 154, 156;
91; 104 (α3); 183, 185-191 (α7); 192; 194-196 (α8); 197, 198; 200, 202 (α9); 204, 206;
129-132; 133-145 (α5); 146, 148, 151, 153;
172;

critical nodes
D92, S102, M117, Y193
E114, F119, A180, I184
D158, I165, M169
R105, L108, S199
S102, L150
Q183, Y185, M188, F196
A139, I142, S148
-

Table E.5: Residue memberships in communities and critical nodes for RGS19 (PDB: 1CMZ (residue 79-206): 81-87 (α1); 92-95
(α2); 98-111 (α3); 115-128 (α4); 133-145 (α5); 160-168 (α6); 178-191 (α7); 193-196 (α8); 200-203 (α9)). Tabulated are data
corresponding to Figure 5.4.
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A

RMSF(Å)

DCC

B

C

D

Figure F.1: The root mean squared fluctuations (RMSF) per residue and the Cα-Cα residueresidue correlation maps for (A) RGS8C89 and RGS8C142 , (B) RGS8C89/I1 and RGS8C142/I1 ,
(C) RGS8C89/I2 and RGS8C142/I2 , and (D) RGS8WT/I2 and RGS8WT/I1 .
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Figure F.2: Shown are optimal pathways from cysteine to sink residues for (A) RGS8 mutants, (B) I1 binding RGS8 mutants, (C) I2 binding RGS8 mutants, (D) dual I1 occupancy
RGS8WT , (E) dual I2 occupancy RGS8WT .
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A

RGS8WT

B

RGS8C89

C

RGS8C142

D

RGS8C89/I1

E

RGS8C142/I1

F

RGS8WT/I1

G

RGS8C89/I2

H

RGS8C142/I2

I

RGS8WT/I2

Figure F.3: Critical nodes for (A) RGS8WT , (B) RGS8C89 , (C) RGS8C142 , (D) RGS8C89/I1 ,
(E) RGS8C142/I1 , (F) RGS8WT/I1 , (G) RGS8C89/I2 , (H) RGS8C142/I2 , and (I) RGS8WT/I2 .
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α4-α5 interhelical loop -- α6-α7interhelical loop

A

RGS8C89/I1

B

RGS8C89/I2
RGS8C89

C

RGS8C142/I1

RGS8WT/I1

RGS8C142/I2

RGS8WT/I2

RGS8C142

RGS8WT

Figure F.4: The computed BSA between the α4-α5 interhelical loop and the α6-α7 interhelical loop in the systems of (A) RGS8C89 , (B) RGS8C142 , and (C) RGS8WT with/without
inhibitor binding.
α6-helix -- α7-helix

A

RGS8C89/I1

B

RGS8C142/I1

C

RGS8WT/I1

RGS8C89/I2

RGS8C142/I2

RGS8WT/I2

RGS8C89

RGS8C142

RGS8WT

Figure F.5: The computed BSA between the α6-helix and the α7-helix in the systems of (A)
RGS8C89 , (B) RGS8C142 , and (C) RGS8WT with/without inhibitor binding.
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community #
C1
C2
C3
C4
C5
C6
C7

residue membership
46; 47-52 (α1); 55; 166, 169-174 (α9); 175, 176;
80-92 (α4); 93-96; 142, 143; 144-148, 150 (α7);
123, 124; 125-134 (α6); 135-139, 141;
64-66, 68-76 (α3); 77-79; 158, 160-164 (α8); 165; 167, 168 (α9);
120, 122;
53, 54, 56; 57-61 (α2); 62, 63; 67 (α3); 149, 151-156 (α7); 157; 159 (α8);
97; 98-112 (α5); 113-119, 121; 140;

critical nodes
D55, D170
L83, F85, T95, F143
R128, T131, L135
R71, L74, F162, M167
E120, N122
L153, M154, Y159
K100, A105, I108, V113, P118

Table F.1: Communities and critical nodes for RGS8W T (PDB: 2ODE (residue 46-176): 47-52 (α1); 57-61 (α2); 64-76 (α3);
80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)).
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community #
C1
C2
C3
C4
C5
C6
C7
C8
C9

residue membership
46; 47-52 (α1); 53, 55;
88-92 (α4); 93-96; 140, 143;
113, 115, 123, 124; 125-134 (α6); 135-137, 139;
56; 57-61 (α2); 62, 63; 64-72, 74-76 (α3); 78; 80, 82-84, 86, 87 (α4);
138;
54; 73 (α3); 77, 79; 151, 153-156 (α7); 157; 158-164 (α8); 165;
81 (α4); 97; 98-112 (α5); 114, 116-122;
85 (α4); 141, 142; 144-150, 152 (α7);
166-174 (α9); 175, 176;
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S79, E155, Y159, F162, S165
E81, K100, F112, V121
F85, T141, A146, Q147, S152
M167, L169, L172

critical nodes
A50, R52, D55
E91, F92, T95, F143
I123, S139
V59, F70, A72, L83, L87

Table F.2: Communities and critical nodes for RGS8C142 (PDB: 2ODE (residue 46-176): 47-52 (α1); 57-61 (α2); 64-76 (α3);
80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)).
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community #
C1
C2
C3
C4
C5
C6
C7

residue membership
46; 47-52 (α1); 53, 55;
85, 87-92 (α4); 95, 96; 140, 142, 143; 144, 146, 147 (α7);
123, 124; 125-134 (α6); 135-139, 141;
56; 58-61 (α2); 62, 63; 64-76 (α3); 77-79; 80, 83 (α4); 158, 162 (α8);
166-174 (α9); 175, 176;
54; 57 (α2); 82, 86 (α4); 145, 148-156 (α7); 157; 159-161, 163, 164 (α8); 165;
81, 84 (α4); 97; 98-112 (α5); 113-122;

critical nodes
A50, W53, D55
L87, T95, A146
I123, T137
L60, L83, F162
Y168, L169, L172
W86, K149, Y159, S165
E81, E84, K100, L101, V121

Table F.3: Communities and critical nodes for RGS8C89 (PDB: 2ODE (residue 46-176): 47-52 (α1); 57-61 (α2); 64-76 (α3);
80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)).
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community #
C1
C2
C3
C4
C5
C6
C7
C8
C9

residue membership
46; 47-52 (α1); 53, 55;
82, 85, 86, 88, 89 (α4); 139, 141, 143; 144-150, 152 (α7);
109 (α5); 113, 115, 123, 124; 125-134 (α6); 135-138, 140, 142;
69, 71-76 (α3); 77-79; 80, 83, 87 (α4); 158, 162 (α8); 167 (α9);
90-92 (α4); 93-97; 98-106 (α5);
54; 151, 153-156 (α7); 157; 159-161, 164 (α8);
81, 84 (α4); 105, 107, 108, 110-112 (α5); 114, 116-122;
56; 57-61 (α2); 62, 63; 64-68, 70 (α3);
163 (α8); 165; 166, 168-174 (α9); 175, 176;

critical nodes
R52, W53
F85, W86, D144, Q147
F109, I123, C142
L83, L87, F162
E90, E91, K104, H106
A54, H151, Y159, R164
E81, R107, V121
F57, L60, L61, G66, F70
L163, K166, Y168, L171

Table F.4: Communities and critical nodes for RGS8C142/I1 (PDB: 2ODE (residue 46-176): 47-52 (α1); 57-61 (α2); 64-76 (α3);
80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)).
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community #
C1
C2
C3
C4
C5
C6
C7
C8

residue membership
46; 48, 50, 52 (α1); 55;
71 (α3); 81-92 (α4); 93-96; 121;
115, 124; 125-134 (α6); 135-142;
53, 54, 56; 57-61 (α2); 62, 63; 64-70, 72-76 (α3); 77-79; 80 (α4); 155 (α7); 157; 158-164 (α8); 165;
166-174 (α9); 175, 176;
123; 143; 144-154, 156 (α7);
97; 98-112 (α5); 113, 114, 116-120, 122;
47, 49, 51 (α1);

critical nodes
D55
L83, F85, F92, T95, V121
T127, R128, T131, L140
W53, F70, Y159, F162, S165
Y168, L169
I123, F143, S152, M154
K100, L101, I108, F109, F112, D114
T51

Table F.5: Communities and critical nodes for RGS8C89/I1 (PDB: 2ODE (residue 46-176): 47-52 (α1); 57-61 (α2); 64-76 (α3);
80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)).
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community #
C1
C2
C3
C4
C5
C6
C7

residue membership
46; 47-52 (α1); 53, 55;
85, 88, 89, 91, 92 (α4); 93-97; 98-105, 108 (α5); 141, 143; 144-148 (α7);
109 (α5); 120, 122-124; 125-134 (α6); 135-140, 142;
56; 58-61 (α2); 62, 63; 64-76 (α3); 77-79; 80, 83 (α4); 158, 161, 162, 164 (α8); 165; 167 (α9);
163 (α8); 166, 168-174 (α9); 175, 176;
54; 57 (α2); 82, 86, 87, 90 (α4); 149-156 (α7); 157; 159, 160 (α8);
81, 84 (α4); 106, 107, 109-112 (α5); 113-119, 121;

critical nodes
W53, D55
S103, Q145, G148
I123, C142
H63, L83, F162
L163, Y168, L171
L87, H151, Y159
E81, E84, H106, V121

Table F.6: Communities and critical nodes for RGS8C142/I2 (PDB: 2ODE (residue 46-176): 47-52 (α1); 57-61 (α2); 64-76 (α3);
80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)).
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community #
C1
C2
C3
C4
C5
C6
C7

residue membership
46; 47-52 (α1); 54, 55; 165; 166-174 (α9); 175, 176;
81-92 (α4); 93-96; 119-122; 145, 147, 148, 150 (α7);
109 (α5); 113, 115, 123, 124; 125-134 (α6); 135, 137, 139, 141, 143; 146 (α7);
52, 56; 57-61 (α2); 62, 63; 64-76 (α3); 77-79; 80 (α4); 158, 159, 161-163 (α8);
136, 138, 140, 142; 144 (α7);
149, 151-156 (α7); 157; 160, 164 (α8);
97; 98-108, 110-112 (α5); 114, 116-118;

critical nodes
D55, S165, Y168
L83, E84, T95, Q147, G148
F109, N134, F143, D146
R71, E80, Y159, F162
Q136, D144
Q136, D144
K100, H106

Table F.7: Communities and critical nodes for RGS8C89/I2 (PDB: 2ODE (residue 46-176): 47-52 (α1); 57-61 (α2); 64-76 (α3);
80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)).

APPENDIX F. SUPPORTING INFORMATION FOR CHAPTER 6

194

community #
C1
C2
C3
C4
C5
C6
C7

residue membership
46; 47-51 (α1);
81-91 (α4); 93, 94, 96; 112 (α5); 119, 121; 145-152, 154, 156 (α7);
124; 126, 127, 129-134 (α6); 135-143; 144 (α7);
65, 68-76 (α3); 77-79; 80 (α4); 167 (α9);
52 (α1); 53-56; 57-61 (α2); 62-63; 64, 66, 67 (α3); 155 (α7); 159 (α8);
153 (α7); 157; 158, 160-164 (α8); 165; 166, 168-174 (α9); 175, 176;
92 (α4); 95, 97; 98-112 (α5); 113-118, 120, 122; 125, 128 (α6);

critical nodes
A50
L83, F85, Q147, M154
F143
F70, M167
R52, V67, Y159
L153, S158, F162, D170
I108, F109, N122

Table F.8: Communities and critical nodes for RGS8W T /I1 (PDB: 2ODE (residue 46-176): 47-52 (α1); 57-61 (α2); 64-76 (α3);
80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)).
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community #
C1
C2
C3
C4
C5
C6
C7
C8

residue membership
46; 47-52 (α1); 53-55;
81, 82, 84-91 (α4); 93, 94, 96; 121, 123;
124; 125-134 (α6); 135-138;
56; 58-61 (α2); 62, 63; 64-76 (α3); 77-79; 80, 83 (α4); 154 (α7); 162 (α8);
139-143; 144-150, 152 (α7);
57 (α2); 122; 151, 155, 156 (α7); 157, 158-161, 163, 164 (α8); 165;
92 (α4); 95, 97; 98-112 (α5); 113-120;
166-174 (α9); 175, 176;

critical nodes
A50, A54, D55
N82, W86, C89, I123
Q126, T131, E137
S56, L61, M154, F162
S139, L140, F143, Q147, V150
N122, H151, Y159, R164, S165
F92, I108, F109, E120
K166, M167, Y168, L172

Table F.9: Communities and critical nodes for RGS8W T /I2 (PDB: 2ODE (residue 46-176): 47-52 (α1); 57-61 (α2); 64-76 (α3);
80-92 (α4); 98-112 (α5); 125-134 (α6); 144-156 (α7); 158-164 (α8); 166-174 (α9)).
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